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Spermatogenesis is a complex process of male germ cell development from  
 
diploid spermatogonia to haploid fertile spermatozoa. Apoptosis plays a vital  
 
role in limiting cell numbers and eliminating defective germ cells. This requires  
 
novel gene products, and precise and well-coordinated programmes of gene  
 
expression. It is therefore possible that a disruption of transcription factor  
 
function would significantly impact germ cell development.  
 
 
The present work was undertaken to use Staput separation followed by culture  
 
of purified germ cells of rodent testis since mammalian spermatogenesis cannot  
 
yet be recreated in vitro. Specificity of separation was assessed using  
 
immunocytochemistry  to  identify  spermatogonia,  spermatocytes  and  
 
 
spermatids. The genotoxins H2O2, doxorubicin, N-ethyl-N-nitrosourea, N-methyl-  
 
N-nitrosourea,  6-mercaptopurine,  5-bromodeoxyuridine,  methyl  
 
methanesulphonate and ethyl methanesulphonate were investigated.  
 
 
Cells were cultured and treated with different concentrations for each agent.  
 
DNA damage and apoptosis were measured by Comet and TUNEL assays  
 
 
I 
respectively. Up-regulation of expression of the transcription factors Tbpl1,  
 
FHL5 and Gtf2a1l that are important post-meiotically, were examined using RT-  
 
PCR and qPCR. Protein production was evaluated using Western blotting.  
 
 
Tbpl1, FHL5 and Gtf2a1l were cloned in-frame into the inducible expression  
 
vector pET/100-TOPO. The recombinant clones were induced and successful  
 
expression of the proteins in E. coli was confirmed by SDS-PAGE and Western  
 
blotting. The recombinant clones obtained were used to demonstrate genotoxin  
 
induced impairment of gene expression.  
 
 
Thus, Staput-isolated rodent testicular germ cells seem to be a suitable model  
 
to study genotoxicity in vitro yielding result comparable to those reported in vivo.  
 
Furthermore, the work shows that genotoxins can impair gene expression.  
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1.1 Background  
 
 
During  spermatogenesis  the  male  germ  cell  undergoes  complex  
 
morphological, biochemical and physiological changes, resulting in the  
 
formation of a mature spermatozoon (Dadoune, 2003). Major modifications in  
 
both cytoplasmic and nuclear structures continue during spermatogenesis as  
 
stringent chronological and stage-specific gene expression is a precondition  
 
for the correct differentiation of round spermatids into mature spermatozoa.  
 
As spermatogenesis progresses, there is an extensive reorganization of the  
 
haploid genome and subsequently widespread DNA condensation (Steger,  
 
1999, Hecht, 1998, Xie et al., 2007). It is now known that the testis has  
 
specialised  transcription  complexes  that  organize  the  differentiation  
 
programme of spermatogenesis, which includes the up-regulation of  
 
expression of TATA-binding protein (TBP) family and its cofactors (Kimmins  
 
et al., 2004). The transcriptional and post-transcriptional regulation of gene  
 
expression during post-meiotic male germ cells is vital and many controlling  
 
proteins have been identified that are fundamental for these processes to  
 
occur correctly (Tanaka and Baba, 2005, O'Bryan and de Kretser, 2006).  
 
These proteins are transcription factors and it is their fundamental role as  
 
critical control elements of cell growth, differentiation, and programmed cell  
 
death (apoptosis) that has stimulated a rising interest in them as possible  
 
pharmaceutical targets for therapeutic intervention in various diseases,  
 
including cancer (Karamouzis et al., 2002). Post meiotic factors such as  
 
germ cell nuclear factor (GCNF) have been proposed as targets for  
 
pharmaceutical invention as male contraceptive (Ivell et al., 2004).  
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Reproductive and developmental disorders are increasingly important areas  
 
of toxicology. Identified causes of such disorders include maternal metabolic  
 
imbalances, as well as therapeutic, and environmental exposure of the  
 
developing germ cells or embryo/foetus to damaging chemicals and physical  
 
agents. Although considerable progress has been made in determining  
 
causes, the aetiology of the majority of birth defects is unknown or only  
 
poorly established (Achermann et al., 2002). It has yet to be understood how  
 
toxicological mechanisms leading to congenital defects operate and what is  
 
the role of the genetic and environmental factors in triggering such  
 
mechanisms (Hood, 2006). Thus, it is clear that both mechanistic studies of  
 
known developmental toxicants and the toxicological assessment of  
 
pharmaceutical agents, industrial chemicals and environmental pollutants, to  
 
which pregnant women may be exposed, will be of importance in the future.  
 
Gametogenesis is an extremely important biological process that is sensitive  
 
to toxic insult (Adler, 2000, Iona et al., 2002). It is well established from  
 
animal models that germ cells affected by chemicals during maturation can  
 
result infertility, cancer in the offspring, and negative effects on the  
 
development of offspring. Certain mutagens, for example, produce heritable  
 
gene mutations and heritable structural and numerical chromosomal  
 
aberrations in germ cells (Allen et al., 1986, Janes et al., 2001).The  
 
consequences of germ cell mutation for subsequent generations include the  
 
following: genetically determined phenotypic alterations without signs of  
 
illness; reduction in fertility; congenital malformations with varying degrees of  
 
severity; and genetic diseases with varying degrees of health impairment  
 
(Brinkworth, 2000).  
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However, many defence mechanisms exist in order to maintain the integrity  
 
of germ cells; for example, proper chromosome synapsis and correct repair  
 
of DNA double strand breaks. They are vital during meiotic cell division in  
 
order to maintain germ cell integrity (Xu et al., 2012). Another defence  
 
mechanism against the induction of genetic damage in germ cells is  
 
apoptosis itself. Programmed cell death is an active process that controls cell  
 
numbers in several tissues and is involved in morphogenesis during  
 
embryonic development and throughout adult life (Raff et al., 1993,  
 
Schwartzman and Cidlowski, 1993, Williams, 1991, Elmore, 2007). Apoptosis  
 
also occurs spontaneously at a variety of phases of germ cell development  
 
and has been shown to play a major role during spermatogenesis (Bartke,  
 
1995, Shaha et al., 2010). Germ cells are highly specialized cells that are  
 
responsible for the propagation of DNA to direct the development of future  
 
generations. Therefore, to ensure the continuation of the species, it is  
 
essential for organisms to maintain the integrity of germ cell DNA. Previous  
 
studies have shown that spermatogenic cells have higher mutation frequency  
 
than somatic cells (Walter et al., 1998, Winn et al., 2000). As a result, any  
 
increase in this rate as a result of toxic exposure increases the risk of  
 
adverse outcomes even higher than somatic cells. Male germ cells may be  
 
vulnerable to damage via chemical toxicants in mitotic spermatogonial cells,  
 
meiotic germ cells spermatocytes, post meiotic spermatids and spermatozoa  
 
under maturation in the epididymis. This could affect the production and  
 
integrity of the mature sperm; in addition, both single stranded and double  
 
breaks might occur in the DNA (Delbes et al., 2010).  
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1.2 Spermatogenesis  
 
 
Spermatogenesis is a complex process of proliferation and differentiation of  
 
male germ cells to create fertile spermatozoa. Spermatogenesis happens in  
 
the seminiferous epithelium and the process of spermatozoa formation is  
 
organised into three distinct phases; mitotic proliferation of spermatogonia,  
 
meiosis in which the diploid spermatocytes undergo two divisions to form  
 
four haploid spermatids, and spermiogenesis which involves a stepwise  
 
maturation of the spermatids to mature spermatozoa. The landmark changes  
 
occurring during spermiogenesis include condensation of chromatin,  
 
formation of the acrosome and the removal of the excess cytoplasm at the  
 
time of spermiation (Eddy, 2002). This process involves complex signaling  
 
mechanisms that regulate gene expression and post-transcriptional and  
 
post-translational modifications during spermatogenesis. These factors  
 
include both paracrine and autocrine (from Sertoli and germ cells) and  
 
endocrine (e.g. androgens, retinoic acids) factors (Hess R, 2005, White-  
 
Cooper and Davidson, 2011).  
 
 
 
1.2.1  Developmental spermatogenic stages and cycle  
 
 
Spermatogenesis in mammals has a synchronized, cyclic form where the  
 
cellular sequence of differentiating germ cells and their intimate, physical  
 
association with Sertoli cells are preserved in a continuous and repeated way  
 
(de Rooij and Russell, 2000). Utilizing this information, the seminiferous  
 
epithelium can be classified into different 'stages' based on the cellular  
 
complement present in a given segment of seminiferous tubule (Figure 1.1).  
 
Assessment of these cellular relations has identified 12 stages of the  
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seminiferous epithelium in mice and 14 stages in rats (Oakberg, 1956,  
 
Leblond and Clermont, 1952, Hermann et al., 2010). Figure 1.1 shows  
 
stages of spermatogenesis and the duration of the spermatogenic cycle.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Diagram showing the cycle of the germ cells. Taken from Bloom  
 
and Fawcett (1975).  
 
 
1.2.2  Sertoli cells  
 
 
Sertoli cells (SCs) are the epithelial supporting cells of the seminiferous  
 
tubules. The SCs play a central role in test is development and  
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spermatogenesis (Johnson et al., 2008). They facilitate the progression of  
 
spermatogenesis to spermatozoa by direct contact and by regulating the  
 
microenvironment in the seminiferous tubules (Griswold, 1998, Johnson et  
 
al., 2008). Moreover, they deliver structural support and nutrition to  
 
developing spermatogenic cells, undertake phagocytosis of degenerating  
 
germ cells and residual bodies, allow release of (maturation phase)  
 
spermatids at spermiation and making of a host of proteins that help control  
 
spermatogenesis in response to pituitary hormones, in particular by  
 
stimulating the mitosis in spermatogonial cells (Bellve and Zheng, 1989,  
 
Buch et al., 1988, Johnson et al., 2008).  
 
 
1.2.3  Spermatogonia  
 
 
The spermatogonial stem cell is an undifferentiated germ cell that preserves  
 
the balance of self‐renewal and differentiation in germ cells in order to  
 
ensure progressive creation of gametes in adult male (Hermann et al., 2010).  
 
Spermatogonia lie at the interface of the blood testes barrier and the  
 
extracellular milieu. Many cells, including Sertoli cells, myoid cells and Leydig  
 
cells contribute to the microenvironment necessary for the correct  
 
development of SSCs (Hermann et al., 2010, Cheng and Mruk, 2012).  
 
Spermatogonial stem cells (SSCs) undergo a number of mitotic divisions in  
 
giving rise to differentiating spermatogonia that are committed to meiosis and  
 
germ cell formation. In mice and rat three different types of SSCs have  
 
recognized depended on cell and nuclear morphology (Hermann et al., 2010,  
 
 
Monesi, 1962, Phillips et al., 2010). These are A  single  (As); A  paired  (Ap); A  
 
aligned  (Tegelenbosch and Derooij, 1993, Oakberg, 1970). In non-primate  
 
mammals (mice), A-single (As) spermatogonia are the stem cells of  
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spermatogenesis. As spermatogonia are single cells that upon mitosis can  
 
divide into two new stem cells. A-paired (Apr) spermatogonia produce  
 
daughter cells that remain connected by an intercellular bridge. The Apr  
 
spermatogonia are predestined to develop further along the spermatogenic  
 
line and to divide into chains of four A-aligned spermatogonia (de Rooij,  
 
2001).  
 
 
There  are  some  well  characterized  markers  of  stem  progenitor  
 
spermatogonia and (Asingle, Apaired and Aaligned such as GFR1 and cKIT.  
 
However, in the two primates different pools of cells have recognized these  
 
 
are A  dark  (dark staining nucleus) and A  pale  (pale staining of nucleus). It is  
 
believed that A  dark  aids as the reserve pool which the true progenitors much  
 
alike the As; A paired , while in the mouse and rat as A  pale  which aid as the  
 
one that gives rise to the differentiated for B1‐spermatogonia (White-Cooper  
 
and Bausek, 2010, Grisanti et al., 2009, Waheeb and Hofmann, 2011).  
 
 
1.2.4  Spermatocytes  
 
 
Spermatocytes are the largest spermatogenic cells. They have a round  
 
shape with a large round nucleus that has a distinct chromatin network,  
 
thread-like appearance characteristic of entrance into cells division  
 
(Manochantr et al., 2003). After their formation, they enter the prophase of  
 
the first meiotic division. In this prophase, the cell passes through 5 sub-  
 
phases: preleptotene, leptotene, zygotene, pachytene and diplotene, taking  
 
about 22 days in mice. Primary spermatocytes replicate their DNA as  
 
preleptotene  spermatocytes  and  therefore  are  2N  (46  [44+XY]  
 
chromosomes) but have 4C DNA content. This first meiotic division gives rise  
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to smaller cells called secondary spermatocytes. These have less dense  
 
nuclear chromatin with only 23 chromosomes and are therefore haploid  
 
despite having 2C DNA. They have a short life, enter the second meiotic  
 
division quickly, and are hence relatively rare in the seminiferous epithelium.  
 
Division of the secondary spermatocytes results in spermatids (Ogura et al.,  
 
1998, Ogura et al., 1997, Tanaka et al., 2003).  
 
 
1.2.5  Spermatids  
 
 
Initially, spermatids are small, round cells with a small round nucleus  
 
containing areas of condensed chromatin. They contain 23 chromosomes  
 
with 1C DNA content. Spermatid differentiation is a complex process called  
 
spermiogenesis, involving the formation of the acrosome, chromatin  
 
condensation, elongation of the nucleus, development of the flagellum, and  
 
loss of excess cytoplasm into structures called residual bodies. In mouse, the  
 
development of the acrosome of spermatids is divided into four phases which  
 
include the Golgi stage, cap stage, acrosomal stage and the maturation  
 
stage (Vernet et al., 2012). Throughout the Golgi stage, many pro-acrosomic  
 
granules are deposited in Golgi vesicles followed by clustering in the vesicle  
 
into a single acrosomic granule, which associates with the nuclear envelope.  
 
Within the subsequent cap and acrosomal stage, the acrosome increases in  
 
size as a result of fusion of extra Golgi-derived vesicles and spreads over the  
 
anterior nuclear pole. The acrosome covers two thirds of the nucleus at the  
 
end of the acrosomal stage and achieves its definitive hook shape during the  
 
maturation phase. During the maturation phase, virtually all the cytoplasm is  
 
shed as residual bodies and phagocytosed by Sertoli cells. The spermatids  
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are in effect immature spermatozoa by now and are released into the lumen  
 
of the tubule (Oakberg, 1956b, Vernet et al., 2012).  
 
 
Most of the divisions of spermatogonial cells are unfinished regarding the  
 
cytoplasm and thus spermatogonia, spermatocytes and spermatids remain  
 
associated with cytoplasmic bridges until maturation into spermatozoa  
 
(Braun et al., 1989). The intercellular bridges deliver a link among the  
 
primary and secondary spermatocytes and spermatids derived from a single  
 
spermatogonium via passing the interchange of information from cell to cell,  
 
these bridges play a vital role in organizing the sequence of events in  
 
spermatogenesis (Braun et al., 1989, Dym, 1994).  
 
 
1.3 Gene expression during spermatogenesis  
 
 
Spermatogenesis is a unique process that occurs in the testis and involves  
 
different phases. First, it is part of an adult's development process which  
 
begins at puberty and progresses during the reproductive life of an adult  
 
male. Second, it is a cellular and physiological procedure which includes  
 
meiosis. The meiotic phase involves cell division which happens within  
 
gametogenesis which is vital for preserving the right chromosomal  
 
complement. Third, the final outcome of the process is a cell type  
 
(spermatozoa) that is functionally and morphologically different from other  
 
cell types in the body. The fourth and final stage of spermatogenesis  
 
includes cell to cell contact, cross‐talk and elaborate signaling among them.  
 
For these phases of spermatogenesis to take place, there needs to be  
 
closely controlled regulation of gene expression. During male germ cells  
 
formation, regulation of gene expression occurs on three levels; intrinsic,  
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interactive and extrinsic control (Eddy, 2002, Kwon et al., 2014). The intrinsic  
 
process regulates which genes are used and when these genes are  
 
expressed. The unique character of this process is germ cell and stage  
 
specific gene expression. The interactive process provides vital support for  
 
germ cell proliferation and progression during the phases of development.  
 
Finally, extrinsic influences, including the steroid and peptide hormones  
 
regulate gene expression and signaling mechanism in somatic cells of  
 
seminiferous tubules which in turn modulates the activity of the germ cells  
 
(Eddy, 2002, Kwon et al., 2014).  
 
 
Furthermore, during spermatogenesis gene expression is extremely  
 
arranged and accurately regulated at two main levels, transcriptional and  
 
translational. In order to complete the progression of spermatozoa, this  
 
process requires numbers of specific transcriptional regulators and the  
 
expression of testis-specific genes or isoforms and unique chromatin  
 
remodeling (Steger, 1999, Meikar et al., 2013, Kimmins et al., 2004).  
 
Regulation of gene expression during spermatogenesis is described in  
 
details in the following section.  
 
 
1.3.1  Regulation of gene transcription during spermatogenesis  
 
 
Transcription is controlled both by epigenetic chromatin modifications and by  
 
several transcription factors that bind to the specific side of DNA sequences  
 
in the promoter regions, thus permitting alterations in chromatin structure and  
 
modulating activity of the transcriptional machinery (Steger, 1999, Meikar et  
 
al., 2013). Some transcription factors are omnipresent and control numerous  
 
genes in a variety of tissues, while others are limited in distribution and  
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control tissue-specific gene expression (Eddy, 1998, Yu et al., 2003). High  
 
levels of transcription of some genes in testicular cells are associated with  
 
the up‐regulation of general transcription factors such as TFIIB, TFIID, TBP  
 
and RNA Polymerase II and the presence of testis-specific transcription  
 
factors such as CREM (Eddy, 2002, Han et al., 2001). CREM is a c‐AMP  
 
responsive element binding protein that binds to CRE (c‐AMP response  
 
elements) on promoter of target genes of both transcriptional activators  
 
(CREM, 1, and 2) (Daniel et al., 2000, Kimmins et al., 2004). CREM is the  
 
main transcriptional activator isoform in the testis, with strong expression in  
 
spermatogenesis where it regulates expression of genes vital for  
 
spermatogenesis (Kimmins et al., 2004, Sassone-Corsi, 2000). Furthermore,  
 
some genes have been found that encode proteins with necessary roles in  
 
the specific function and structure of spermatogenic cells such as protamines  
 
and transition proteins. Transition proteins are families of extremely basic  
 
chromosomal structural proteins that consecutively substitute the histones  
 
within elongating and elongated spermatids, leading to conversion of  
 
chromatin from a nucleosomal organization to smooth fibrils (Zhao et al.,  
 
2004, Kleene, 2001). Some multi-subunit transcription factor complexes bind  
 
a varied range of regulatory elements in the promoter regions of many  
 
spermatogenesis-expressed genes instead of merely TATA box, CRE box or  
 
other specific DNA promoter sequences used in somatic cells.  
 
 
DNA methylation is a process that requires conserved DNA sequences at  
 
cytosine bases to be converted to 5-methylcytosine by DNA methyl  
 
transferase (DNMT) enzymes (Suzuki and Bird, 2008). Methylation is thought  
 
to play a vital role in containing gene expression, probably by blocking the  
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promoters at which activating transcription factors would bind. Disturbance of  
 
proper DNA methylation shows that it is fundamental for cell differentiation  
 
and in modulating gene expression with increased methylation of promoters  
 
generally correlating with low or no transcription (Suzuki and Bird, 2008).  
 
Although methylation patterns can be influenced by exogenous signals, in  
 
spermatogenic cells, it is mainly determined by the intrinsic genetic  
 
programme of the cell (Estecio and Issa, 2011).  
 
 
1.3.2  Regulation of translation during spermatogenesis  
 
 
Regulation of translation is an essential feature of gene expression in meiotic  
 
and haploid spermatogenic cells in mammals (Kleene, 2003). Translational  
 
regulation of nucleoprotein transcripts has been shown to be important for  
 
control of the expression of transition proteins, protamines and other post-  
 
meiotically expressed factors (Kleene, 2003, Steger et al., 1998). The genes  
 
for protamines and transition proteins are transcribed in both round and  
 
elongating spermatids (Steger et al., 2000). The mRNAs transcripts of  
 
transition protein and protamines are stored for several days as  
 
ribonucleoprotein (MRNP) and are then translated in elongating and  
 
elongated spermatids (Kleene, 1996, Dadoune, 1995, Tseden et al., 2007). It  
 
has been shown that, in haploid spermatids, virtually every mRNA displays  
 
evidence of translational repression. This involves protein repressors which  
 
bind to the poly-A tail or specific RNA sequences located in the 3'-UTR  
 
(Steger, 1999, Steger et al., 2000). For example, Studies in transgenic mice  
 
have shown that a sequence in the last 62 nucleotides of the 3' untranslated  
 
region UTR regulates translation of protamine 1 mRNA in spermatids  
 
(Kleene, 2003, Braun et al., 1989).  
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1.3.3  TATA binding protein family  
 
 
Differentiation of spermatids involves upregulated expression of the TATA-  
 
binding protein (TBP) family and its associated cofactors (TBP) family  
 
(Kimmins et al., 2004). TBP is a part of the general transcriptional machinery  
 
that is involved in transcription from three distinct nuclear RNA polymerases,  
 
each of which requires a unique set of general transcription factors  
 
(Hernandez, 1993, Lescure et al., 1994, Koster and Timmers, 2014). TBP  
 
was discovered as the key component of the transcription factor TFIID  
 
complex, mediating contact with the core promoter by interaction with the  
 
TATA-box (Kao et al., 1990, Blair et al., 2012). In addition, it was found to  
 
mediate DNA contact in the SL1 complex and the TFIIIB complex during  
 
transcription of rRNAs via RNA polymerase I (Hernandez, 1993, Knutson  
 
and Hahn, 2011). Additionally, other members of the TBP-family were  
 
identified, first termed the TBP related factors (TRFs), which are especially  
 
found in metazoa (Dantonel et al., 1999, Sepe et al., 2011). They function in  
 
some complexes involved in core promoter recognition and assembly of the  
 
pre-initiation complex. As a result of gene duplication, eukaryotes have  
 
expanded their repertoire of TATA-binding proteins, leading to a variable  
 
composition of the transcription machinery. In vertebrates, this repertoire  
 
consists of TBP, TBP-like factor (TLF) and TBP2. All three factors are  
 
essential, with TLF and TBP2 playing a significant role in development and  
 
differentiation, specifically gametogenesis and early embryonic development,  
 
while TBP dominates somatic cell transcription. TBP-related factors might  
 
compete for promoters when co-expressed, but also show preferential  
 
interactions with subsets of promoters. Initiation factor switching occurs as a  
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result of differential expression of these proteins in gametes, embryos and  
 
somatic cells. Paralogs of TFIIA and TAF subunits account for additional  
 
variation in the transcription initiation complex. This variation in core  
 
promoter recognition accommodates the expanded regulatory capacity and  
 
specificity required for germ cells and embryonic development in higher  
 
eukaryotes (Akhtar and Veenstra, 2011).  
 
 
1.3.4  TATA box binding protein-like 1 (Tbpl 1)  
 
 
Tbpl 1 is a protein usually thought to belong to the general transcription  
 
initiation complex (Martianov et al., 2002).The rule of transcription initiation  
 
by RNA polymerase II (Pol II) is vital to any developmental process.  
 
Nevertheless, there are different types of TATA-binding protein like factor  
 
(TLF) between metazoan species, from C.elegans to human (Dantonel et al.,  
 
1999, Koster and Timmers, 2014). These include: TLF (Kaltenbach et al.,  
 
2000, Akhtar and Veenstra, 2011), TBP related factor 2 (TRF2) (Rabenstein  
 
et al., 1999, Duttke et al., 2014), TRF and TBP related protein (TRP) (Li et  
 
al., 2014 , Moore et al., 1999, Maldonado, 1999); TLF is similar in sequence  
 
to TBP but has a unique distribution in spermatogenesis. Transcription  
 
reactions in vitro have clearly demonstrated that TLF is unable to substitute  
 
for TBP (Moore et al., 1999, Verma et al., 2013) due to variations in the DNA  
 
interaction region (Berk, 2000). TLF does interact however with the general  
 
transcription factors TFIIA and TFIIB, and has been demonstrated to bind the  
 
pes-10 promoter (Kaltenbach et al., 2000). Overexpression of TLF in human  
 
cells can lead to reciprocal regulation of the NF1 and c-fos genes. As the  
 
TATA-less NF1 gene is directly up-regulated; the TATA-dependent c-fos  
 
gene is repressed by the overexpression of TLF (Chong et al., 2005b). TLF  
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has been found to be part of a complex with DNA replication-related element  
 
binding factor (DREF). Certainly, the DREF/TLF complex is demonstrated to  
 
control the DRE-element involving an upstream promoter in the tandem  
 
promoter of the Drosophila PCNA gene (Hochheimer et al., 2002). An  
 
additional target is the histone H1 promoter, which is exclusively regulated by  
 
TLF, while the core histones (H2A, H2B, H3 and H4) in the tandemly  
 
arranged Drosophila histone gene cluster are regulated in a TBP-dependent  
 
manner. DREF is unable to co-localize with TLF at the histone cluster  
 
suggesting the existence of a distinct TLF-containing promoter recognition  
 
complex (Isogai et al., 2007). However, TLF shows redundancy in ear ly  
 
embryogenesis in mouse as TLF knockout mice are viable. The males are  
 
infertile due to late arrest in spermiogenesis, which is concordant with the  
 
differential expression of TLF in humans and mice whereby high post-meiotic  
 
expression levels are seen (Martianov et al., 2001).  
 
 
1.3.5  Four and a half LIM domains 5 (FHL5)  
 
 
The transcriptional regulation of postmeiotic genes follows highly specific  
 
rules that seem to be unique to male germ cells (Sassone-Corsi, 2002, Gan  
 
et al., 2013). CREM has been described as a master switch for numerous  
 
postmeiotic genes, and its function involves some components of the general  
 
transcription machinery, such as transcription factor IIA (De Cesare et al.,  
 
2003, Wu et al., 2010) and a testis-specific co-activator, ACT (Fimia et al.,  
 
1999). ACT, activator of cAMP-responsive element modulator in testis is a  
 
LIM-only protein that interacts with transcription factor CREM in postmeiotic  
 
male germ cells and enhances CREM-dependent transcription. CREM  
 
regulates many crucial genes required for spermatid maturation, and  
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targeted mutation of the Crem gene in the mouse germ-line blocks  
 
spermatogenesis (Fimia et al., 1999, Wu et al., 2010). The CREM has been  
 
shown to bind Fhl5 which is specially expressed in meiotic spermatocytes  
 
and extremely persuaded into the post-meiotic round spermatids (Lardenois  
 
et al., 2009). Fhl5 is a protein having four and a half LIM domains which are  
 
protein-protein interaction motifs that form numerous factors needed for  
 
physiological processes such as transcription and signal transduction  
 
(Blendy et al., 1996, Kimmins et al., 2004). In yeast and mammals,  
 
transfection assay using heterologous promoter constructs has shown that  
 
FHL5 protein mediated strong reporter gene expression. Furthermore, FHL5  
 
has been found to be dynamic with its pattern of nuclear and cytoplasmic  
 
localization throughout early and late phases of spermiogenesis, which is  
 
mediated by direct interaction with the Kif17b kinesin motor protein (Fimia et  
 
al., 1999, Macho et al., 2002).  
 
 
During the postmeiotic phase of spermatogenesis, a testis specific protein is  
 
required: Activator of CREM in the Testis (ACT), which allows stage-specific  
 
activation of CREM and thus induction of gene expression (Cheng, 2008,  
 
Lardenois et al., 2009). Both ACT and the transcription factor CREM are  
 
essential for the temporal control of gene expression (Fimia et al., 2000).  
 
Transcriptional activation of those genes is principally regulated by the  
 
transcription factor CREM, activates phosphorylation, which in turn by its co-  
 
activator ACT (Fimia et al., 1999, Wu et al., 2010). It has been found that for  
 
normal spermatogenesis, the correct expression of ACT and the CREM-  
 
regulated gene expression pathway is crucial (Nantel et al., 1996, Liu et al.,  
 
2010). Sub-cellular localisation of ACT is regulated by a kinesin motor  
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protein (KIF17b), which interacts with ACT in haploid spermatids. This allows  
 
ACT to be transported from the nucleus to the cytoplasm at particular steps  
 
of spermatids development (Wong-Riley and Besharse, 2012, Kotaja et al.,  
 
2004). ACT is detected in both the nucleus and cytoplasm of the elongating  
 
spermatids (Macho et al., 2002, Wong-Riley and Besharse, 2012) and it  
 
plays a major role in the regulation of the expression of protamines and other  
 
key spermiogenesis proteins (Carrell et al., 2007).  
 
 
Thus, there have been a number of transcription factors identified, which play  
 
a crucial role in the transcriptional activation of genes in haploid spermatids;  
 
unfortunately, due to the lack of any spermatid cell lines many questions  
 
concerning haploid gene expression are still unanswered (Bukowska et al.,  
 
2013, Bellefroid et al., 1998, Cunliffe et al., 1990, Lee et al., 1996). Many  
 
genes with essential functions in spermatogenesis contain the cAMP  
 
response element in their proximal promorter (Sassone-Corsi, 1998, Liu et  
 
al., 2010). This recognizes via the CREM modulator, a main regulator of  
 
gene expression in germ cells (Masquilier et al., 1993, Kimmins et al., 2004,  
 
VanGompel and Xu, 2010).  
 
 
1.3.6  General transcription factor IIA, 1-like (Gtf2a1l)  
 
 
ALF (TFIIA alpha/beta-like factor) is a germ cell-specific counterpart of the  
 
large (alpha/beta) subunit of the general transcription factor TFIIA. This  
 
factor is able to interact with the small TFIIA subunit ( ) to form a  
 
heterodimeric complex that stabilizes binding of TBP to promoter DNA  
 
(Upadhyaya et al., 2002, Akhtar and Veenstra, 2011). It binds specific DNA  
 
sequences to control the transcription of genetic information from DNA to  
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mRNA. This protein contributes to post-meiotic gene expression during  
 
spermatogenesis as a regulator of transcription. Transcription factors place  
 
RNA polymerase at the start of protein coding sequences. Subsequently the  
 
polymerase is released to transcribe the mRNA. ALF is generally expressed  
 
and transcriptionally up-regulated in male germ cells (Han et al., 2001,  
 
Upadhyaya et al., 2002). Previous work has demonstrated that the  
 
expression of ALF is restricted to male germ cells in the testis of mice and  
 
humans (Upadhyaya et al., 1999, Ozer et al., 2000), specifically in the  
 
pachytene stage of meiosis I along with a number of other transcription  
 
factors (Han et al., 2001). However, biochemical characterization of  
 
recombinant ALF-TFIIA and TFIIA/-TFIIA complexes did not reveal  
 
significant differences in vitro (Upadhyaya et al., 2002), and it remains  
 
unclear what specific role ALF might play during germ cell development  
 
(Huang et al., 2006).  
 
 
Expression of ALF protein and investigation of its function in the testis of  
 
mouse make it valuable for the study of male infertility as many different  
 
defects in the protein can damage sperm production (Huang et al., 2006).  
 
ALF is an interesting model for the study of gene regulation in germ cells  
 
because its developmentally regulated expression through the pachytene  
 
stage of meiotic prophase in males parallels that of other germ cell-specific  
 
transcription factors (Schmidt and Schibler, 1995, Han et al., 2001, Catena et  
 
al., 2005).  
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1.3.7  Mechanism of transcription regulation factors during male germ  
 
cells  
 
 
Transcription factors of the cAMP-response-element binding protein (CREB)-  
 
CREM family, target genes with cAMP response element containing the  
 
palindromic consensus sequence TGACGTCA (Sassone-Corsi et al., 1988).  
 
CREM is a key regulatory gene for spermatogenesis. In vivo, CREM is  
 
regulated by the secretion of follicle stimulating hormone (FSH) as  
 
demonstrated in rats and golden hamster (Foulkes et al., 1993). Activation of  
 
CREM results in downstream phosphorylation of protein kinase A or mitogen  
 
activated protein kinases (MAPKs). Phosphorylation of CREM at serine 117  
 
results in interaction with co-activators which link CREM to the transcription  
 
machinery through TFIIB, which are core proteins of the preinitiation complex  
 
(Foulkes et al., 1993). The activity of CREM is enhanced through association  
 
with the LIM-only protein, activator of CREM in the testis (ACT). The CREM-  
 
ACT pair is regulated by a kinesin protein named KIF17b, which is similar to  
 
an isoform found in the brain, KIF17 (Macho et al., 2002). The cellular  
 
distribution of KIF17b and ACT are spermatogenic-stage-specific. They are  
 
both present in the nucleus in the round spermatid stage and are both in the  
 
cytoplasm at stage VIII in elongated spermatids. This suggests that KIF17b  
 
regulates the transcription of CREM by removing ACT from the nucleus. This  
 
assertion is supported by the inhibition of the expression of CREM target  
 
genes by KIF17b through sequestration of ACT in the cytosol (Macho et al.,  
 
2002). CREM is a key regulator of transcription in male germ cells in  
 
association with general transcription initiation complex. Transcription is  
 
initiated by basal transcription factors (TFIIA, B, D, E) and their associated  
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factors- TBP-associated factors (TAFs) through interaction with the promoter  
 
elements which includes a TATA-box. All proteins aggregating at the TATA  
 
box are referred to as TATA-box binding proteins (TBPs). TBP is important  
 
but not essential for RNA polymerase II interaction with the promoter and  
 
initiation of transcription (Wieczorek et al., 1998). While TFIIA/-like factor  
 
is expressed in the testis, TFIIB, TBP and RNA polymerase II are highly  
 
expressed in round spermatids (Kimmins et al., 2004). TBP-like factor (TLF)  
 
has sequence similarity with TBP but cannot substitute for TBP. TLF  
 
interacts with TFIIA and TFIIB at the pes-10 promoter. This has been linked  
 
to a possible role in gene transcription from a TATA-less promoter, a feature  
 
of CYP51, a post-meiotic CREM target gene (Kaltenbach et al., 2000). TFIID,  
 
a component of the TBP complex is essential for the transcription of protein  
 
coding genes. TAF7L, a testis specific paralogue of TAF7 associates with  
 
TFIID (Bhattacharya et al., 2014). TAF7 and TAF7L have mutually exclusive  
 
roles; while TAF7 is found in the nucleus in developing germ cell and in late-  
 
pachytene stage, TAF7L appears in the nucleus as TAF7 moves to the  
 
cytosol and remains in the nucleus until transition to elongating spermatids  
 
(Kimmins et al., 2004).  
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Figure 1.2: Transcription initiation complexes that organize spermiogenesis.  
 
Adapted from Kimmins et al., (2004).  
 
 
1.4 Genotoxicity  
 
 
Genotoxins are a large group of substances that induce changes to the  
 
structure and/or function of genes by chemical interaction with DNA and non-  
 
DNA targets (Maurici et al., 2005).  
 
 
Male reproductive genotoxins are chemicals that can affect reproductive  
 
competence in the male via genetic damage, apoptosis or mutation in the  
 
gametes. They may cause fertility impairment and may also be risk factors  
 
for developmental defects and heritable diseases in the offspring. This latter  
 
process is known as male-mediated teratogenesis (Anderson et al., 2014,  
 
Anderson, 2005). There is rising concern over the possible heritable effects  
 
 
 
 
22  
of chemical mutagens used as anticancer drugs (Witt and Bishop, 1996,  
 
Vilarino-Guell et al., 2003).  
 
 
1.4.1  DNA damage  
 
 
DNA damage is broadly divided into two major classes, endogenous DNA  
 
damage and exogenously or environmentally-induced DNA damage.  
 
Endogenous DNA damage includes the DNA damage caused by free  
 
radicals or alkylating agents endogenously generated during cellular  
 
metabolism, hydrolytic damage and DNA replication errors and chemical  
 
mutagens. Environmentally-induced DNA damage refers to that caused by  
 
physical and chemical agents generated outside the cell (Tuteja et al., 2001,  
 
Rastogi et al., 2010). There are many different types of DNA damage and  
 
some examples are shown in Figure 1.3.  
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Figure 1.3: Different types of DNA damage that can occur after exposure to  
 
chemicals or radiation  (From http://www.radiation-scott.org/radsource/3-  
 
0.htm, accessed on 23/01/2015).  
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1.4.1.1 Types of DNA damage  
 
 
1.4.1.1.1 Oxidation  
 
 
Oxidative DNA damage includes reactive oxygen species (ROS).  ROS  
 
readily attack DNA and can produce many types of DNA lesions, such as  
 
oxidized DNA bases, basic sites, and both single-(SSB) and double-strand  
 
DNA breaks (DSB), which, if they eventually involve damage to DNA repair  
 
enzyme genes, can lead to genomic instability (Evans et al., 2004, Krokan et  
 
al., 1997). DNA oxidation by ROS that are generated during the cells via  
 
normal aerobic metabolism is one of the most common types of endogenous  
 
DNA damage (Wang et al., 2013). ROS react with nucleic acids and proteins,  
 
producing oxidative damage to these macromolecules (Chakravarti and  
 
Chakravarti, 2007, Karihtala and Soini, 2007). The most reactive ROS is the  
 
hydroxyl radical. This can cause the oxidation of DNA bases; the most  
 
common adduct formed is 7, 8-dihydro-8-oxo-deoxyguanosine (8-oxodG)  
 
(Dizdaroglu et al., 2002).  It is an extremely mutagenic lesion that in  
 
consequence leads to G: C to T: A transversions (Grollman and Moriya,  
 
1993, Wang et al., 2013). In addition, the hydroxyl radical can react with  
 
adenine in a similar way to guanine, however this lesion is far more  
 
uncommon in DNA damage than 8-oxodG. If unrepaired, the 8-oxodG base  
 
will no longer pair with cytosine but instead pairs with adenosine and is  
 
replaced with a thymine at the next round of DNA replication (Russo et al.,  
 
2004). Damage caused by ROS can be neutralized by raised antioxidant  
 
defenses, which include superoxide dismutase, glutathione peroxidase and  
 
catalase to scavenge ROS and convert it to nontoxic forms (Alexeyev, 2009).  
 
Many studies have reported that oxidative damage is common in sperm and  
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testicular DNA (Wellejus et al., 2000, Tremellen, 2008, Kushwaha and Jena,  
 
2012). Furthermore, it has been found that the level of damage in terms of  
 
(8-oxodG) is closely associated with male infertility (Loft et al., 2003,  
 
Wellejus et al., 2004).  
 
 
There are two step theories for the origins of DNA damage in the male germ.  
 
This theory suggests that an extensive diversity of clinical and environmental  
 
factors is susceptive, alone or in combination, of making oxidative stress in  
 
the testes (Aitken and Koppers, 2011). During step one, oxidative stress  
 
damages spermiogenesis resulting in the making of faulty spermatozoa  
 
having poorly protaminated chromatin (Aitken and Koppers, 2011). These  
 
faulty spermatozoa have a propensity to default to an apoptotic cascade that  
 
includes the generation of ROS via the sperm mitochondria (Aitken and  
 
Koppers, 2011). During the step two, these ROS attacks the poorly changed  
 
chromatin making oxidized DNA base adducts (8OHdG) that eventually  
 
results in DNA strand breakage and cell death (Aitken and Koppers, 2011,  
 
De Iuliis et al., 2009, Irvine et al., 2000) as shown in Figure1.4.  
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Figure 1.4: Two step theories for the origins of DNA damage into the male  
 
germ line. Adapted from Aitken and Koppers (2011).  
 
 
 
1.4.1.1.2 Alkylation  
 
 
Alkylation is the transfer of an alkyl group from one molecule to another,  
 
leading to a base alteration, with the simplest type of modification being  
 
methylation. Alkylation is accomplished by an alkyl electrophile, alkyl  
 
nucleophile or sometimes as alkyl radical (Gocke et al., 2009, Drablos et al.,  
 
2004a).  
 
 
 
 
 
 
 
 
27  
Absorption of ultraviolet radiation affects adjacent thymine residues causing  
 
a DNA strand to be joined via creation of the bond resulting in thymine dimer  
 
formation (Narayanan et al., 2010).  
 
 
1.4.1.1.3 Alkylating agents  
 
 
Many alkylating agents have roles as chemotherapeutic agents against a  
 
range of experimental and human cancers (Kondo et al., 2010, Sancar et al.,  
 
2004). These agents exhibit cellular cytotoxicity as they interact directly with  
 
cellular DNA, creating a huge range of genetic alterations such as base  
 
alkylation, double- and single-DNA strand breaks and cross-linking etc  
 
(Kondo et al., 2010, Sancar et al., 2004).  
 
 
Alkylating agents represent one of the most important types of anticancer  
 
agents and play an important role in the treatment of numerous types of  
 
cancers (Kondo et al., 2010).  Exposure to alkylating agents is principal  
 
cause of DNA and RNA damage, generating adducts that can compromise  
 
genomic integrity (Drablos et al., 2004b). Formed adducts can disrupt  
 
transcription and replication, and initiate apoptosis or be mutagenic if left  
 
unrepaired (Drablos et al., 2004b, Hecht, 1999, Bahadur et al., 2005). It has  
 
even been suggested that exposure to chemotherapy is one of the causes of  
 
the alleged significant decrease in the sperm counts for the past 50 years.  
 
Male germ cells were shown to be acutely influenced via different  
 
chemotherapeutic agent (Holm et al., 2009).  
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1.4.1.1.3.1 N-ethyl-N-nitrosourea (ENU) and N-methyl-N-nitrosourea  
 
(MNU) mutagenesis  
 
 
N-ethyl-N-nitrosourea (ENU) and N-methyl-N-nitrosourea (MNU) (Figures 1.5  
 
and 1.6) are well-known, potent, direct-acting, transplacental mutagens and  
 
carcinogens (Donovan and Smith, 2010).  ENU and MNU are potent  
 
mutagens, and mainly affect spermatogonial stem cells. ENU and MNU have  
 
found be induced random point mutations in the spermatogonial stem cells at  
 
a frequency of ~150 × 10-5 per locus in mice (Russell et al., 1979).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: Structural formula of ENU  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Structural formula of MNU  
 
 
The molecular damage caused by alkylating agents is enormous. Both ENU  
 
and MNU cause DNA damage by transferring a methyl or ethyl group to the  
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oxygen or nitrogen atoms of nucleic acid bases (van Boxtel et al., 2010,  
 
Noveroske et al., 2000, Wyatt and Pittman, 2006). For example, ENU causes  
 
ethylation of the bases in DNA at the 7-N and the 6-O positions. When 7-  
 
ethylguanine is produced, it pairs with thymine to cause G: C to A: T  
 
transition mutation (Noveroske et al., 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7: Mechanism of action of ENU. A) Alkylation of thymine results in  
 
the formation of O4-ethylthymine which is recognised as cytosine and  
 
mispairs with guanine. B) Mispairing leads to the corresponding base  
 
exchange during DNA replication. Taken from Noveroske et al., (2000).  
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1.4.1.2.1.2 Methyl methanesulfonate (MMS) and ethyl methanesulfonate  
 
(EMS) mutagenesis  
 
 
Methyl methanesulfonate (MMS) and ethyl methanesulfonate (EMS) are  
 
monofunctional DNA methylation agents that chemically alter DNA and are  
 
known carcinogens (Greer and Rinehart, 2009, Beranek, 1990). Many  
 
possible reaction sites for MMS and EMS have been identified in the four  
 
bases of DNA although the different bases have different ranges of reactive  
 
sites: guanine, N1, N3, N7, N2; adenine, N1, N3, N7 and N6; and O6;  
 
cytosine, N3, N4 and O2; thymine, N3, O2 and O4 (Friedberg et al., 2006).  
 
Adducts of these chemicals can block DNA synthesis and may form  
 
mismatches leading to transition mutations (Lindahl et al., 1988). MMS and  
 
EMS mainly methylate DNA on N7-deoxyguanine and N3-deoxyadenine  
 
(Wang et al., 1992). MMS is a directly acting DNA-methylating agent  
 
effecting alkylation of base nitrogens such as 7-methylguanine, while the  
 
oxidizing agent peroxynitrite creates reactive oxygen species (ROS) and  
 
oxidized base damage such as 8-oxoguanine (Horton and Wilson, 2013).  
 
These N‐alkylations have the ability to be repaired rapidly and have a  
 
minimal potential for mutagenicity. Thus, MMS mutagenicity can occur via  
 
abasic site by ‐elimination of the N‐glycosylic bond or by a DNA glycosylase  
 
repair enzyme (Glaab et al., 1998, Seidel et al., 2004).  
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Figure 1.8: Structural formula of MMS  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9: Structural formula of EMS  
 
 
1.4.1.2.1.3 6 Mercaptopurine (6MP)  
 
 
6-Mercaptopurine (6MP) is one of the most common chemotherapy agents  
 
used to treatment of childhood acute lymphoblastic leukemia (Rehman et al.,  
 
2014, Karran, 2006). It is also used in the treatment of inflammatory  
 
disorders, and as an immunosuppressant (Rehman et al., 2014). 6-MP is a  
 
member of the antimetabolite class of chemotherapy agents that leads to  
 
inhibition of de novo purine synthesis (Swann et al., 1996, Rehman et al.,  
 
2014). Different mechanisms of action of 6-MP have been described for  
 
thiopurines including: the blocking of replication via incorporation into DNA  
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and transcription via incorporation into RNA; blocking Rac-1-mediated signal  
 
transduction; and an antimetabolic effect during inhibition of GTP synthesis  
 
by 6-methyl thioinosine monophosphate (6-MeTIMP) (Cara et al., 2004,  
 
Prufer et al., 2014). 6-MP is also able to regulate the expression of genes,  
 
which it can either up- or down-regulate (Taki et al., 2013).  
 
 
A gene expression study has also reported thiopurine-induced mutation  
 
during the expression of genes involved in protein- and ATP-biosynthesis  
 
(Zaza et al., 2005). Mice treated with 6-MP has showed that, significant  
 
mutation were showed in the expression of genes related to inflammatory  
 
responses, oxidative stress, and cell death (Kim HL et al.,2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10: Structural formula of 6 Mercaptopurine  
 
 
 
 
 
1.4.1.2.1.4 5-Bromo-2′-deoxyuridine (5-BrdU)  
 
 
Bromodeoxyuridine (BrdU) is a synthetic thymidine analog that is commonly  
 
used in the detection of proliferating cells in living tissues and as a cell cycle  
 
marker (Webster et al., 2014). BrdU is incorporation into DNA results in  
 
many types of DNA damage, including mutations, sister chromatid  
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exchanges, chromatid breaks and micronucleation (Anisimov, 1994, Wojcik  
 
et al., 2003, Sato et al., 1993). Furthermore, it has been shown to induce  
 
polyploidization and hypermethylation of DNA (Call and Thilly, 1991, Hsu and  
 
Somers, 1962, Masterson and O'Dea, 2007). BrdU is incorporated into  
 
replicating DNA when the cell is preparing for division (during the S-phase of  
 
the cell), thus increasing the risk of transition mutations in dividing cells  
 
(Webster et al., 2014). Its effect on gene expression has not been  
 
investigated. However, an in vitro study by Endoh et al. (2007) showed that  
 
the expression of ectopic genes increased when cells were treated with BrdU  
 
close to the time of transfection (Endoh et al., 2007). In contrast, BrdU was  
 
found to decrease expression of endogenous genes (Meleady and Clynes,  
 
2001, Lin et al., 1989, Webster et al., 2014). In many primary and  
 
transformed cell types, it has been shown that, BrdU administration results in  
 
the upregulation of some senescence-related mRNAs and proteins (Suzuki  
 
et al., 2001, Ross et al., 2008).  
 
 
Work by Schmid et al., (2001) showed an effect of BrdU on the duration of  
 
meiosis in male mice. The development time from meiotic divisions in  
 
spermatocytes to epididymal sperm was evaluated by labeling cells with  
 
BrdU within the last S-phase preleptotene (Schmid et al., 2001).  
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Figure 1.11: Structural formula of 5-Bromo-2′-deoxyuridine  
 
 
The incorporation of BrdU into DNA has been found to be very valuable in  
 
many biological systems to study the fraction of S phase cells, the banding  
 
pattern of early and late replicating regions of chromosomes and their  
 
subnuclear localization, as well as the size and distribution of replicons on  
 
separate DNA fibers (Dolbeare, 1995, Lengronne et al., 2001).  
 
 
 
1.4.1.2.1.5 Doxorubicin (Adriamycin)  
 
 
Doxorubicin is one of the most common chemotherapeutic agents used in  
 
the treatment of a variety of cancers. Doxorubicin is an anthracycline  
 
antibiotic isolated from the bacterium Streptomyces peucetius var. caesius  
 
which was obtained from S. peucetius via mutagenic treatment (Li et al.,  
 
2008, Arcamone et al., 2000). It causes antitumour activity by producing  
 
DNA damage through three major mechanisms. The first is intercalation into  
 
DNA, which may disrupt replication and transcription of genomic DNA and  
 
lead to the death of cancer cells (Tewey et al., 1984, Lei et al., 2012).  
 
Secondly, it inhibits both cellular DNA and RNA synthesis, presumably by  
 
direct binding (Momparler et al., 1976, Li et al., 2008). The third mechanism  
 
is its action as an inhibitor of DNA topoisomerases I and II (Wassermann et  
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al., 1990). Doxorubicin can also interact with the cell membrane, by binding  
 
to negatively charged phospholipids; it changes the membrane dynamics  
 
and fluidity, this causes lipid peroxidation and interferes with membrane  
 
related enzyme activity (Speelmans et al., 1994, Parker et al., 2001).  
 
However, an indirect mechanism for doxorubicin action has been proposed.  
 
Metabolism of doxorubicin inside the cell creates free radicals by means of  
 
redox reactions. This reactive oxygen species can then harm DNA by  
 
oxidation of bases and effect lipid peroxidation in the cell membrane, causing  
 
indirect cytotoxicity of doxorubicin (Umlauf and Horky, 2002, Suominen et al.,  
 
2003).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.12: Structural formula of doxorubicin  
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Many studies have reported that doxorubicin can impair male fertility by the  
 
induction of DNA damage in spermatogenic cells (Baumgartner et al., 2004,  
 
Kang et al., 2002). Throughout spermatogenesis, the different germ cell  
 
types have different susceptibilities to genotoxic agents (Aguilar-Mahecha et  
 
al., 2005).  Therefore, the nature and extent of genotoxicity caused by  
 
doxorubicin during spermatogenesis is cell-type dependent (Kang et al.,  
 
2002, Prahalathan et al., 2004). The genotoxicity of doxorubicin on  
 
spermatogonial cells and spermatocytes during meiosis and rapidly  
 
differentiation has been evident by a number of studies (Kang et al., 2002,  
 
Prahalathan et al., 2004).  
 
 
1.4.2  Mismatches of DNA  
 
 
The cell requires continual repair to maintain integrity of DNA replication, to  
 
preserve genome stability and to ensure the proliferation of species  
 
(Mukherjee et al., 2010). Mutation can occur through mismatches of DNA  
 
bases resulting in replication errors in which the wrong DNA bases are  
 
stitched into place in newly forming DNA strands. Other replication errors  
 
include the skipping over or incorrect insertion of DNA bases. Spontaneous  
 
or induced base modifications and recombination errors can also lead to  
 
mutation (Marti et al., 2002). Some genotoxic agents such as the alkylating  
 
agents described above can covalently bind to DNA and produce errors in  
 
DNA replication, thus increasing the number of mutations (Fox et al., 2012).  
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1.4.3  Cross linkages  
 
 
DNA crosslinking damage happen when crosslinking agents covalently join  
 
two nucleotide residues from either the same DNA strand (intrastrand  
 
crosslink [ICLs]) or different strands (interstrand crosslink). Intrastrand  
 
crosslinks can be easily removed via the nucleotide excision repair (NER)  
 
mechanism (Y Huang et al., 2013, Odonovan et al., 1994). Bulky adducts  
 
produced by exposure to exogenous compounds, including some antibiotics  
 
such as mitomycin C, can react with reagents such as nitrite ion to form  
 
covalent linkages between bases in one strand (Hlavin et al., 2010, Balu et  
 
al., 2006). More focused studies have been reported on the chemistry of  
 
DNA crosslinking compounds used as chemotherapeutic agents (Brulikova  
 
et al., 2012, Rajski and Williams, 1998). DNA crosslinks can also occurred by  
 
ultra violet light, especially the formation of intrastrand dimers between two  
 
pyrimidines, known as cyclobutane pyrimidine dimers (CPDs) on the same  
 
strand (Nejedly et al., 2001, Cecchini et al., 2005, Ichihashi et al., 2003).  
 
 
1.5 Apoptosis  
 
 
Apoptosis (programmed cell death) is a well-defined physiological process  
 
that serves to eliminate damaged, diseased, or superfluous cells from  
 
various tissues of the body (Wyllie et al., 1980, Richburg, 2000, Thompson,  
 
1995). Kerr, Wyllie and Currie were the first to use the term apoptosis or  
 
programmed cell death (Kerr et al., 1972, Wyllie et al., 1980). Apoptosis of  
 
germ cells plays a crucial role in regulating the number of spermatogenic  
 
cells supported by Sertoli cells through the first wave of spermatogenesis  
 
(Silva et al., 2011). Apoptosis during spermatogenesis has been widely  
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studied in mice and rat (Choi et al., 2004). The balance between levels of  
 
germ cell differentiation, proliferation and apoptosis is vital to the regulation  
 
of germ cell number during spermatogenesis. During the initiation of  
 
spermatogenesis, an apoptotic wave is required to remove irregular germ  
 
cells and to preserve the correct ratio between maturing germ cells and  
 
Sertoli cells (Koji, 2001, Giampietri et al., 2005). Many studies have shown  
 
that pathological conditions such as exposure to anticancer agents, exposure  
 
to ionizing radiation or toxic substances, hormonal depletion, heat stress,  
 
and loss of stem cell factor signalling can induce male germ cells apoptosis  
 
(Richburg, 2000, Choi et al., 2004, Gosden and Spears, 1997).  
 
 
1.5.1  The process of apoptosis  
 
 
Apoptosis is arbitrarily divided into initiation, signalling and execution stages  
 
by which cells speedily execute a death programme (Steller, 1995). There  
 
are two main pathways for apoptosis:  The extrinsic or death receptor  
 
pathway and the intrinsic or mitochondrial pathway and molecules of one  
 
pathway can influence the other (Igney and Krammer, 2002, Zimmermann  
 
and Green, 2001). In addition, other pathways can be involved, such as the  
 
perforin/granzyme pathway that induces apoptosis by either granzyme A or  
 
granzyme B (Martinvalet et al., 2005).  
 
 
Apoptosis is characterized by specific morphologic and biochemical  
 
properties. Morphologically, apoptosis is characterised by a series of   
 
structural changes such as membrane blebbing, chromatin condensation,  
 
cell volume shrinkage and cellular fragmentation into membrane apoptotic  
 
bodies (Steller, 1995, Majno and Joris, 1995, Wyllie et al., 1980).  
 
 
 
39  
Biochemically, apoptosis is characterised by events that include DNA  
 
laddering and DNA cleavage, phosphatidylserine exposure to the external  
 
leaflet of the plasma membrane and activation of caspase cascades (Fadok  
 
et al., 1992, Wyllie et al., 1980, Shaha et al., 2010).  
 
 
 
1.5.2  Apoptosis in male germ cells  
 
 
1.5.2.1  Apoptosis via the intrinsic pathway  
 
 
The intrinsic pathway is activated in response to many forms of cellular  
 
stimuli, including DNA damage, oxidative stress and endoplasmic reticulum  
 
stress (Kroemer et al., 2007). These types of stimuli lead to mitochondrial  
 
dysfunction, involving changes in the inner mitochondrial membrane and  
 
opening of the mitochondrial penetrability transition pore (Kroemer et al.,  
 
2007). Subsequent activation of pro apoptotic, BH3-on of the members of the  
 
Bcl-2 family, down-regulate the anti-apoptotic proteins Bcl-2, Bcl-xL and Mcl-  
 
1, leading to disruption of mitochondrial membrane potential and release of  
 
Cytochrome c and S mac from the mitochondria into the cytosol, where  
 
Cytochrome c binds to apoptotic protease activating factor 1 (Apaf 1) and  
 
dATP. The subsequent activation of initiator caspase 9 and the following  
 
proteolytic activation of caspases 3, 6, and 7 ultimately results in the death of  
 
the cell (Taylor et al., 2008). See Figure 1.13 below for a summary of the  
 
process.  
 
 
1.5.2.2 Apoptosis via the extrinsic pathway  
 
 
The extrinsic pathway of apoptosis is activated by the binding of a death  
 
receptor, such as Fas, DR5 or tumour necrosis factor (TNF) receptor 1 to its  
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respective ligand (Peter and Krammer, 2003, Janssen et al., 2003). FASL  
 
binds to FAS, which induces the trimerization of FAS receptors and results in  
 
the binding of the adapter protein Fas-associated death domain-containing  
 
protein. The association of the adaptor FADD with Fas by the death domain  
 
leads to recruitment of pro-caspase 8 and results in the formation of the  
 
death inducing signalling complex (DISC), which leads to the auto-proteolytic  
 
processing of the caspases and initiates the process of apoptosis (Wajant,  
 
2002). Similarly, binding of TNF ligand to TNF receptor results in the binding  
 
of the adapter protein TRADD.  The extrinsic pathway via Fas is also  
 
illustrated in (Figure 1.13).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13: Schematic representation of the intrinsic and extrinsic pathways  
 
of apoptosis. Taken from Tan et al., (2014).  
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Many studies have shown that the intracellular balance of BclxL and Bax  
 
proteins plays a vital role during the early apoptotic wave (Russell et al.,  
 
2002, Yan et al., 2000, Adams and Cory, 2007, Vergara et al., 2011). A  
 
number of studies have also shown that the Fas/FasL system is the major  
 
inducer of germ cell apoptosis under particular pathological conditions such  
 
as exposure to chemotherapy drugs and hormone deprivation (Francavilla et  
 
al., 2000, Rockett et al., 2001, Aitken and Baker, 2013). In fact, some  
 
authors have reported that Fasl is only expressed in germ cells (Francavilla  
 
et al., 2000, Xu et al., 1999), while other authors claim that Fasl is present  
 
only in Sertoli cells (Woolveridge et al., 1999, Riccioli et al., 2000). The p53  
 
is another common protein and has been defined as controller of both cell  
 
proliferation and apoptosis. Similar to Bcl-2 family members, p53 modulates  
 
the intracellular death-signaling pathway. A number of reports have showed  
 
the role of p53 in apoptosis during spermatogenesis. p53 plays a critical role  
 
in  mediating  both  spontaneous  and  injury  induced  apoptosis  in  
 
spermatogonial cells. Nevertheless, the majority of these reports showed that  
 
p53 is associated with regulation of apoptosis during mitotically active of  
 
spermatogonia. Another report showed that p53 might also control apoptosis  
 
in meiotic and postmeiotic germ cells (Figure 1.14) (Richburg, 2000, Beumer  
 
et al., 1998, Inoue et al., 2014).  
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Figure 1.14: Diagram drawing illustrated points at which apoptosis happens  
 
within germ cells, the pro- and anti-apoptotic molecules involved and the  
 
functions of the apoptotic process associated with different phases of sperm  
 
differentiation and maturation. Taken from Shaha et al., (2010).  
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1.6 Methodologies to detect DNA damage, apoptosis and mutations in  
 
germ cells  
 
 
Many methods have been used to investigate the induction of DNA damage  
 
and heritable effects of toxins in germ cells (Sutherland et al., 2000,  
 
Brendler-Schwaab et al., 2005).  
 
 
The isolation of homogeneous populations of individual spermatogenic cell  
 
types is increasingly viewed as a model system for different types of studies  
 
of germ cell proliferation and differentiation (Chang et al., 2011b). There is no  
 
dependable cell culture system for spermatogenic differentiation in vitro, in  
 
addition most biological investigations on spermatogenic cells need tissue  
 
harvested from animal models such as mouse and rat (Bryant et al., 2013),  
 
The testis contains both non-spermatogenic cells (Leydig, Sertoli, myeloid,  
 
and epithelial cells) and spermatogenic cells (spermatogonia, spermatocytes,  
 
round spermatids, condensing spermatids and spermatozoa); hence,  
 
mechanistic studies in spermatogenesis need the isolation and enrichment of  
 
these different cell types (Bryant et al., 2013).  
 
 
The possibility of obtaining homogeneous germ cells at defined stages of  
 
development is a prerequisite for the study of meiotic and post-meiotic germ  
 
cell function. Several methods have been proposed for separation of animal  
 
cells based on velocity sedimentation, equilibrium density fractionation,  
 
electrophoretic mobility and partition through aqueous, two-phase polymer  
 
systems (Bellve, 1993, Guo et al., 2004). The isolation and culture of  
 
homogeneous populations of the individual germ cells has permitted the  
 
analysis of gene expression in these cells in addition to studying their  
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mechanisms and growth requirements (De Miguel and Donovan, 2000, Dolci  
 
et al., 1991). Some important factors have been found in spermatogenic cells  
 
cultures in vitro; these factors are physiologically related to spermatogenic  
 
cells growth and development in vivo. Such factors include leukemia  
 
inhibitory factor (LIF) which was recognized as an important spermatogenic  
 
cells survival factor and mitogen in culture (De Miguel and Donovan, 2000,  
 
Dolci et al., 1991). Because of the complex process of spermatogenesis  
 
which depends on special hormones and different molecular conditions int  
 
the testes, a dependable in vitro culture system for the full procedure of germ  
 
cells have not yet been fully developed (Hess et al., 2006, Dores et al.,  
 
2012). Methods of cell culture have been established in order to create or to  
 
mimic cells, which are similar to primordial germ. However, to date these  
 
methods were unable to produce large numbers of these cells and also failed  
 
to generate later spermatogenic cell types in vitro (Hayashi et al., 2011,  
 
Easley et al., 2012). It is well known that the spermatogenic cell types are  
 
significantly different in size, this difference allows for a single cell  
 
suspension gained from whole testes to be separated with liquid gradient  
 
(Miller and Phillips, 1969, Bryant et al., 2013). The staput method is a unity-  
 
gravity cells sedimentation system that allows the purification of specific cell  
 
types based on size and density through a linear BSA gradient. The optimal  
 
conditions for rodent cells have been reported (Miller, 1984, Bryant et al.,  
 
2013). The successful application of this technique to male germ cell  
 
fractions has been described (Lam et al., 1970, Meistric.Ml et al., 1973,  
 
Bryant et al., 2013, Boucheron and Baxendale, 2012). The staput has  
 
numerous advantages compared with the two commonly used approaches  
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for isolating germ cells types; FACS and elutriation. The method needs only  
 
numerous pieces of specific glassware assembled in a cold room. Therefore,  
 
it is cheaper than using a cell sorter or an elutriator (Bastos et al., 2005). The  
 
sta-put method yields higher amounts of cells per cell type and the purity of  
 
each cell population is higher than those obtained with FACS (Getun et al.,  
 
2011). Currently, cell sorting using magnetic beads, magnetic activated cell  
 
sorting (MACS) has been used for enrichment of spermatogonial cells from a  
 
mixed germ cell population; however, it is not appropriate for isolation of  
 
spermatocytes and spermatids because of lack of information of suitable  
 
surface markers (Gassei et al., 2009). For study that needs large number of  
 
yields of germ cells types at ~90% purity, the sta-put is a perfect technique  
 
(Bryant et al., 2013).  
 
 
In vitro experiments demonstrated that the unit-gravity sedimentation cell  
 
separation could be a valuable method to make appropriate assessment of  
 
DNA, mRNA and protein and investigate the biochemical and toxic effects of  
 
pharmacological agents on germ cells.  
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Figure 1.15: Diagram of staput purified of male cells that were stained with  
 
antibodies for specific proteins. Spermatogonia were detected with anti-  
 
GDNFR (Panel A); spermatocytes were detected anti-SCP3 (Panel B) and  
 
Spermatids were detected with anti-TP1 (Panel C). Viewing magnification  
 
×400.  
 
 
 
1.6.1  Terminal deoxynucleotidyl transferase dUTP nick end labelling  
 
assay  
 
 
Recently, increasing numbers of tests have become available to assess DNA  
 
damage in germ cells. (TUNEL) assay is one of the most common tests to  
 
measure DNA damage in germ cells. The TUNEL assay measures both  
 
single and double strand DNA fragmentations, measures a definitive end  
 
point (presence of 3′-OH) (Sun et al., 1997, Zini and Sigman, 2009). The  
 
terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL)  
 
assay was first reported by Gavrieli et al., in 1992, and since then, it has  
 
been widely used for detecting apoptotic cells in situ, and has been the most  
 
commonly used test to assess DNA damage in spermatozoa (Sharma et al.,  
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2010, Gavrieli et al., 1992). The assay is based on the ability of the enzyme  
 
terminal deoxynucleotidyl transferase (TdT) to catalyze the addition of dUTP  
 
to the 3′-OH end of the fragmented DNA. The enzyme can also add labeled  
 
nucleotides for example biotin-dUTP, DIG-dUTP or fluorescein-dUTP to the  
 
3′ terminus of a DNA molecule (Figure 1.16) (Alipour et al., 2011, Kyrylkova  
 
et al., 2012).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.16: Schematics of TUNEL assay for measurement of DNA damage  
 
in sperm. Adapted from Malvezzi et al., (2014).  
 
 
 
1.6.2  Comet assay single cell gel electrophoresis  
 
 
The single cell gel electrophoresis (SCG or SCGE) assay (also called the  
 
Comet assay) is a sensitive, visual, rapid and quantitative technique that is  
 
used to detect and measure DNA damage, including double-strand and  
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single-strand breaks, in cells or nuclei isolated from multiple tissues of  
 
animals, usually rodents after a variety of genotoxic insults (Tice et al., 2000,  
 
Haines et al., 2002, Burlinson et al., 2007). The assay has been applied to  
 
both  human  and  animal  cells.  It  has  also  been  reviewed  and  
 
recommendations published by numerous expert groups (Kirkland and Speit,  
 
2008, Rothfuss et al., 2010, Tice et al., 2000, Haines et al., 1998). The  
 
alkaline version of the Comet assay with a pH 13 has demonstrated its  
 
reliability in numerous testing conditions. It is an accepted assay for  
 
genotoxicological assessments and has been approved via the UK  
 
Committee on Mutagenicity of Chemicals in Food, Consumer Products and  
 
Environment and US Food and Drug Administration (Burlinson et al., 2007).  
 
Part of the reason for this approval has been the development of a standard  
 
protocol and acceptance criteria for the assay through the IWGT working  
 
parties and international Comet assay workshops (Tice et al., 2000, Collins,  
 
2004, Hartmann et al., 2003).  
 
 
DNA damage is assessed subsequently by denaturation of the DNA into  
 
single-stranded DNA. This procedure involves numerous steps. Firstly, cells  
 
are embedded in an agarose layer on slides between other layers of  
 
agarose. Next, cells are lysed with detergent and salt which acts to remove  
 
cellular protein content. Nucleoids are formed containing supercoiled loops of  
 
DNA. Then, either under alkaline or neutral pH conditions, the DNA is  
 
allowed to unwind before being subjected to electrophoresis.  
 
 
The principle of the Comet assay is the migration of DNA in an agarose  
 
matrix under electrophoretic conditions. Ethidium bromide (EtBr) is then  
 
applied to stain the DNA prior to being observed under a fluorescence  
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microscope. Thus EtBr-based staining permits the analysis of an image that  
 
resembles a comet with a distinct head and tail.  The cells have the  
 
appearance of a comet, in which the head contains undamaged/intact DNA,  
 
whilst the tail consists of fragmented and/or damaged DNA segments  
 
(Hartmann et al., 2003, Collins, 2004). Detection of changed DNA migration  
 
is reliant on many parameters for example the temperature, the duration of  
 
alkaline unwinding, pH, the concentration of agarose in the gel, voltage,  
 
amperage and duration of electrophoresis (Hartmann et al., 2003).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.17: An image of cells marked with comet parameters, showing  
 
parts of head undamaged DNA and tail damaged DNA.  
 
 
For in vitro toxicity of environmental chemicals, the Comet assay has been  
 
used on different cell types and has also been used in vivo toxicity in tissue  
 
samples harvested from animals. Furthermore, it is a valid method to assess  
 
whether antioxidants micronutrients are able to keep the integrity of the  
 
genetic material (Heaton et al., 2002, Anderson et al., 1997, Novotna et al.,  
 
2007). Many genotoxicity studies have used Comet assay to assess DNA  
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damage in early mixed male germ cells (Nixon et al., 2012, Nixon et al.,  
 
2014, Villani et al., 2013).  
 
 
The Comet assay is an easy and rapid technique that is simple to perform. It  
 
needs only small amounts of test substance and can be performed on  
 
different types of cells. The Comet assay is therefore a key technique in the  
 
early development of drugs and other compounds for human use. It acts as a  
 
mechanistic tool and genotoxicity predictor (Apostolou et al., 2014).  
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1.7 Aims of project  
 
 
It has been suggested that exposure to environmental toxicants causes  
 
DNA damage and/or apoptosis, potentially leading to male fertility problems  
 
or heritable DNA damage or mutation in human. Since current assays are  
 
heavily reliant on in vivo tests, the development of rapid, in vitro assays is  
 
urgently required.  
 
 
The specific objectives of this project are as follows:  
 
 
A.  Separation  of  spermatogenic  cell  types  using  staput  velocity  
 
sedimentation. Isolated cells will be characterized further by using specific  
 
markers to identify spermatogonia, spermatocytes and spermatids.  
 
 
B. To investigate the effect of H2O2 and doxorubicin on isolated germ cell  
 
apoptosis.  
 
 
C. To evaluate the cytotoxic and genotoxic potential of N-ethyl-N-nitrosourea  
 
(ENU) and N-methyl-N-nitrosourea (MNU), 6-mercaptopurine (6-MP) and 5-  
 
Bromo-2′-deoxyuridine (5-BrdU) and methyl methanesulfonate (MMS) and  
 
ethyl methanesulfonate (EMS) in isolated germ cells.  
 
 
D. To clone and express Tbpl1, FHL5 and Gtf2a1l from mouse testis. This  
 
will enable the expression patterns of the Tbpl1, FHL5 and Gtf2a1l genes in  
 
spermatocytes and spermatids at both the mRNA and protein levels to be  
 
confirmed. The effect of ENU and MMS on Tbpl1, FHL5 and Gtf2a1l  
 
expression in spermatocytes and spermatids at both mRNA and protein  
 
levels which are expressed in E. coli will then be assessed.  
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Chapter 2. Material and methods  
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2.1 Materials  
 
 
2.1.1  Chemicals and reagents  
 
 
General Laboratory reagents and Dulbecco's Modified Eagle's Medium - high  
 
glucose were purchased from Fisher Scientific Co. (Itasca, IL) and Sigma  
 
Chemical Co. (Gillingham, UK). N-Nitroso-N-methylurea (MNU); N-Nitroso-N-  
 
ethylurea (ENU), 5-Bromo-2′-deoxyuridine (5-BrdU), ethyl methanesulfonate  
 
(EMS), methyl methanesulfonate, (MMS) was dissolved in Phosphate  
 
buffered saline (PBS; pH 7.3 ± 0.2) before treatment, and 6-mercaptopurine  
 
(6-MP) (Sigma) was dissolved in dimethyl sulfoxide (DMSO) before  
 
treatment, and the concentrations were adjusted to (0.05, 0.5 and 1.0 mM).  
 
 
PCR  reagents  and  endonuclease  were  purchased  from  Promega  
 
(Southampton Science, UK) and used according to the manufacturer's  
 
protocol. Cloning vector pET100/D TOPO was from Invitrogen (Carlsbad,  
 
USA). PCR primers were obtained from Sigma. All other reagents and  
 
chemicals were purchased from Sigma or Fisher Scientific (Loughborough,  
 
UK) unless otherwise specified. Ethidium Bromide was also purchased from  
 
Sigma (E-8751).  
 
 
2.1.2  Buffers and solutions  
 
 
The following solutions and buffers were used for this study: Tris-acetate-  
 
EDTA buffer (50 X) (TAE; 2 M Tris/HCl; 5.7 % (v/v) acetic acid; 50 mM  
 
EDTA; pH 8.0). Tris-Boric acid- EDTA buffer (5 X) (TBE; 440 mM Tris; 440  
 
mM boric acid; 10 mM EDTA; pH 8.4). Sodium dodecyl sulfate loading buffer  
 
(1 X) (SDS; 250 mM Tris-HCl; 500 mM DTT; 10 % (w/v) SEMS; 0.5% (w/v)).  
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Sodium dodecyl sulfate-polyacrylamide gel electrophoresis buffer (10 X)  
 
(SDS-PAGE; 250 mM Tris-HCl; 2.5 M glycine; 1 % (w/v) SDS; pH 8.3).  
 
Coomassie bright blue staining buffer: 2.5 g Coomassie R250; 45.5 % (v/v)  
 
methanol; 9.2 % (v/v) acetic acid. Coomassie bright blue destaining buffer:  
 
25 % (v/v) isopropanol; 10 % (v/v) acetic acid. Bouin Solution (75% (v/v)  
 
saturated picric acid, 5% (v/v) glacial acetic acid, and 9% (v/v) formaldehyde  
 
in water.  
 
 
 
2.2 Cell culture  
 
 
2.2.1  Staput isolation of germ cells fractions  
 
 
2.2.1.1 Testis isolation  
 
 
Sexually mature NMRI mice and rat (National Medical Research Institute)  
 
weighing 25-30 g mice and rats weighing 250-300 g (10-12 weeks old) were  
 
 
used in this study. Animals were sacrificed by cervical dislocation under CO2  
 
anaesthesia.  Animals were  obtained from  the  Institute of  Cancer  
 
Therapeutics, University of Bradford, UK where they were maintained under  
 
standard conditions. All animal care procedures were carried out according  
 
to the National Research Council's Guide for the Care and Use of Laboratory  
 
Animals. The testes are removed and pooled in 50 mL of ice-cold DMEM, in  
 
a 50 mL Falcon tube, on ice. Once all testes are collected, each testicle in  
 
the pool is quickly decapsulated in a large culture plate containing fresh ice-  
 
cold DMEM, using two pairs of forceps. The seminiferous cords are  
 
transferred into a new 50 mL tube containing 20 mL of fresh DMEM, on ice.  
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After the decapsulated testis/seminiferous cords settle on the bottom of the  
 
tube, the supernatant is gently removed with a pipette.  
 
 
2.2.1.2 Tissue digestion  
 
 
The progressive digestion of testicular tissue is the key to an efficient  
 
isolation of individual cells. There are three basic steps. In the first step, the  
 
seminiferous  tubules  are  treated  with  a mixture  of  collagenase,  
 
hyaluronidase, and DNase I, to remove the interstitial cells, namely, myoid  
 
and Leydig cells. The second step is digestion with trypsin which dissociates  
 
the seminiferous tubules and releases the Sertoli and germ cells. DNase I is  
 
added to this step to reduce viscosity thus, cellular aggregation. Finally, the  
 
cell suspension is further purified, by panning; this exploits the fact that  
 
sertoli cells will adhere to the surface of the plastic culture dish while germ  
 
cells remain in suspension. At this point, tissue digestion and the primary  
 
separation of adherent and nonadherent cells are complete; the sample is  
 
ready for additional purification through a BSA gradient.  
 
 
Seminiferous tubule pellet was incubated in a solution of DMEM containing 2  
 
mg/ml collagenase I, 0.5 mg/ml DNase I and 1 mg/ml hyaluronidase. Sample  
 
was then gently swirl by hand and placed in water bath at 37 °C for 30  
 
minutes with shaking at 5 minutes interval. Sample was then removed from  
 
the water bath and the tubule tissue was allowed to settle to the bottom of  
 
the tube. Supernatant in the tube containing the interstitial cells was gently  
 
pipetted off with more care to avoided removing the partially digested  
 
tubules. A 3 ml of 0.25 % Trypsin-EDTA and 300 l DNase I were added to  
 
the tubule tissue pellet, containing predominantly germ cells and Sertoli cells.  
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Sample was swirled by hand and placed in a water bath at 37 °C for 15  
 
minutes with gentle shaking at 5 minutes interval during this period to allow  
 
the tissue to settle to the bottom of the tube again. Supernatant containing  
 
cells in suspension was transferred without disturbing the larger chunks, into  
 
a fresh falcon tube containing 20 ml of DMEM + 10 % FBS on ice to inhibit  
 
proteolytic activity. 3 ml of 0.25 % Trypsin-EDTA and 300 l DNase I was  
 
added to the remaining cell pellet and swirled by hand then placed in a water  
 
bath for 15 minutes incubation at 37 °C. The tube was shaken by hand every  
 
5 min during this period to assist in dissociating the germ cells and the Sertoli  
 
cells. The supernatant was removed gently and added to the previously  
 
prepared 50 ml Falcon tube containing 20 ml of DMEM + 10 % FBS and the  
 
first supernatant removed from the digestion. This pool should now contain  
 
predominantly germ and sertoli cells. The cell suspension was filtered  
 
through a sterile 0.80 m nylon filter to remove any undigested fragments or  
 
cell clumps. The filtered cells were centrifuged at 800 x g for 10 minutes at  
 
room temperature. Remove the supernatant and resuspend the cell pellet in  
 
10 ml DMEM.  
 
 
2.2.1.3 BSA gradient  
 
 
Good construction of the gradient is essential for effective cell separation.  
 
Extreme care should be taken to ensure that the gradient is both even and  
 
stable. After the cells have been grossly separated into Sertoli cell (adhering  
 
to the culture plates) and germ cell (in suspension in culture medium)  
 
fractions. As many of the supernatant, enriched with germ cells were  
 
removed and transferred to fresh 50 ml tubes. The supernatant was  
 
centrifuged for 10 minutes at 800 x g. The BSA gradient was prepared using  
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250 ml of 4 % and 250 mL of 2 % BSA in DMEM. Both BSA solutions were  
 
filtered before used with a 0.45-m filter mounted.  
 
 
2.2.1.4 Principles of staput  
 
 
The BSA solutions were transferred into the gradient maker apparatus, which  
 
was assembled as shown in figure 2.1 and connected to a 250 ml cell buffer  
 
chamber. The gradient valve between the two chambers was opened to  
 
allow the two BSA solutions to mix, and then opened the release valve  
 
allowing the BSA to flow into the syringe to generate the gradient. While the  
 
BSA gradient is stabilizing, the supernatant was removed from the  
 
centrifuged of the cell suspension. Pool the pellets from several tubes  
 
together, and resuspend in DMEM media to a total volume of 3 ml. 10 l was  
 
taken from the suspension to determine the cell number by using a  
 
haemocytometer under light microscopy. Gently overlay the top of the  
 
formed BSA gradient with the 3 mL cell suspension. The top of the syringe  
 
containing cells/gradient was covered with parafilm to minimize disturbance  
 
and changes in pH due to oxidation. After 2.5 h at room temperature, cells  
 
were collected in 12 ml fractions eluted drop wise into 45 test tubes (Figure  
 
2.1). Fractions were placed on the ice immediately after collection (Bryant et  
 
al., 2013, Bellve et al., 1977).  
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Figure 2.1: Diagram shows the staput apparatus involve of two graduated  
 
gradient chambers, a cell buffer chamber, two magnetic stirrers, two Teflon  
 
spin bars, a sedimentation chamber with a staput buffle and a 3 way micro  
 
metering valve. Silicone tubes connect the graduated gradient chambers, cell  
 
buffer chamber and the sedimentation chamber to each other.  
 
 
 
2.2.1.5 Cell counting  
 
 
In order for the cells to be counted, 100 l of the original cell suspension was  
 
transferred to an Eppendorf tube. A dilution of 1:1 was conducted when the  
 
cell suspension was mixed with 100 l of 0.4 % trypan blue solution. A  
 
neubauer haemocytometer slide with coverslip was prepared and 10 l of  
 
this cell suspension was transferred to the chamber. The cells were counted  
 
in 4 grids per chamber under the microscope, using the 10 x focus. The  
 
average number of cells of 4 grids was calculated and this number was used  
 
to count the total number of cells by using the following calculations:-  
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Number of cells/ml = [average cell number] x [104] x [dilution factor]  
 
 
Total number of cells = [Cells/ml] x [volume of original cell suspension (ml)]  
 
 
2.2.1.6  Viabilities  
 
 
Viability of the germ cells in the cell suspension obtained after enzymatic  
 
digestion and in each isolated fraction was determined using the Trypan blue  
 
exclusion test (10 µl of 0.05 % Trypan blue was added to 10 µl of cell  
 
suspension) (Talbot and Chacon, 1981).10 µl from each tube was transferred  
 
to a haemocytometer and observed under a microscope. Cells that stained  
 
blue were considered dead.  
 
 
2.2.1.7 Cell identification  
 
 
The percentage number of germ cells types was determined based on size  
 
and morphology and confirmed by using specific cell markers and evaluated  
 
by immunohistochemical staining.  
 
 
2.3 Immunohistochemical  
 
 
2.3.1  Collection and fixation  
 
 
The tissues were fixed in Bouin's solution, after fixation, the tissue samples  
 
were prepared for processing and embedding. Shandon Citadel 2000 Tissue  
 
Processor was used for automated tissue processing (Table 2.1). Processed  
 
tissue samples were then embedded in paraffin.  
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Table 2.1: Shows the protocol for mouse section processing  
 
 
 
Step  
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
 
 
7 
 
 
8 
 
 
9 
 
 
10  
 
 
11  
 
 
12  
 
 
 
Substance  
 
 
Formalin/mouse testis  
 
 
70% EtOH  
 
 
80% EtOH  
 
 
90% EtOH  
 
 
Abs. EtOH  
 
 
Abs. EtOH  
 
 
Abs. EtOH  
 
 
Xylene  
 
 
Xylene  
 
 
Xylene  
 
 
Paraffin (58 °C)  
 
 
Paraffin (58 °C)  
 
 
 
Duration  
 
 
- 
 
 
3h  
 
 
3h  
 
 
3h  
 
 
1h  
 
 
2h  
 
 
2h  
 
 
1h  
 
 
2h  
 
 
2h  
 
 
2h  
 
 
1.5-4 h  
 
 
 
 
 
2.3.2  Tissue preparation  
 
 
The tissue blocks were first placed on a 4°C cold plate for 15 minutes before  
 
sectioning. Leitz wetzlar 1512 microtome blades were utilized to cut 5 - 8 m  
 
thick sections. The sections were placed in a water bath at room  
 
temperature, attached to Super Frost™ Plus micro-scope slides on glass  
 
slides coated with poly-l-lysine, and placed shortly in 52°C water bath to  
 
straighten the tissue section. The slides were left at room temperature in an  
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upwards position for 30 - 60 minutes to remove excess water. The slides  
 
were then placed in an oven at 45°C for either 2 hours or overnight. After the  
 
heat-treatment, the slides were ready for immunohistochemistry staining.  
 
 
2.3.3  Immunohistochemical staining of mouse tissue sections  
 
 
An immunostaining procedure was performed on paraffin-embedded mouse  
 
tissue sections. Paraffin embedding tissue samples were fixed with 4 %  
 
formaldehyde in PBS. 4-5 µm thick paraff in t issue sections were  
 
deparaffinised with Histoclear (Fisher Scientific) and graded ethanol, and  
 
antigen retrieval was performed by heating the sections in 10 mM sodium  
 
citrate buffer, pH 6.0, at 95° C for 30 minutes in a microwave. The blocking  
 
step prior to incubation with the primary antibody was performed with either  
 
5-10% normal goat serum or 1 % BSA in PBS. Anti-GDNFR (1:100; Abcam,  
 
Cambridge, UK), anti-SCP3 rabbit polyclonal antibody (1:400; Abcam,  
 
Cambridge, UK), rabbit polyclonal anti -TP1 antibody (1:50; Abcam,  
 
Cambridge, UK), rabbit polyclonal were used as the primary antibodies. The  
 
sections were then incubated at 4°C overnight, followed by washing with  
 
PBS. For bright-field microscopy, bound primary antibodies were detected  
 
with secondary, biotinylated anti-rabbit-IgG antibody for 30 minutes at room  
 
temperature. Signals were developed with 3, 3-diaminobenzine (DAB) for 10  
 
minutes and counterstained with haematoxylin and a coverslip was applied  
 
using histomount mounting medium (Fisher Scientific, Fair Lawn, NJ).  
 
Immunostained sections were examined on a Zeiss Axio Imager Z1  
 
microscope. Microscopy images were captured using AxioCam digital  
 
microscope cameras and AxioVision image processing (Carl Zeiss Vision,  
 
Germany).  
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2.3.4  Immunohistochemical staining of isolated germ cells  
 
 
The fractions of cells used were grown on coverslips in 6-well plastic culture  
 
plates with DMEM containing 10 % FBS, 100 Unit/ml penicillin, and 100  
 
mg/ml streptomycin. The cells were serum starved in DMEM (with the  
 
antibiotics) for 16 h to allow the cells to attach to the coverslips, fixed with 4  
 
% formaldehyde for 10 min and washed twice, each for 5 min, in PBS  
 
containing 0.5 % BSA. A 1 h block in PBS containing 0.1 % BSA, 0.05 %  
 
Triton X-100, and 1% goat serum was performed. Anti -SCP3 rabbit  
 
polyclonal antibody (1:400; Abcam, Cambridge, UK), rabbit polyclonal anti-  
 
TP1 antibody (1:50; Abcam, Cambridge, UK), rabbit polyclonal anti-GDNFR  
 
(1:100; Abcam, Cambridge, UK), were used as the primary antibodies, and  
 
were incubated at 4°C overnight, followed by washing with PBS. The slides  
 
were subsequently incubated with secondary, biotinylated anti-rabbit-IgG  
 
antibody for 30 min at room temperature. Signals were developed with 3,3'-  
 
Diaminobenzidine (DAB) for 10 min and counterstained with haematoxylin  
 
(Hsu et al., 1981, Khalfaoui et al., 2011), and a coverslip was applied using  
 
Histomount  mounting  medium  (Fisher  Scientific,  Fair  Lawn,  NJ).  
 
Preparations of cells representing each fraction were scored for the presence  
 
of cells positive for each of the three markers and their total number per  
 
fraction calculated. Only fractions showing suitable purity of a specific cell  
 
type were used to set up the cultures.  
 
 
2.4 Testicular germ cells culture prior to TUNEL assay  
 
 
The isolated testicular germ cells were seeded onto coverslips in 6-well  
 
plastic culture plates with DMEM containing 10 % foetal bovine serum (FBS),  
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100 Unit/ml penicillin, and 100 mg/ml streptomycin (5 × 106 cells/ml; 1 ml per  
 
well) at 37°C then the medium was changed and they were serum starved in  
 
DMEM (with antibiotics) for 16 hours to allow the cells to attach to the  
 
coverslips. They were then incubated for 2 hours with or without treatment.  
 
Incubations with treatments were made at final concentrations of drugs in  
 
triplicate. A temperature of 37 °C would not be suitable for long-term cultures  
 
of spermatogenic cells, which thrive best at a temperature 1-2 °C below core  
 
body temperature in humans. Attempts to recreate spermatogenesis in vitro  
 
typically use a culture temperature of 35 °C, often maintained for several  
 
weeks (Reuter et al., 2012). Cells cultured for a single day at 37 °C are  
 
healthy in appearance and only minimal numbers fail to survive, so these  
 
conditions were deemed suitable for the short-term experiments reported  
 
here (Habas et al., 2014). Treated and untreated cells were fixed with 4 %  
 
formaldehyde for 10 minutes and washed twice, each for 5 minutes in PBS  
 
containing 0.5 % BSA and stored in 70 % (v/v) ethanol until further use.  
 
 
2.5 TUNEL assay  
 
 
TUNEL assay for apoptosis evaluation were performed on separate cell  
 
samples of the same cell populations as previously described (Gavrieli et al.,  
 
1992). Briefly, the slides were incubated with TUNEL reaction mixture (30  
 
mM Tris pH 7.4; 140 mM sodium cacodylate; 1 mM cobalt chloride; 5 µM  
 
biotin-16-deoxyuridine triphosphate; 0.3 U/µl terminal deoxynucleotidyl  
 
transferase [Tdt];all from Sigma) for 60 minutes (humidity chamber, 37°C)  
 
 
and then washed twice in PBS. (H2O2-blocking of endogenous peroxidases  
 
was not performed as the testis is low in peroxidases so it is rarely  
 
necessary). After multiple washing steps, the cells were treated with 2 % v/v  
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extravidin peroxidase in TBS with 0.1 % w/v BSA for 30 min (humidity  
 
chamber, 37°C), rinsed with PBS, and visualised by adding 3, 3 -  
 
diaminobenzine (DAB) for 10 minutes at room temperature. They were  
 
washed in PBS, counterstained using haematoxylin staining, and finally,  
 
mounted for light microscopic observation. For the negative controls,  
 
sections were incubated with the reaction mix without TdT instead of the full  
 
TUNEL reaction mixture.  
 
 
2.6 Single cell gel electrophoresis (SGCE) Comet assay  
 
 
2.6.1 Treatment cells  
 
 
Freshly isolated germ approximately (1.5 - 2.5 x 105 cell/ml) suspensions  
 
were mixed with fresh RPMI medium (total volume 1000 µl). 100 l of mixed  
 
germ cells were then added to each treatment tube (100 l mixed germ cells,  
 
890 l RPMI medium, plus 10 l of chemical or 900 l for the negative  
 
control). Cells were treated with different concentrations of drugs for 1 hour  
 
at 37 °C, then the germ cells treated and untreated were immediately used in  
 
the Comet assay.  
 
 
2.6.2 Embedding of cells in agarose  
 
 
Fully frosted microscope slides were covered with a basic layer of 1 %  
 
normal melting point agarose (Invitrogen, Paisley, UK: 15517-022). The  
 
slides were dried in a 60 °C cabinet overnight and then stored at room  
 
temperature. Dry slides were stored until used. Purified germ cells  
 
(spermatogonia, spermatocytes and spermatids) were assayed for DNA  
 
damage using alkaline single-cell electrophoresis assay using the method  
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described by Anderson et al (1997) with slight modifications. Briefly, after  
 
treatment, isolated germ cells samples were centrifuged and the supernatant  
 
was discarded. Next, 100 l of 1 % low melting agarose (LMP) (Invitrogen,  
 
Paisley, UK: 15517-022) was added to cell pellet to create a cell suspension.  
 
The cell suspension was transferred to slides pre-coated with 1 % normal  
 
melting point (NMP) agarose. The slides were placed on an ice block for 5  
 
min, after which 100 l of 0.5 % LMP was added on top and slides were  
 
placed on ice for 5 minutes. The slides then were submerged in cell lysis  
 
buffer (2.5 M NaCl, 100 mM EDTA), 10 mM Tris HCl pH 10.0 containing 1 %  
 
Triton X-100 and 40 mM dithiothreitol) for 1 hour at room temperature and  
 
protected from light. Following this initial lysis period, proteinase K was  
 
added to the lysis solution (final concentration 10 g/ml) and additional lysis  
 
was performed at 37 °C for 2.5 hours (Hughes et al., 1997). Following lysis,  
 
slides were placed in the electrophoresis buffer (0.3 M NaOH, 1 mM EDTA)  
 
for 30 minutes and then subjected to electrophoresis at a setting of 20 V  
 
(approximately 300 mA) for 30 minutes at 4 °C. After electrophoresis, slides  
 
were neutralised 3 times for 5 minutes using Tris buffer. Cells were stained  
 
using EtBr (20 µl/ml) and slides were covered with cover slips and the DNA  
 
integrity of 50-100 cells per slide were scored at 200 X magnification with an  
 
Olympus fluorescent microscope (Leica, UK) equipped with a BP546/10  
 
excitation filter and a 590 nm barrier filter. Slides were analyzed by a  
 
computerized image analysis system (Comet 6.0; Kinetic Imaging, UK) was  
 
used from each replicate slide. In the Comet assay, Olive tail moment and  
 
tail DNA were measured for isolated germ cells.  
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2.6.3 Scoring and analysis of Comet slides  
 
 
Visual and computerized image analyses of DNA damage were carried out in  
 
accordance with the published protocols (Anderson and Plewa, 1998).  
 
Samples were run in triplicates, and 100 cells were randomly analyzed per  
 
 
slide at 200  X magnification with an Olympus fluorescent microscope (Andor  
 
Technology Ltd, Belfast, UK). Equipped with a BP546/10 excitation filter and  
 
a 590 nm barrier filter. Slides were analyzed by a computerized image  
 
analysis system using Comet 6 software; Kinetic Imaging (Andor Technology  
 
Ltd, Belfast, UK) was used. Comet tail length is the maximum distance the  
 
damaged DNA migrates from the centre of the cell nucleus, and the tail  
 
movement is a product of the tail length and the percentage of tail DNA,  
 
which gives a more integrated measurement of overall DNA damage in the  
 
isolated germ cells.  
 
 
2.6.4 Scoring and analysis of TUNEL slides  
 
 
For TUNEL staining, Spermatogonia, spermatocytes and spermatids were  
 
evaluated for morphology and staining, The following findings were  
 
considered to represent apoptosis: marked condensation of chromatin and  
 
cytoplasm clearly staining strongly brown or brown/black; The TUNEL-  
 
positive cells were scored in several fields on each coverslip to yield a total  
 
of at least 100 cells under a 40 × objective of an Olympus CKX31  
 
microscope. Values represent percentages from at least 100 cells from each  
 
culture. SPSS statistical software was used to perform One-Way ANOVA  
 
(Bonferroni), Mann Whitney U and Kolmogorov-Smirnov Z tests for  
 
differences were considered as significant at p < 0.05.  
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2.7 Periodic acid-Schiff/Hematoxylin staining  
 
 
The slides were placed 2 times for 5 minutes each in xylene, 100 % ethanol,  
 
96 % ethanol, 80 % and 70 % ethanol. Finally the slides were washed with  
 
distilled water and placed in 0.5 % periodic acid for 5 minutes. After washing  
 
the slides in 3 changes of water, they were incubated in Schiff's reagent for  
 
15 minutes. Slides were incubated 2 x with 0.55 % potassium metabisulfite  
 
for 1 minutes to remove excess reagent and washed in running tap water for  
 
10 minutes to allow the colour to develop. After counterstaining with acidified  
 
hematoxylin for 90 seconds, slides were dehydrated using, 70 %, 80 %, 96  
 
% Ethanol, 100 % ethanol and xylene for 5 minutes each and mounted with  
 
Histomount II.  
 
 
2.8 Molecular biology: RT-PCR  
 
 
2.8.1 RNA extraction from tissue  
 
 
The total RNA and mRNA were extracted from the mouse testis using either  
 
a TRIzol reagent (Invitrogen) or ™ Mammalian Total RNA Miniprep Kit  
 
(Sigma, Aldrich). The testes were obtained from adult male mice (NMRI, 12-  
 
16 weeks old), which were sacrif iced by cervical dislocation after  
 
 
anaesthetising with CO2 and then were removed, and stored at -80 ºC until  
 
use.  
 
 
2.8.2 RNA preparation  
 
 
To avoid RNAse contamination, disposable plastic ware and RNAse-free  
 
water was used whenever possible.  
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2.8.3 Total RNA isolation from cells  
 
 
The PureLink™ RNA Mini Kit (Invitrogen life technologies, UK) was used for  
 
total RNA preparation. In the case of RNA isolation from cultured cells, the  
 
dishes were placed on ice and the medium was removed; cell layers were  
 
collected by scraping in 1 ml RNA lysis buffer The lysate was passed through  
 
a 20 G needle 10 times, the samples were centrifuged at 11,000×g for 2 min  
 
and the supernatants were collected. The eluate was transferred into a  
 
filtration column and centrifuged for 2 min at 13000 x g, Then 70 % ethanol  
 
was added to the filtration column and mixed thoroughly. This combination of  
 
lysate filtrate and ethanol was transferred to a binding column and  
 
centrifuged for 15 seconds at 10000 x g, the flow through was discarded.  
 
The binding column was washed to remove contaminants. This was  
 
achieved by the addition of 500 µl of wash solution 1 to the column and  
 
centrifugation for 15 seconds at 10000 x g. Then 500 µl of wash solution 1  
 
was added to the column and centrifuged at 10000 x g for 15 seconds. The  
 
filtrate column was transferred to a new collection tube; 750 µl of wash  
 
solution 2 was added and centrifuged for 2 minutes at 10000 x g. The filtrate  
 
column transferred to a new collection tube and 50 µl of elution solution was  
 
added and centrifuged for 1 minute at 10000 x g. The elution buffer releases  
 
the purified RNA from the column. The eluted RNA was stored at -80ºC for  
 
subsequent use.  
 
 
2.8.4 mRNA isolation  
 
 
mRNA was isolated from total RNA for use in oligo-dT primer reverse  
 
transcription using a Genelute™ Mammalian mRNA Miniprep Kit (Sigma,  
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Aldrich, UK). Approximately 30 mg of testis tissue was lysed and  
 
homogenized. The homogenate was transferred onto a filtration column and  
 
centrifuged for 2 min at 10000 x g. Then, 70% ethanol was added to the  
 
filtration column and mixed thoroughly. This combination of lysate filtrate and  
 
ethanol was transferred to a binding column and after centrifugation for 15  
 
seconds at 10000 x g, the flow- through was discarded. The binding column  
 
was then washed to remove contaminants. This was achieved by the  
 
addition of 500 µl of wash solution 1 to the column and centrifugation for 15  
 
seconds at 10000 x g. This step was repeated with DNase 1; 10 µl of DNase  
 
1 was added to 70 µl of DNase digest buffer and mixed by inversion and 80  
 
µl was transferred directly onto the filter in the binding column. The sample  
 
was incubated at room temperature for 15 minutes. Then 500 µl of wash  
 
solution 1 was added to the column and centrifuged at 10000 x g for 15  
 
seconds. The filtrate column was transferred to a new collection tube; 500 µl  
 
of wash solution 2 was added and centrifuged for 2 min at 10000 x g. The  
 
filtrate column transferred to a new collection tube and 50 µl of elution  
 
solution was added and centrifuged for 1 minute at 10000 x g.  
 
 
2.8.5 Measurement of quantity and purity of total RNA  
 
 
The concentration of the RNA samples extracted was determined by  
 
electrophoresis through a 1 % (w/v) agarose gel, the quality of total RNA  
 
samples were estimated by visualising the sharply defined ribosomal units  
 
28s and 18s, present at 4.7 Kb and 1.9 Kb respectively for mouse. The purity  
 
of the RNA yield was quantified spectrophotometrically by calculating the  
 
ratio of the samples optical density at 260 nm and 280 nm. RNA samples  
 
with an OD260/280 ratio between 1.9 and 2.1 were considered to be  
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sufficiently pure for further experiments. The concentration in g/ml can be  
 
calculated from the absorbance value:  
 
 
A260 x dilution factor x 40 g/ml  
 
 
2.8.6 DNase I treatment  
 
 
Amplification grade DNase I was used to remove any contaminating genomic  
 
DNA from the isolated RNA. 2 g of RNA, manufacturer supplied reaction  
 
buffer and DNase I were incubated at room temperature for 15 minutes. To  
 
inactivate the DNase I, EDTA was added to a final concentration of 2.3 mM  
 
and the reaction was heated to 65 °C for 10 minutes. The resulting DNA-free  
 
RNA was then used for cDNA synthesis.  
 
 
2.8.7 Reverse Transcription  
 
 
The isolated RNA was reverse transcribed using Reverse Transcription  
 
System kit (Promega). The complimentary DNA (cDNA) reactions were  
 
carried out on a PCR Sprint or Whatman-Biometra thermal Cycler. In  
 
preparation for first-strand synthesis, 2 l of total RNA (1ug) and 1 l of Oligo  
 
(dT) Primer (0.5 µg / µl) or Random Primers (0.5 µg/µl) was incubated at 70  
 
°C for 10 minutes. The reaction mix for first strand synthesis consisted of 4 l  
 
 
of MgCl2, 25mM, 2 µl of reverse transcription 10 X buffer, 2 µl of dNTPs  
 
mixture, 10 mM, 0.5 µl of Recombinant RNasin Ribonuclease Inhibitor, 15 U  
 
of AMV reverse transcriptase (High Conc.).  The first strand synthesis  
 
reaction incubated at 42 °C for 15 minutes, and then at 90 °C for 5 minutes  
 
to inactivate the reverse transcriptase.  
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2.8.8  Primer design  
 
 
For each gene, a pair of primers was designed using Primer3Plus software  
 
(www.bioinformatics.nI). The primers were ordered from Sigma-Aldrich  
 
Company Ltd. (Gill ingham, UK), and were resuspended to a final  
 
concentration of 100 ng/µl in nuclease free water.  
 
 
Table 2.2 Detailed the primers sequences and the PCR product sizes for  
 
each gene tested. In addition, gene -actin was used as a positive control.  
 
 
 
Gene  Primer  
 
 
B-actin  
 
 
 
 
 
Tbpl1  
 
 
 
 
 
FHL5  
 
 
 
 
 
Gtf2a1l  
 
 
 
 
 
T7-pET-100  
 
 
F: 5´-TATCCCGGGTAACCCTTCTC-3´  
 
 
R: 5´-TGCTGGGAGTCTCAGGACAG-3´  
 
 
F: 5´-CACCATGGATGCAGACAGTGATGTT-3´  
 
 
R: 5´-TAAAATCTCCTTCCTGCTTTCA-3´  
 
 
F: 5´- CACCATGACAAGTAGTCAATTTGATTGT-3´  
 
 
R: 5´-CTAAGCGTCAGTGTCTGC-3´  
 
 
F: 5´-CACCATGGCCTTCATCAACCTG-3´  
 
 
R: 5´- CCACTCAGCTTCACCAATG-3´  
 
 
F: 5´-TAATACGACTCACTATAGGG-3´  
 
 
R: 5´-TAGTTATTGCTCAGCGGTGG-3´  
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2.8.9 Polymerase chain Reaction (PCR)  
 
 
2.8.9.1 Standard PCR conditions:  
 
 
PCRs were performed using 1 µl to 5 µl of cDNA (or Plasmid) template, 17 µl  
 
of nuclease free water, 2.5 µl of 10 x PCR buffer, 1.5 µl of magnesium  
 
chloride (25 mM), 1 µl of dNTPs (10 mM), 100 ng of forward primer, 100 ng  
 
of reverse primer and 2.5 U of Taq DNA polymerase in a total volume of 25  
 
µl. reactions were denatured for 30 seconds at 94 ºC (or 5 minutes at 98 ºC  
 
with KOD DNA polymerase), then subjected to 30 cycles of 95 ºC for 30 ºC  
 
seconds, 58-63 ºC for 20 seconds, and 72 ºC for 1-2 minutes. This was  
 
followed by a final 10 minutes extension step at 72 °C and a 4 ºC hold step.  
 
The reaction mixture was run in either a thermal cycler (UVI gene thermal  
 
cycle, PCR Sprint or Whatman-Biometra thermal cyclers).  
 
 
Pfu DNA polymerase (Promega) was used for high fidelity cloning PCRs.  
 
DNA was amplified in a 20 µl reaction containing 1 µl of cDNA template, 5 x  
 
amplifications buffer, 1 mM magnesium sulfate, 100 ng of each forward and  
 
reverse primer. 0.3 mM dNTPs, 2.5 U Pfu DNA polymerase and nuclease  
 
free water. Reactions were performed with a 2 minutes 98 ºC denaturation  
 
step, followed by 30 cycles of 15 seconds denaturation at 98 ºC, 30 seconds  
 
primer annealing at 58-63 ºC (depending on primer composition) and 5  
 
minutes of primers extension (based on at least 1 minute per kb of DNA to  
 
be amplified) at 70 ºC. The final extension step of 5 minute at 72 ºC was  
 
followed by a 4 ºC hold step. A negative control without (cDNA template) was  
 
also incubated in the same manner. The samples were subjected to  
 
electrophoresis through 0.75 -1.5 % (w/v) agarose gel.  
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2.8.9.2 Quantitative real-time PCR assay  
 
 
QRT-PCR reactions were carried out using the StepOnePlus™ real-time  
 
PCR instrument (Applied Biosystems). Quantitative RT-PCR was used to  
 
quantify the mRNA expression of Tbpl1, FHL5 and Gtf2a1l in isolated male  
 
germ cells and DNA plasmid purified from the host cells BL2 (DE3). QPCR  
 
was prepared in triplicates of 20 l reaction mixture in MicroAmp optical 96-  
 
well reaction plates and sealed with optical adhesive covers (Applied  
 
Biosystems). Each reaction well contains 2 l of template DNA, 2 l of 10 ×  
 
SYBR® Green PCR Master Mix (Applied Biosystems), and 12.5 pmol each of  
 
forward and reverse primers. Real-time QPCR was conducted with the  
 
following cycling conditions: 50 °C for 2 min, 95 °C for 20 sec, followed by 50  
 
cycles of 95 °C for 15 s and 60 °C for 30 s each. The data obtained from  
 
each reaction was analysed by StepOne™ Software v 2.2.2. Relative  
 
representing groups the change level in the gene expression from real-time  
 
 
QPCR between experimental groups was calculated by comparative CT  
 
method. The data was analysed by calculating the relative quantification  
 
(RQ) using the equation: RQ = 2-∆CT x100, where ∆CT = CT of target gene- CT  
 
of endogenous gene (Housekeeping gene). Evaluation of 2-∆CT indicates the  
 
fold change in gene expression, normalized to the internal control (-actin)  
 
which enable the comparison between differently treated cells. DNA plasmid  
 
from untreated bacteria was used as the control value (internal positive  
 
control) in order to calculate the fold change in gene expression.  
 
Concentrations of plasmid were measured by absorbance at 260 nm with a  
 
UV/Vis Spectrophotometer (Beckman Coulter, Fullerton, CA). The ratio of  
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absorbance at 260 and 280 nm, (OD260 / OD280), was routinely found to be  
 
between 1.8 and 2.0, indicating minimum protein contamination.  
 
 
2.9 Molecular biology: Methods for DNA  
 
 
2.9.1 Agarose gel electrophoresis  
 
 
RNA or DNA fragments were size-separated in the horizontal electrical field  
 
being embedded into the agarose-matrix. Depending on the expected sizes  
 
of RNA/DNA fragments, 0.75 to 2 % (w/v) agarose gels in 1X TBE buffer  
 
were prepared. Gels always contained 0.5 g/ml ethidium bromine to  
 
visualize nucleic acids later on. Before loading into gel slots, nucleic acids  
 
were mixed 1/1 (v/v) with the DNA loading dye. The electrophoresis was run  
 
in the standard TBE-running buffer at 100-121 V in a horizontal  
 
electrophoresis tank (geneflow, UK). After the run, DNA/RNA bands were  
 
photographed under transillumination and recorded using a digital gel  
 
documentation system (UVItec, Cambridge, UK). Sizes of experimental  
 
bands were determined according to the standard DNA ladder run in parallel  
 
in (high, middle or low range) (Fermentas, UK).  
 
 
2.9.2  Purifying gel DNA bands  
 
 
DNA bands were weighed. Following the Qiagen MinElute Handbook for  
 
purifying the DNA, 3 times the volume of solubilizing Buffer QG (Qiagen) was  
 
added to 1 times the volume of gel and incubated for 10 minutes at 70 °C.  
 
The fluid was transferred to a Qiagen MinElute column and centrifuged for 1  
 
minute at 10000 x g to bind the DNA to the column. The flow-through was  
 
discarded and the column washed with 500 l of Buffer QG. This was re-  
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centrifuged and the flow-through discarded. 750 l of washing Buffer PE  
 
(Qiagen) was added to the column, left to stand for 10 minutes and  
 
centrifuged at 10000 x g for 1 minute. The flow-through was discarded and  
 
the column re-spun for another minute. The column was placed in a sterile  
 
Eppendorf tube. 10 l of eluting Buffer EB (Qiagen) was added to the column  
 
and left for 1 minute for optimal elution. This was centrifuged at 13000 x g for  
 
1 minute. The DNA was then stored at -20 oC. The DNA was analysed by  
 
electrophoresis on a 1.5 % agarose gel.  
 
 
2.9.3  Plasmid DNA isolation  
 
 
Plasmid isolation was performed by the alkaline lysis procedure using the  
 
QIAprep Miniprep TM kit and protocol from Qiagen Inc (Valencia, CA, USA).  
 
Briefly, 3 ml of an overnight culture was centrifuged at 10,000 x g and the  
 
pellet was resuspended in buffer P1, 250 l of 50 mM Tris.Cl (pH 8) buffer  
 
containing 10 mM EDTA and 0.1 mg/ml of RNase A. Following a sequential  
 
addition of buffer P2, 250 l of 200 mM NaOH containing 1 % SDS solution  
 
and 350 l of 3 M potassium acetate, the sample was mixed gently and  
 
centrifuged for 10 minutes at highest speed. The supernatant was carefully  
 
applied to the QIAprep column (Qiagen) and centrifuged briefly. The column  
 
was washed with buffer PB, 0.5 ml of guanidine HCl and isopropanol solution  
 
(pH 4.5), followed by buffer PE, 0.75 ml of 80 % ethanol. Finally, the plasmid  
 
DNA was eluted by the addition of buffer EB, 50 l of 10 mM Tris.Cl, 1 mM  
 
EDTA (pH 8.5), and centrifuged for 1 minute at maximum speed in a micro  
 
centrifuge.  
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2.9.4  Restriction endonuclease digestion of plasmid DNA  
 
 
Restriction enzymes digestion was carried out in a volume of 10 l containing  
 
1X buffer (10 mM Tris-HCl (pH 7.4), 300 mM NaCl, 1 mM DTT, 0.1 mM  
 
EDTA, 50% glycerol, 0.5 mg/ml BSA.), 1-10 µg of DNA plasmid or PCR  
 
product and 5 to 10 units of restriction enzymes and the volume made up to  
 
20 µl with nuclease free water. The mixture was typically incubated at 37 ºC  
 
for one hour followed by heat inactivation at 65 ºC for 20 minutes. The  
 
restriction enzymes commonly used in this study were Hind III, EcoRI,  
 
EcoRV and PstI.  
 
 
2.9.5  DNA quantification  
 
 
The concentration of DNA was measured using measured in a Smart Spec  
 
Plus spectrophotometer (Bio-Rad, Richmond, CA). The purity of the DNA  
 
after purification was confirmed by analysis of absorbance ratio at 260/280.  
 
The 260/280 ratio was used for determination of DNA purity against protein  
 
contamination; the standard ratio for plasmid purity is 1.8 - 2.0.  
 
 
2.10 Molecular Biology: cloning  
 
 
2.10.1 Bacterial growth media  
 
 
2.10.1.1 SOC medium  
 
 
SOC medium was made by dissolving 2 % w/v bacto-tryptone, 0.5 % w/v  
 
 
yeast in a total volume of 1 litre of dH2O containing 10 mM NaCl, 2.5 mM  
 
KCI, 10 mM MaCl2 and 10 mM MgSO4. The pH of the solutions was adjusted  
 
to pH 7.5 and autoclaved for sterilisation and 0.4 % v/v glucose solution  
 
added.  
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2.10.1.2 Luria-Bertani (LB) bacterial growth medium  
 
 
LB medium was prepared with dH2O containing 1 % (w/v) bacto-tryptone, 0.5  
 
% (w/v) yeast, 1 % (w/v) NaCl in a total volume of 1 litre of dH2O. The pH  
 
was adjusted to 7.0 and autoclaved for sterilization (121 ºC for 15 minutes).  
 
LB agar was made as described above, but supplemented with 2 % (w/v) per  
 
litre of bacto-agar added before adjusting the pH and sterilization.  
 
 
2.10.1.3 Antibiotic stock solution  
 
 
A. Ampicillin stocks were made (100 mg/ml): 1 g ampicillin was added to 10  
 
 
ml dH2O, sterilized by filtering the solution through syringe filter (0.2 mM), 1.0  
 
mL aliquots in individual eppendorf tubes was prepared and stored at -20  
 
ºC.  
 
 
B. Kanamycin (100 mg/ml): 1 g kanamycin was added to 10 ml dH2O;  
 
solution was sterile-filtered through syringe filter (0.2 mM), 1 mL aliquots in  
 
eppendorf tubes were stored at -20oC.  
 
 
2.10.1.4 Bacterial strains used for expression  
 
 
Bacterial strains and plasmids used in this work were strains of E.coli. The  
 
pET100/D-TOPOR vector from Invitrogen (Carlsbad, USA) containing the  
 
insert was used to transform BL21Star™ (DE3) from Invitrogen (Carlsbad,  
 
USA) competent cells (genotype: F-ompThSEMSB (rB-, mB-) gal dcm  
 
rne131 (DE3)) according to the manufacturer's instructions. Briefly, 10 ng of  
 
plasmid DNA was used to transform 50 L of BL21 Star™ (DE3) One ShotR  
 
cells, which were heat shocked at 42 ºC for 30 seconds and incubated in 250  
 
 
 
 
 
78  
l SOC medium for 1 hour. The entire transformation reaction was added to  
 
10 ml of LB containing 100 g/ml ampicillin.  
 
 
The recombinant of pET100/D-TOPOR vector was used to transform DH5  
 
competent cells (Genotype: F- 80lacZM15  (lacZYA-argF) U169 recA1  
 
endA1 hSEMR17 (rK-, mK+) phoAsupE44 - thi-1gyrA96 relA1). Barfly, 10  
 
ng of vector was used to transform a 100 l cell aliquot. Cells were then heat  
 
shocked at 42 ºC for 45 seconds and incubated in 200 l SOC medium for 1  
 
hour 50 minutes and 100 l of each transformation was plated on selective  
 
LB plate containing100 g/ ml ampicillin.  
 
 
2.10.1.5 Cloning of the PCR product into PET100/D  
 
 
The Tbpl1, FHL5 and Gtf2a1l fragments obtained by PCR amplification were  
 
cloned into the PET 100/D vector. Briefly, 2 l of fresh PCR products were  
 
mixed with 1 l of TOPO vector, 1 l of salt solution and 3 l of sterile  
 
distilled water. 3 l of the above cloning reaction were used to transform 50  
 
l of E. coli Top 10 cells from Invitrogen (Carlsbad, USA), using the heat  
 
shock method. The cells were mixed with the insert, incubated at room  
 
temperature for 5 minutes, and then incubated on ice for 30 minutes. The  
 
reaction was heat-shocked for 30 seconds at 42 ºC. Then, 250 l of SOC  
 
medium (Invitrogen) was added to the tube and incubated at 37 ºC with  
 
shaking for an additional 1 hour. Finally, 100 l and 200 l of the transformed  
 
cells were spread on pre-warmed LB-amp agar plates with 100 µg/ml  
 
ampicillin. Recombinant plasmid was isolated and analyzed by PCR  
 
amplification using T7 forward promoter primer (Invitrogen) and reverse  
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Tbpl1, FHL5 and Gtf2a1l primers (Schulte et al.), and restriction digestion by  
 
HindIII and EcoRV. Results were analyzed by agarose gel electrophoresis.  
 
 
2.10.2  Protein expression  
 
 
2.10.2.1 Expression of recombinant protein in E. coli  
 
 
Recombinant plasmid (10 ng in a 5 l volume) was used to transform 250 l  
 
of competent E. coli BL21 Star (DE3) Star by the heat shock method. After  
 
30 minutes of incubation at 37 ºC, the transformation reaction was added to  
 
10 ml of LB-amp medium and grown for 16 hours at 37 ºC with shaking. 500  
 
µl of the overnight culture was added to 10 ml of LB-amp medium and grown  
 
 
for another 2 hours or until OD600 reached 0.6 to 0.8. The culture was then  
 
divided into 2 tubes, one of which was induced by the addition of 1 mM  
 
isopropyl -D thiogalactoside (IPTG), while the other was used as a non-  
 
induced control. Competent cells transformed with empty vector were used  
 
as a negative control. From each culture 500 l were removed every hour for  
 
4 to 6 hours and analyzed by SDS PAGE.  
 
 
2.10.2.2 Purification of recombinant protein from E. coli lysates  
 
 
Recombinant plasmid DNA was cloned into the pET vector in order to obtain  
 
a fusion protein with 6XHis-tag at the N- terminal in order to facilitate its  
 
purification by affinity column chromatography under native or denaturing  
 
condition using Sigma-HIS-Select® Spin Columns.  
 
 
2.10.2.2.1 Purification under native condition  
 
 
Purification was performed under native condition as described by the  
 
manufacturer. The pellet from an overnight 10 ml culture was harvested and  
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resuspended in 1 ml Lysis buffer containing 50 mM NaH2PO4; 300 mM NaCl;  
 
10 mM imidazole (pH 8). The solution was sonicated on ice using six 10-  
 
second bursts at high intensity with a10-second cooling period between each  
 
burst. After 15 minute centrifugation at 3000 X g the supernatant was  
 
removed and purified under native conditions. In order to recover the  
 
insoluble proteins the pellet was purified under denaturing conditions. The  
 
supernatant was used for column purification. Columns were prepared  
 
according to the respective sample (soluble or insoluble). Initially, the resin  
 
 
was washed with native binding buffer 50 mM NaH2PO4, 300 mM NaCl, 20  
 
mM imidazole, pH 8. The supernatant was aspirated and the resin was  
 
washed three times with native binding buffer and used to pack a column.  
 
The soluble protein was collected in 1ml fractions after the addition of 100 µl  
 
of native elution buffer. The sample containing insoluble proteins was added  
 
to the column and allowed to bind for 30 minutes. The resin was  
 
resuspended three times in native wash buffer and used to pack a column.  
 
Elution and collection of the protein was as above. Purified lysate of E. coli  
 
BL21 transformed with an empty vector served as the negative control. The  
 
samples obtained were analyzed by SDS-PAGE.  
 
 
2.10.2.2.2 Purification under denaturing condition  
 
 
For purification under denaturing conditions, a 10 ml form overnight culture of  
 
induced cells was harvested by centrifugation for 10 minute at 3000 X g and  
 
the supernatant discarded. The cells were resuspended in 1 ml of denaturing  
 
 
lysis buffer containing 7 M urea; 0.1 M NaH2PO4; 0.01 M Tris.Cl, pH 8.0 and  
 
gently vortexed for 30 seconds. The cells were then incubated with agitation  
 
for 15 min at room temperature. The lysate was the centrifuged at 12,000 x g  
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for 15 - 30 min at room temperature to remove the pellet the cellular debris  
 
and the supernatant containing the protein transferred to a fresh tube.  
 
Column was prepared according to the respective sample (soluble or  
 
insoluble). Initially, the resin was washed with denaturing binding buffer 7 M  
 
 
urea; 0.1 M NaH2PO4; 0.01 M Tris.Cl, pH 8.0 then centrifuged for 2 min at  
 
890 x g. The resin was then pelleted by centrifugation at 10000 x g for 1  
 
minute and the supernatant (saving 10 µl for SDS-PAGE analysis). The  
 
pellet was washed three times with denaturing binding buffer 8 M urea; 0.1 M  
 
 
NaH2PO4; 0.01 M Tris.Cl; pH 6.3 and the mixture centrifuged at 10000 x g for  
 
1 minute and the supernatant saved. (saving 10 µl for SDS-PAGE analysis).  
 
The protein was eluted twice with 100 l of elution buffer 8 M urea; 0.1 M  
 
 
NaH2PO4; 0.01 M Tris.Cl; pH 4.5. The fractions obtained were analyzed by  
 
SDS-PAGE.  
 
 
2.11 Protein quantification  
 
 
The amount of protein in cell lysates was quantified to ensure equal loading  
 
in western blot gels. The concentration of proteins purified by HIS-Select®  
 
Spin Columns and cell lysates was quantified using Bradford protein assay  
 
(Bio-rad 500-0120) according to the manufacturer's instructions, with the  
 
detergent compatible with use of bovine serum albumin as the standard  
 
(200, 400, 600, 800, and 1000 mg/ml). Initially, dilutions of the protein  
 
standard were prepared at above concentrations and 5 µl of the standard or  
 
the cell lysate were added to individual wells of a 96 well-plate in triplicate.  
 
25 µl of reagent A* (2 % v/v reagent S in reagent A) was added to each well  
 
and 200 µl of reagent B then were added onto each well. Both samples and  
 
BSA controls were mixed by inversion and left at room temperature for 15  
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minutes. Prepared standard BSA concentration samples were read at  
 
absorbance 750 nm, each sample producing a triplicate reading to allow the  
 
average of these triplicates to be calculated and a standard curve was drawn  
 
(Figure 2.2). 30-40 µg of total protein was used for electrophoresis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Shows standard curve of bovine serum albumin and protein  
 
concentrations. This curve was used to calculate the protein concentration of  
 
the protein extracts.  
 
 
 
 
2.12  Western blot analysis  
 
 
2.12.1 Total protein extraction  
 
 
Total cellular protein was extracted from both untreated and treated cells  
 
(spermatocytes and spermatids). Cells were first washed with PBS and  
 
scrapped off into 300 µl of lysis buffer (60 mM Tris, 2 % SDS, 100 mM DTT).  
 
Detached cells were placed on ice for 5 minutes and then vortexed for 30  
 
seconds. The cells were placed on ice for 30 minutes with occasional  
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vortexing. The samples were centrifuged at 12 000 x g at room temperature  
 
for 5 minutes. The proteins were then transferred to a new 1.5 ml centrifuge  
 
tubes. The protein concentrations were determined using Bradford assay as  
 
described in section 2.11. The samples were mixed with 2X sample buffer  
 
containing 10 mM DTT and stored at -80 ºC for further use.  
 
 
2.12.2  SDS-polyacrylamide-gel-electrophoresis  
 
 
Samples to be analyzed (recombinant E. coli cells, cell extract) were  
 
separated on 12 % SDS-PAGE gel. Separation was performed at 100 V for 2  
 
hour and the gel was stained with Coomassie brilliant blue (R-250) for 1  
 
hour. The denatured polypeptides bind SDS to get a uniform negative charge  
 
and therefore migrate through a polyacrylamide-gel according to their sizes.  
 
Before loading on the SDS-polyacrylamide gel, these samples were thawed  
 
and boiled for 5 minutes, 40 g of protein were loaded onto a 12 % SDS  
 
PAGE.  
 
 
2.12.3  Preparation of SDS PAGE  
 
 
A Bio-Rad mini protein gel electrophoresis kit (500-0120) was used to run the  
 
gels. Tris buffers were prepared for both resolving gel and stacking gel. The  
 
resolving gel was prepared as follows, 10 % (w/v) of (bis/acrylamide 40 % -  
 
37:5:1, 1.5 M Tris base and 0.4 % (w/v) SDS, pH 8.4). 0.03 % (w/v) of freshly  
 
prepared ammonium persulphate (APS) and 0.03 % (v/v) of TEMED were  
 
then added to solidify the gel. The resolving gel was immediately pipetted  
 
between glass plates and spacers (1.0 mm thick) to a level 1 cm below the  
 
bottom of the comb when inserted and overlaid with 0.1% (w/v) SDS solution  
 
and polymerisation allowed to occur for 1 hour. The overlaid SDS was  
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removed and a 3 % of stacking gel (bis/acrylamide 40 % -37:5:1, 0.5M Tris  
 
base and 0.4 % w/v SDS, 0.01 % (w/v) ammonium persulphate and 0.1 %  
 
(v/v) TEMED, pH 6.8) was poured on the top and a 1 mm comb was  
 
inserted. Following gel polymerization, they were assembled and placed in a  
 
prespex tank containing electrophoresis running buffer (25 mM Tris base,  
 
192 mM glycine and 0.1% (w/v) SDS). Appropriate volume from each sample  
 
containing 30-40 µg protein was loaded per well as well as 5 µl prestained  
 
protein ladders (Thermo Fisher Scientific, UK) and biotinylated standards  
 
(New England Biolabs, UK). Samples were electrophoresed at a constant  
 
voltage of 100 V for 2 hours.  
 
 
2.12.4  Commassie brilliant blue staining  
 
 
The polyacrylamide gel was stained with Coomassie Blue to detect proteins.  
 
The gel was put into staining solution consisting of: 0.25 % (w/v) Coomassie  
 
Blue, 40 % (v/v) methanol, 7 % (v/v) acetic acid and placed on a shaker at 50  
 
rmp for 1 hour. Enough stain was used to allow the gel to float freely in a  
 
Petri dish. The stain was replaced by 3 volumes of Destain I (4 % (v/v)  
 
methanol, 7 % (v/v) acetic acid) and shaken for 40 minutes. Destain II (5 %  
 
(v/v) methanol, 7 % (v/v) acetic acid) replaced Destain I. This was shaken  
 
overnight at room temperature and then inspected for bands.  
 
 
2.12.5 Western blot analyses of Tbpl1, FHL5 and Gtf2a1l in isolated  
 
germ cells and purified recombinant protein.  
 
 
Spermatocytes and spermatids were seeded onto 6-well plastic culture  
 
plates with DMEM containing 10 % foetal bovine serum (FBS), 100 Unit/ml  
 
penicillin, and 100 mg/ml streptomycin (5 × 106 cells/ml; 1 ml per well) at 37  
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°C The medium was changed and they were serum starved in DMEM (with  
 
antibiotics) for 16 hours. They were then incubated for 1 hour with or without  
 
drugs. Total cellular protein was extracted from both untreated and treated  
 
cells (spermatocytes and spermatids). Cells were lysed in SDS lysis buffer  
 
(60 mM Tris, 2 % SDS, 100 mM DTT) and protein concentrations were  
 
determined with a commercial kit (Bradford Protein Assay, Biorad, UK). 40  
 
g of total protein was mixed with an equal volume of 2 X SDS loading  
 
buffer, resolved by SDS PAGE (10 % SDS polyacrylamide gel) and  
 
transferred to nitrocellulose membranes. Blots were blocked for 1 hour with  
 
blocking buffer (PBS, 0.5 % skim milk powder, and 0.1 % Tween-20), and  
 
incubated with primary antibodies against Tbpl1, FHL5 and Gtf2a1l. Anti-  
 
Tbpl1 rabbit polyclonal antibody (1:5000; Sigma-Aldrich, UK), rabbit  
 
polyclonal anti-FHL5 antibody (1:2000; Sigma-Aldrich, UK), rabbit polyclonal  
 
anti- Gtf2a1l (1:3000; Sigma-Aldrich, UK), and mouse monoclonal anti-  
 
GAPDH (1:1,000; Abcam, Cambridge, UK), were incubated with blots in 1%  
 
BSA in TBS-T overnight at 4 °C. On the next day, blots were washed in  
 
PBST (PBS, 0.1 % Tween-20) and incubated with HRP-conjugated  
 
secondary antibody (1:5,000) for 1 hour at room temperature. Blots were  
 
then washed in PBST; the bands were visualized by Novex® ECL  
 
Chemiluminescent Substrate Reagent Kit according to the manufacturer's  
 
instructions. Digital images were captured and density measurements were  
 
made using commercial software (Quanity One, Biorad). In addition, Western  
 
blotting was performed on cells lysate samples containing Tbpl1, FHL5 and  
 
Gtf2a1l on the purified recombinant protein obtained under native conditions  
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or denaturing conditions. Membranes were exposed to Tbpl1, FHL5 and  
 
Gtf2a1l antibodies in 1 % BSA in TBS-T overnight at 4°C.  
 
 
2.12.6  Western blot analyses of histidine tag in purified recombinant  
 
protein.  
 
 
The anti-His antibody was used to detect His Tagged recombinant proteins  
 
by recognising five consecutive Histidine residues. The membrane was  
 
incubated over night with mouse anti-his HRP (AbD Serotec, UK) diluted 1:  
 
5,000 in blocking buffer and washed three times with PBST at 4 °C. On the  
 
next day, blots were washed in PBST (PBS, 0.1% Tween-20) and incubated  
 
for 1 hour with sheep anti-mouse IgG diluted 1:30,000 for 1 h at RT. Blots  
 
were then washed in PBST; the bands were visualized by Novex® ECL  
 
Chemiluminescent Substrate Reagent Kit according to the manufacturer's  
 
instructions. Digital images were captured and density measurements were  
 
made using commercial software (Quanity One, Biorad).  
 
 
2.13 Statistical analysis  
 
 
Statistical analysis was performed with SPSS 16.0. The normality of the data  
 
was determined using the Kolmogorov-Smirnov test. The normality of the  
 
data was determined using the paired Student t-test. One-way-ANOVA  
 
analyses were performed to compare differences between control groups  
 
and treated groups. A 'P' value of (< 0.05) was considered statistically  
 
significant. The same statistical analyses were carried out in all chapters  
 
unless otherwise specified.  
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Chapter 3. Effect of hydrogen peroxide (H2O2) on germ cells in mice  
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3.1 Introduction  
 
 
Testing germline-genotoxicity in the male is generally undertaken in vivo,  
 
partly because of the difficulty of achieving full spermatogenesis in vitro and  
 
partly because mating studies are currently the only reliable way of testing  
 
heritable effects. The associated expense and ethical issues mean there is a  
 
constant need for the development of novel in vitro assays (as demonstrated  
 
by the European REACH regulation [EU, 2007], for example). This will  
 
require an in vitro test system that allows examination of individual germ cell  
 
types. It should also have high sensitivity and be suitable for the rapid  
 
screening of large numbers of chemicals. We propose that the use of Staput  
 
to separate highly enriched populations of spermatogonia, spermatocytes  
 
and spermatids, and their subsequent culture in the presence of putative  
 
genotoxins or reproductive toxins, coupled with the measurement of  
 
appropriate end-points of damage, has the potential to meet this need.  
 
These three germ cell categories contain the three major events occurring in  
 
spermatogenesis:  mitotic  proliferation  (spermatogonia);  meiosis  
 
(spermatocytes); and spermiogenic differentiation (spermatids). Therefore,  
 
even though each type contains a number of different sub-types, they make  
 
suitable groupings for toxicity analysis as all the parts of each process are  
 
covered within each cell population used.  
 
 
The ability to study specific germ cell types will also be useful in more  
 
fundamental studies of reproductive biology. During spermatogenesis, the  
 
male germ cell undergoes complex morphological, biochemical, and  
 
physiological changes, resulting in the formation of a mature spermatozoon.  
 
This dynamic procedure depends upon Sertoli cells that provide supply  
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nutrients, hormones and structural support to the germ cells and temporal  
 
regulation of their development, and on Leydig cells that synthesise the  
 
steroid hormones necessary for germ cell differentiation (Cheng and Mruk,  
 
2010, O'Shaughnessy et al., 2009, Meistrich and Hess, 2013). Even after  
 
decades of research in the field of male fertility, critical spermatogenic  
 
events, including Sertoli cell-germ cell interaction and mechanisms of  
 
androgen action, remain to be completely understood. A more in-depth  
 
understanding of these spermatogenic events will require, for example, the  
 
ability to study specific molecular signatures of individual testicular cells. That  
 
in turn will require the isolation of purified populations of spermatogenic cells  
 
as one of the crucial steps to address these important issues. Over the  
 
years, a range of approaches have been used to successfully isolate  
 
testicular cells (Chang et al., 2011), including elutriation and fluorescence  
 
activated cell sorter (FACS) (Bastos et al., 2005, Meistrich and Trostle,  
 
1975). Velocity sedimentation separation using Staput chambers is another  
 
of the approaches used to isolate spermatogenic cells (Han et al., 2001,  
 
Bellve et al., 1977) and has been more widely used, presumably because of  
 
the high purity of fractions that is possible and relatively low unit-cost of the  
 
experiments. Germ cell apoptosis is very common during the various stages  
 
of mammalian testicular development up to a point midway through  
 
spermatid development, when nuclear condensation has advanced too far to  
 
permit the de novo gene expression on which post-meiotic DNA repair and  
 
presumably apoptosis depends (Leduc et al., 2008). However, understanding  
 
of the mechanisms underlying male germ cell apoptosis is still limited (Koji  
 
and Hishikawa, 2003); although its role in removing genetically damaged  
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cells from the germ line is well accepted. Testicular cells are prone to  
 
 
oxidation by H2O2 and other reactive oxygen species (ROS) (Peltola et al.,  
 
1994, Maheshwari et al., 2009) which represent probably the commonest  
 
form of exposure to genotoxins that most cells encounter. ROS are  
 
chemically reactive molecules containing oxygen. They are generated as a  
 
natural by-product of the metabolism of oxygen and have a central role in  
 
sperm maturation as well as the acrosome reaction when expressed at low  
 
levels (Schulte et al., 2010). One of the main ROS formed during germ cells  
 
 
development is hydrogen peroxide (H2O2) (Moustafa et al., 2004). H2O2  
 
constitutes the major ROS form in sperm but its effective role as an  
 
endogenous inducer of germ cell apoptosis is mostly uncertain (Aitken et al.,  
 
 
1998, Maheshwari et al., 2009). H2O2 is also known to modulate a variety of  
 
cell functions. It is a potent ROS, but its lower biological activity compared  
 
with many other ROS, combined with its capacity to cross membranes and  
 
diffuse away from the site of generation, makes it an ideal molecule in signal  
 
transduction, and it is involved in inducing the acrosome reaction in sperm  
 
(Hampton and Orrenius, 1997, Tremellen, 2008). The plasma membrane of  
 
testicular cells is rich in polyunsaturated fatty acids, thus making it prone to  
 
 
oxidation by H2O2 and other ROSs as it is well known that oxidative stress  
 
causes DNA damage (Tremellen, 2008). Previous studies have shown that  
 
 
male germ cells displayed a much higher sensitivity to H2O2 in comparison to  
 
other cells (Maheshwari et al., 2009).  
 
 
Enriched populations of germ cells in the mouse thus seem suitable for  
 
analysis of the effects of genotoxins using the TUNEL assay. Since similar  
 
mechanisms could operate in the generation of pathological states in the  
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testis, the approach may also be important in studies of infertility in the  
 
future.  
 
 
3.2 Materials and Methods  
 
 
All information relevant to the experiments reported in this study is presented  
 
in section 2.1. Cell culture and the staput isolation of germ cell fractions are  
 
described in section 2.2 and 2.2.1 respectively. Cell counting in section  
 
2.2.1.5. Viabilities of the cells in section 2.2.1.6. Cell identification in section  
 
2.2.1.7.  Immunohistochemistry,  collection,  and  fixation  and  tissue  
 
preparation are described in sections 2.3, 2.3.1 and 2.3.2 respectively.  
 
Immunohistochemical staining of mouse tissue sections and isolation of  
 
germ cells are described in sections 2.3.3 and 2.3.4. TUNEL assay in section  
 
2.4 and 2.5. Statistical analysis was performed in SPSS 16.0.  
 
 
3.3 Results  
 
 
3.3.1 Purification of germ cells  
 
 
Microscopic examination of each of 12 ml fractions collected from the Staput  
 
chamber indicated that spermatids were concentrated in fractions 18-20,  
 
spermatocytes in the fractions 25-29, and spermatogonia in fractions 29-33,  
 
as shown in Figurer .3.1. This confirmed that different types of germ cells  
 
could be separated from each other on the basis of their density and size  
 
using staput.  
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Figure 3.1: Velocity sedimentation separation of germ cells of the mouse  
 
Spermatids, characterised by Tp1 antibody staining, sediment first, followed  
 
by spermatocytes (Scp3 antibody staining), then spermatogonia (GDNFR  
 
antibody staining). Microscopic examination of each fraction isolated by  
 
Staput showed that the maximum concentration of spermatids was in the  
 
fractions (18-20), followed by spermatocytes in the fractions (25-29),  
 
spermatogina in the fractions (29-33).  
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Figure 3.2: Immunohistochemical staining of Staput purified mouse testicular  
 
cells. Mouse testicular cells were stained with antibodies for specific proteins.  
 
Spermatids were detected with anti-TP1 (Panel A); spermatocytes were  
 
detected anti-SCP3 (Panel B) and spermatogonia were detected with anti-  
 
GDNFR (Panel C). Viewing magnification ×400.  
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3.3.2  Immunohistochemical staining of mouse tissue sections  
 
 
An immunostaining procedure was performed on paraffin-embedded mouse  
 
tissue sections. Paraffin embedding tissue samples was processed as  
 
described in sections 2.3.3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: Immunohistochemical staining of paraffin embedded sections of  
 
mouse testis. Tissue sections from mouse testicles were paraffin-embedded  
 
and stained with anti-GDNFR in order to detect spermatogonia. Hematoxylin  
 
was used for counterstaining.  
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Figure  3.4:  Spermatocytes  staining  using  immunohistochemistry.  
 
Immunohistochemistry staining was performed on paraffin embedded  
 
sections of mouse testis. Hematoxylin was used for counterstaining.  
 
Spermatocytes were detected with anti-SCP3.  
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Figure  3.5:  Immunohistochemical  staining  of  spermatids.  
 
Immunohistochemical staining  was  performed  on  paraffin  embedded  
 
sections of mouse testis. Hematoxylin was used for counterstaining.  
 
Spermatids were detected with anti-TP1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
97  
  
Figure 3.6: Assessment of the purity of the fractions. Cultured cells from all  
 
fractions were stained for each of the three antibodies and scored to  
 
determine their relative proportion in each fraction. The results for the three  
 
fractions showing the highest purity for each cell type are shown. The  
 
numbers are for total numbers of each cell type per fraction. It was found that  
 
specific fractions contained high purities of the individual cell types:  
 
spermatids in fraction F19; spermatocytes in F27; spermatogonia in F30;  
 
(Figure 3.3) so only these fractions were used for cell culture.  
 
 
3.3.3  Purification of germ cells by western blot  
 
 
Extractions of whole cell were made from each cell population and western  
 
blot analysis was performed to show protein expression differences for each  
 
population. Spermatids were detected with anti-TP1; spermatocytes were  
 
detected anti-SCP3 and spermatogonia were detected with anti-GDNFR.  
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Figure 3.7: A Western blot analysis on Staput-purified mouse testicular cells  
 
Specific protein was detected in each isolated cell fraction by specific  
 
antibody. The anti-GDNF antibody was used to indicate the Spermatogonia  
 
(panel A), anti SCP-3 antibody was used to indicate the spermatocytes  
 
(panel B), anti-TP1antibody (panel C), and the protein loading control  
 
GAPDH were shown (panel D).  
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The relative expression level of GDNF, SPC3 and TP1 was measured by  
 
GDNF, SPC3 and TP1/ GAPDH ratio. Results are the mean ± SEM. from  
 
four independent experiments ***p < 0.001. B Comparison of GDFNR, SCP3  
 
and TP1 respectively expression in isolated testicular germ cells,  
 
spermatogonia, spermatocytes, and spermatids were examined by western  
 
blot analysis and quantitative densitometry of GDNFR, SCP3 and Tp1 and  
 
GAPDH immunoblot bands was determined. The density of each band was  
 
quantified by the use of Image 1.45 software. The relative expression level of  
 
GDFNR, SCP3 and TP1 was measured by GDFNR, SCP3 and TP1 /  
 
GAPDH ratio. Results are the mean ± SEM. from three independent  
 
experiments (***p < 0.001) versus 24 day-old mouse testis.  
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Figure 3.8: Effect of H2O2 treatment on germ cells evaluated in the TUNEL  
 
assay. Columns represent the mean percentages ± SEM of apoptotic cells  
 
for each of the three concentrations of hydrogen peroxide used (0, 1.0 and  
 
10 µM). Data were obtained from three independent experiments. Each dose  
 
level within a cell type has been compared with the respective 0 µM group  
 
(***p < 0.001).  
 
 
Immunocytochemistry analysis was used successfully in this study to identify  
 
the principal classes of male germ cells following separation via Staput:  
 
examples of cells labelled with the different antibodies are shown in Figure  
 
.3.2. It was critical to determine the purity of the fractions so that cells from  
 
each of the fractions could be scored after binding to different antibodies. It  
 
was found that specific fractions contained high purities of the individual cell  
 
types: spermatids in fraction F19; spermatocytes in F27; spermatogonia in  
 
F30; (Figure 3.6). Therefore, only these fractions were used for cell culture. It  
 
also provides valuable information about the presence and the cellular  
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localization of proteins within the cells on paraffin embedded sections of  
 
mouse testis (Figures 3.3, 3.4 and 3.5).  
 
 
3.3.4  TUNEL assay  
 
 
The outcome of H2O2 treatment on mouse testis was evaluated by the  
 
TUNEL assay and results expressed as percentages of apoptotic cells, are  
 
shown in Figurer 3.8. The TUNEL assay revealed that all cells types had  
 
undergone significant levels of apoptosis compared with the controls (p   
 
0.001). Representative apoptotic cells from treated and non-treated samples  
 
 
are illustrated in Figure 3.9 .The results of the induction of apoptosis by H2O2  
 
treatment of different germ cell types are shown in Figure. 3.8. After  
 
treatment with H2O2 (1 and 10 µM) for 2 hours, a significant increase (p   
 
0.001) in spermatogonial apoptosis to 47% was observed when cells were  
 
 
treated with 1 µM H2O2. Moreover, the apoptosis of spermatogonial cells  
 
treated with 10 µM H2O2 showed a further significant increase to 62 % when  
 
compared with control (p  0.001). Following treatment with 1 µM H2O2,  
 
spermatocytes showed an increase in cell apoptosis to 38%, which was  
 
statistically significant when compared with the corresponding controls (p   
 
0.001). A further increase to 51 % in cell apoptosis was observed when cells  
 
 
were treated with 10 µM H2O2. This increase was significant compared with  
 
controls (p  0.001). Cell apoptosis was significantly increased to 29 % when  
 
cells were treated with 1 µM H2O2 (p  0.001). The apoptosis of spermatids  
 
treated with 10 µM H2O2 was significantly increased to 40 % compared to the  
 
corresponding controls (p  0.001). Figure 3.8 additionally shows that while  
 
the levels of spontaneous apoptosis are similar for all three germ cell types in  
 
 
the control group, the response of spermatids to both 1 and 10 µM H2O2 was  
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markedly lower than that of spermatogonia, with spermatocytes intermediate  
 
between them in both cases. The difference was statistically significant (p   
 
0.001) between the cell types.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9: Effect of H2O2 treatment on germ cells of the mouse evaluated  
 
by the TUNEL assay. Cells treated with 10 µM H2O2 (A) were compared with  
 
untreated cells (A1). Arrows indicate representative TUNEL-positive  
 
(apoptotic) cells in each case. Viewing magnification × 400.  
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3.4 Discussion  
 
 
Despite recent advances in the study of male germ line cells in terms of  
 
genetics and development, our understanding of the effect of toxins on  
 
specific cell types has been largely limited to what can be achieved by, often  
 
cumbersome, in vivo studies to make such distinctions. The results  
 
presented here demonstrate that a suspension of mouse germ cells can be  
 
obtained from testicular tissue and fractionated into large homogenous  
 
populations of spermatogonia, spermatocytes, spermatids and spermatozoa  
 
using staput.  
 
 
Validation  of  the  system  involved  using  Western  blot  and  
 
immunohistochemistry to determine the purity of the cell populations isolated  
 
by staput (Bellve et al., 1977, Simon et al., 2010, Bryant et al., 2013), using  
 
antibodies against: TP1 to detect spermatids; SCP3 to detect spermatocytes;  
 
and GDNFR to detect spermatogonia. TP1 is an important nuclear protein in  
 
spermatids as histones are replaced by protamines during spermatogenesis.  
 
Its specificity to the haploid phase of spermatogenesis makes it a useful  
 
marker for spermatids as previously discussed (Meistrich et al., 1994, Yu et  
 
al., 2000). Spermatocytes can be located by the presence of Scp3.  
 
Synaptonemal complexes are structures formed between homologous  
 
chromosomes during meiotic prophase, thought to be involved in  
 
chromosome pairing and recombination (Brockway et al., 2014) . They  
 
comprise lateral and central elements and the two components have been  
 
identified in rodents, one of which is the SCP3 (Dobson et al., 1994,  
 
Lammers et al., 1995). Spermatogonia can be labelled by GDNFR (Savitt et  
 
al., 2012). Sertoli cells secrete a ligand to GDNFR called GFR-1 (Viglietto et  
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al., 2000). The binding of this substrate-ligand complex activates the Ret  
 
receptor tyrosine kinase (Tadokoro et al., 2002).This mediates an  
 
intracellular response that is linked to the proliferation of an undifferentiated  
 
type A spermatogonia and is therefore considered a good marker for these  
 
 
types of spermatogonia (Meng et al., 2000). Hydrogen peroxide (H2O2) has  
 
been found to induce apoptosis in a various cell types and although the  
 
 
sensitivity of germ line cells to H2O2 is not fully understood, DNA strand  
 
breakage by the production of free radicals is the trigger for the programmed  
 
 
cell death. The results of the present study show that H2O2, even at a low  
 
concentration of H2O2 of 1 µM, has the ability to induce apoptosis in  
 
testicular germ cells in vitro. This is in line with what has been reported  
 
previously (Maheshwari et al., 2009) demonstrating concordance between  
 
our approach to preparing testicular germ cells and previous methodologies.  
 
 
In the present work, following 2 hours of treatment with 10 µm H2O2, a 10-  
 
fold increase in the proportion of apoptotic cells was found. There was a  
 
statistically significant induction of apoptosis in germ line cells (p < 0.001).  
 
 
The spermatogonia were significantly more affected by H2O2 than the  
 
spermatocytes, which were significantly more affected than spermatids. This  
 
correlates with the proportion of dividing cells expected to be present in  
 
these populations. Thus, if dividing cells are more susceptible to genetic  
 
damage than non-dividing cells, this could account for the lowest amount of  
 
apoptosis occurring in the latter population. Indeed, there are a number of  
 
different types of cells within spermatogonia, spermatocytes and spermatids,  
 
each of which could have different susceptibilities to genetic damage.  
 
Therefore, one challenge for the future will be to examine chemicals that  
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react primarily with each germ cell type, and to refine the Staput separation  
 
so as to isolate more specific and well defined populations. Furthermore,  
 
such a clear difference in sensitivity may be highly important in the toxicity  
 
assessment of other chemicals but would be very difficult to demonstrate  
 
with in vivo studies. Therefore, we believe that our approach holds significant  
 
advantages for the development of sensitive and specific in vitro reproductive  
 
and genetic toxicology assays.  
 
 
Staput separation of specific germ cell types, coupled with short term in vitro  
 
culture shows potential for the rapid assessment of toxins in multiple germ  
 
cell types with high sensitivity. Notably, it allows the examination of high  
 
numbers of cells such as spermatogonia, which are normally present in  
 
relatively low amounts  in vivo, compared with spermatocytes and  
 
spermatids. Overall, the present work shows that this in vitro system has  
 
potential to be a sensitive, rapid screen for reproductive toxins.  
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Chapter 4. Effect of doxorubicin on germ cells in mice  
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4.1 Introduction  
 
 
Anthracyclines such as doxorubicin, widely used to treat various types of  
 
tumours, may result in induced testicular toxicity and oxidative stress  
 
(Badkoobeh et al., 2013). One of the frequently used chemotherapeutic  
 
drugs is the extremely effective anthracycline doxorubicin (Badkoobeh et al.,  
 
2013). Doxorubicin is the antineoplastic drug of choice in the treatment of  
 
various types of tumours, such as childhood leukemia and testicular cancer,  
 
though one of its adverse effects is male infertility (Shamberger et al., 1981,  
 
Imahie et al., 1995, Prahalathan et al., 2005, Vendramini et al., 2010).  
 
Doxorubicin has become the interest of several researchers since the  
 
mechanism by which it induces toxicity is known; however, novel strategies  
 
are being developed to prevent the harmful effects of this drug (Finn et al.,  
 
2011). A number of studies have reported the toxicity of doxorubicin in  
 
organs, such as liver and kidney as well as in testes, in which testicular  
 
dysfunction and male infertility has been reported (Hou et al., 2005,  
 
Yagmurca et al., 2007). Because of the importance of doxorubicin in treating  
 
many types of haematological and solid tumours, various pharmacological  
 
and non-pharmacological plans have recently been suggested to counteract  
 
its toxicity, specifically antioxidant supplements and physical exercise  
 
(Alshabanah et al., 2010). Increasing investigational evidence suggests that  
 
doxorubicin treatment induces testes dysfunction mostly due to excessive  
 
production of ROS and increased susceptibility to apoptosis, especially those  
 
under rapid and constant proliferation, such as the male germ cells (Hou et  
 
al., 2005, Shinoda et al., 1999, Yeh et al., 2007).  
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Doxorubicin has also been reported to be a somatic cell mutagen in humans  
 
and animals (Smith, 2003, Pulte et al., 2008). The number of male germ cells  
 
that undergo apoptosis has been increasing due to response to numerous  
 
chemotherapeutic agents involving anthracyclines (Sjoblom et al., 1998,  
 
Zanetti et al., 2007). The cells most sensitive to doxorubicin are the early  
 
spermatogenic cells, spermatogonia and meiotically dividing spermatocytes  
 
(Sjoblom et al., 1998, Shinoda et al., 1999, Zanetti et al., 2007). In 1979, (Lu  
 
and Meistrich, 1979) reported that even a low dose of doxorubicin was able  
 
to target male germ cells in mice, mainly spermatogonia, and lead eventually  
 
to seminiferous epithelium depletion. Moreover, it was harmless to primary  
 
spermatocytes (Lu and Meistrich, 1979). Doxorubicin caused testicular  
 
toxicity and it mainly exerts its effect on premeiotic spermatogonial cell,  
 
because of its high division rate and slow cell cycle (Lu and Meistrich, 1979,  
 
Bechter et al., 1987, Jahnukainen et al., 2000). Doxorubicin uses potent  
 
anticancer activity during a mechanism that includes intercalation with DNA  
 
and an inhibition of topoisomerase II activity that results in replication-  
 
dependent, site-selective double-strand breaks in DNA (Myers CE, 1990,  
 
Quiles et al., 2002). Doxorubicin also has been shown to interfere with a vital  
 
molecule included in transcription and stability of chromosome, the DNA  
 
methyl transferase 1 - DNMT1 inducing apoptosis (Yokochi and Robertson,  
 
2004). Therefore, it can target the immature germ cell line, leading to long or  
 
short term male infertility (Dacunha et al., 1983, Meistrich, 2013). This  
 
genotoxic effect leads to up-regulation of cancer suppressor gene, p53, a  
 
substantial mediator of cell cycle arrest designed to prevent DNA replication  
 
in the presence of DNA damage and this leads to apoptosis (Bunz et al.,  
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1998). Recent studies have also shown that doxorubicin is capable of  
 
reducing the viability of cancer cells through RNA damage (Fimognari et al.,  
 
2008).  
 
 
The chemical structure of doxorubicin favours the generation of free radicals  
 
and the compound can bind to iron and form complexes with DNA, resulting  
 
in DNA damage (Eliot et al., 1984, Ravi and Das, 2004). Moreover, it  
 
promotes the generation of free radicals and the initiation of oxidative stress,  
 
leading to cellular injury (Injac and Strukelj, 2008). This free radical  
 
generation from doxorubicin might contribute as genotoxicity in normal cells  
 
(Quiles et al., 2002). It has been reported that doxorubicin induces ROS  
 
generation in different cancer cells (Gouaze et al., 2001). However, the main  
 
mechanism of action of doxorubicin induced ROS in tumour cell is still not  
 
completely  known.  Many  studies  have  shown  that  inhibition  of  
 
overexpression of antioxidant enzymes that induced oxidative stress by  
 
doxorubicin prevents apoptosis in tumour cells (Gouaze et al., 2001, Suresh  
 
et al., 2003). Blocking the activity of endogenous antioxidants, such as  
 
glutathione produced by tumour cells, made them more vulnerable to  
 
doxorubicin (Mallery et al., 1999, Poirson-Bichat et al., 2000).  
 
 
Many studies have showed that exposure to doxorubicin caused significant  
 
increase in chromosomal aberrations in spermatocyte (Attia et al., 2010,  
 
Meistrich et al., 1990, Abraham and Franz, 1983). It also increases the  
 
incidence of meiotic micronuclei in male rats resulting in reduced fertility  
 
(Baumgartner et al., 2004). Furthermore, increased total number of cells with  
 
structural chromosomal aberrations, and severe inhibition in the mitotic  
 
activity of spermatogonia was found following doxorubicin treatment in male  
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mice (Tohamy et al., 2003). The negative effect of doxorubicin on the  
 
premeiotic S-phase of mouse spermatocytes has been reported (Russo and  
 
Levis, 1992). In the rat testis, doxorubicin was shown to inhibit DNA  
 
synthesis and to induce apoptosis (Jahnukainen et al., 2000), in addition to  
 
induction of spermatid micronuclei (Lahdetie et al., 1994). Furthermore,  
 
incident of morphological changes and degeneration of male germ cells have  
 
showed that sperm cells were undergoing apoptosis as revealed by in situ  
 
terminal deoxynucleotidyl transferase mediated dUTP nick end labeling  
 
(TUNEL assay) (Shinoda et al., 1999, Yeh et al., 2009). Moreover,  
 
histological analysis and  flow cytometry  have showed an increase in  
 
apoptotic cells of  both aneuploid and diploid spermatids of mouse male  
 
germ cells (Katoh et al., 1990).  
 
 
The present investigation was designed to determine whether exposure of  
 
mice germ cells to doxorubicin induces DNA damage in the form of strand  
 
breaks and apoptosis in male germ cells. If so, what is the relative sensitivity  
 
of specific cell types to doxorubicin. Additionally, the usefulness of in vitro  
 
cultures of mice spermatogonia, spermatocytes and spermatids, in  
 
conjunction with the Comet assay TUNEL Assay is reported.  
 
 
4.2 Materials and Methods  
 
 
All information relevant to the experiments reported in this study is presented  
 
in section 2.1. Cell culture and the staput isolation of germ cell fractions are  
 
described in section 2.2 and 2.2.1 respectively. Cell counting in section  
 
2.2.1.5. Viabilities of the cells in section 2.2.1.6. Cell identification in section  
 
2.2.1.7.  Immunohistochemistry,  collection,  and  fixation  and  tissue  
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preparation were described in sections 2.3, 2.3.1 and 2.3.2 respectively.  
 
Immunohistochemical staining of mouse tissue sections and isolation of  
 
germ cells were described in sections 2.3.3 and 2.3.4. TUNEL assay in  
 
section 2.4 and Comet assay in section 2.5. Statistical analysis was  
 
performed in SPSS 16.0.  
 
 
 
 
4.3 Results  
 
 
4.3.1 Treatment of cells with doxorubicin  
 
 
Cells were cultured and treated with different concentrations (0, 0.05, 0.5,  
 
and 1 mM) of doxorubicin for 1 hour at 37 °C. Germ cells (treated and  
 
untreated) were immediately used in the Comet assay as described  
 
previously in section 2.7. For TUNEL assay, doxorubicin was added to the  
 
isolated germ cells in 6-well plastic culture plates with DMEM media at 37 °C  
 
to yield final concentrations of 0.05, 0.5, and 1 mM, respectively. In both  
 
cases, treated and untreated cells were fixed with 4 % formaldehyde for 10  
 
minutes and washed twice, each for 5 minutes in PBS containing 0.5 % BSA  
 
and stored at in 70 % (v/v) ethanol and TUNEL assay was performed as  
 
described in sections 2.5 and 2.6.  
 
 
4.3.2  Effect of doxorubicin on isolated testicular germ cells  
 
 
To verify the level of sensitivity of male germ cells to doxorubicin, purification  
 
of male germ cells from adult mice were used as cellular material, and  
 
doxorubicin was used as a source of genotoxicity. DNA damage in isolated  
 
germ cell spermatogonia, spermatocytes and spermatids was evaluated  
 
using the Comet assay. In addition the presence of apoptosis was  
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determined by terminal deoxynucleotidyl transferase-mediated dUTP nick  
 
end-labeling (TUNEL) detection in situ and by an increase in apoptotic cells.  
 
 
4.3.2.1 Comet assay  
 
 
The results of the single cell gel electrophoresis analysis are shown in Figure  
 
4.1, 4.2 and 4.3. Comet image of isolated germ cells before (untreated cells)  
 
and after treatment with different concentration of doxorubicin. Control cells  
 
show an intact head, while the damaged cells show a reduced head and a  
 
comet tail; the bigger the damage, the greater the tail (Figure 4.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Comparison of control, comet, and apoptotic cells based on  
 
fluorescence microscopy germ cells treated with different concentration of  
 
DOX showing DNA damage (magnification X 400) (A) Control cells in  
 
standard alkaline Comet assay; (B) 0.05 mM DOX treated cells; (C) 0.5 mM  
 
DOX treated cells; (D) 1 mM DOX treated cells.  
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The responses of purified germ cells to DOX in the Comet assay (OTM and  
 
tail DNA) are shown in Figure 4.2 and 4.3. A significant increase in the OTM  
 
and tail DNA of spermatogina from 2.5 (OTM) and 37.17 % (tail DNA),  
 
respectively, was observed when treated with 0.05 mM DOX. Furthermore,  
 
at 0.5 mM, OTM and tail DNA damage showed a further significant increase  
 
to 4.9 and 46 % respectively in spermatogonial cells compared with control  
 
(p  0.001). Additionally, on treatment of spermatogonial cells with 1 mM the  
 
DNA damage increased further to 7.4 for OTM and 59.35 % for tail DNA. In  
 
contrast, spermatocytes showed significant increase in the OTM and tail  
 
DNA at 0.5 mM DOX 3.8 for OTM and 40.97 % for tail DNA, which was  
 
statistically significant compared with the corresponding controls (p  0.01).  
 
Additionally, when spermatocytes cells treated with 1 mM the DNA damage  
 
increased further to 5.7 for OTM and 43.61 % for tail DNA while, spermatids  
 
showed only significant increase in the olive tail moments but not in tail DNA  
 
at 0.5 mM DOX 2.1 for OTM, when compared with the corresponding  
 
controls (p  0.05). Moreover, Cells when treated with 1 mM the DNA  
 
damage increased further to 4.25 for OTM and 42.21 % for tail DNA.  
 
 
Results of the Comet assay with purified germ cells showed increase in olive  
 
moment, tail moments and increase in the tail DNA as indicators of DNA  
 
damage induced by doxorubicin exposure of germ cells in vitro. For the  
 
treatment with 0.05 mM DOX, hardly was any DNA damage found on the  
 
spermatocytes and spermatids, suggesting that there was very little or no  
 
cytotoxic on these cells; however, spermatogonia was found more sensitive  
 
to 0.05 mM which might be due to cytotoxic effects of DOX.  
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Figure 4.2: DNA damage induced in mice germ cells by doxorubicin  
 
treatment. The distribution of mouse spermatogonia, spermatocytes and  
 
spermatids with different extent of DNA damage (0 ± 3) was determined by  
 
the Olive tail moment after treatment with 0.05, 0.5 and 1 mM doxorubicin.  
 
The results are shown as mean ± SEM of 3 independent experiments, (***  
 
p<0.001, **p<0.01, *p<0.05 when compared with the respective control  
 
group).  
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Figure 4.3: Comet assay results obtained from exposure of 0.05, 0.5, and 1  
 
mM concentrations of doxorubicin to germ cells. Comet parameters, % tail  
 
DNA were taken into account to measure DNA damage. The results are  
 
shown as mean ± SEM of 3 independent experiments, (*** p<0.001,  
 
**p<0.01, *p<0.05 when compared with the respective control group).  
 
 
 
 
4.3.3 TUNEL assay  
 
 
TUNEL assays for apoptosis evaluation were performed on separate cell  
 
samples of the same cell populations as described in detail in sections 2.5  
 
and 2.6. The result of doxorubicin treatment on isolated germ cells of mouse  
 
testis was expressed as mean percentages ± SEM of apoptotic cells. The  
 
TUNEL assay revealed that all cells types had undergone significant levels of  
 
apoptosis compared with the controls (p  0.001). The results of the  
 
induction of apoptosis by DOX treatment of different germ cell types are  
 
shown in Figure 4.4. After treatment with DOX (0, 0.05, 0.5 and 1 mM) for 1  
 
hour, a significant increase (p  0.01) in spermatogonial apoptosis to 11 %  
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was observed when cells were treated with 0.05 mM DOX. Moreover, the  
 
apoptosis of spermatogonial cells treated with 0.5 mM dox showed a further  
 
significant increase to 23 % when compared with control (p  0.001). Further  
 
increase was observed when the cells were treated with 1 mM DOX.  
 
Following treatment with 0.5 mM DOX, spermatocytes cells showed an  
 
increase in cell apoptosis to 15 %, which was statistically significant when  
 
compared with the corresponding controls (p  0.01). A further increase to 34  
 
% in cell apoptosis was observed when cells were treated with 1 mM DOX.  
 
This increase was significant compared with controls (p  0.001). The  
 
apoptosis of spermatids treated with 0.5 mM dox was significantly increased  
 
to 13 % compared to the corresponding controls (p  0.05). A further  
 
increase to 24 % in cell apoptosis was observed when cells were treated with  
 
1 mM DOX. This increase was significant compared with controls (p  0.01).  
 
 
Furthermore, Figure 4.4 shows that though the levels of spontaneous  
 
apoptosis are different between all three germ cell types in the control group,  
 
the response of spermatids to 0.05, 0.5 and 1 mM DOX was clearly lower  
 
than that of spermatogonia, with spermatocytes intermediate among them in  
 
both cases. The difference was statistically significant (p  0.001) between  
 
the cell types.  
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Figure 4.4: Effect of DOX treatment on germ cells evaluated in the TUNEL  
 
assay. Columns represent the mean percentages ± SEM of apoptotic cells  
 
for each of the three concentrations of DOX used (0, 0.05, 0.5 and 1 mM).  
 
Data were obtained from three independent experiments. Each dose level  
 
within a cell type has been compared with its respective control group (*P  
 
<0.05 = **P <0.01 = *** P <0.001).  
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4.4 Discussion  
 
 
Male germ cells are known to be one of the tissues vulnerable to toxicity of  
 
chemotherapeutic drugs such as doxorubicin (Hou et al., 2005). The  
 
pervious study showed that the side effect of doxorubicin induces oxidative  
 
stress and precipitates cell apoptosis in testicular tissues (Yeh et al., 2009).  
 
In comparison to normal tissue, tumours are characterized by uncontrolled  
 
division. The process of cell division- normal or cancerous cell- is through the  
 
cell cycle. The cell cycle goes from the resting phase, through active growing  
 
phases and then to mitosis (division). The ability of chemotherapy to kill  
 
cancer cells depends on its ability to halt cell division. Therefore,  
 
chemotherapy is most effective at killing cells that are rapidly dividing.  
 
Unfortunately, chemotherapeutic agents can not differentiate between the  
 
cancerous and the normal cells. It has been shown that apoptosis is one of  
 
the mechanisms in cell destruction following chemotherapy (Hou et al.,  
 
2005). A wide range of conditions are known to increase the rate of germ cell  
 
apoptosis in testis such as testicular ischemia and toxic substances  
 
(Sakallioglu et al., 2007, Mendez Palacios et al., 2014, Mohammadnejad et  
 
al., 2012). The potential infertility causing complication renders protection of  
 
testicular tissue a critical issue whenever doxorubicin is employed for anti-  
 
neoplastic chemotherapy. A previous study has shown that doxorubicin  
 
impaired mouse testicular structure through inflicting oxidative stress and  
 
inducing cell apoptosis (Yeh et al., 2007). The present study clearly validates  
 
that the magnitude of DNA damage is related to both the dose administered  
 
and germ cell types exposed to doxorubicin. The goal of the current study  
 
was to investigate the usefulness of in vitro germ cell culture, in combination  
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with the Comet assay, to determine DNA damage induced via genotoxic  
 
agents in male germ cells in mice. As the genotoxic effect of doxorubicin on  
 
male germ cells is well recognized, this genotoxic agent was used in the  
 
present study. We report here the application of the Comet assay to the  
 
analysis of DNA strand-break evolution in cultured germ cells in mice  
 
(spermatogonia, spermatocytes and spermatids). Isolated germ cells were  
 
treated with doxorubicin for 1 hour at 37°C in vitro and DNA damage was  
 
assessed using the Comet assay. DNA damage showed a significant  
 
increase in Olive tail moment and tail DNA percentage after being exposed  
 
to doses of 0.05 and 0.5 mM doxorubicin (Figure 4.2 and 4.3). Our results  
 
indicate that spermatogonia reach the significance threshold with low  
 
concentrations of doxorubicin. This may be due to the fact that toxicity of this  
 
drug is mediated by its interaction with topoisomerase II, an enzyme that is  
 
abundant in cells undergoing rapid and constant proliferation (Brilhante et al.,  
 
2012). Thus, in the testis, spermatogonial cells are the main target of  
 
doxorubicin, because of their intense and continuous proliferative activity  
 
(Brilhante et al., 2012). The Comet assay is a very useful tool in genotoxicity  
 
studies (Tice et al., 2000, Gaivao and Sierra, 2014) and a method for  
 
sensitive and rapid detection of DNA strand breaks in individual cells  
 
(Fairbairn et al., 1995, Liao et al., 2009). The Comet assay also produces  
 
reliable result for induced DNA damage in a short time. Our results show that  
 
the Comet assay is useable for the investigation of DNA damage induction  
 
and provide a useful system for genotoxicity evaluation of chemicals and the  
 
investigation of DNA damage induction in isolated germ cells.  
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It is well recognized that doxorubicin induces apoptosis in early  
 
spermatogonia, which results in a decrease in the size of the pool of germ  
 
line stem cell (Holm et al., 2009, Hou et al., 2005). In addition, other studies  
 
have shown increased apoptosis in spermatogonia and spermatocytes  
 
following doxorubicin treatment (Baumgartner et al., 2004, Brilhante et al.,  
 
2012).  
 
 
Based on the evidence provided in these studies; it could be asserted that  
 
the spermatogenic cells are prone to the effect of doxorubicin, especially  
 
those undergoing rapid proliferation, such as spermatogonia. The results  
 
derived from this study suggest that the initiation phase of spermatogenesis  
 
is highly sensitive to doxorubicin-induced apoptosis. The observations  
 
confirm the genotoxic capacity of doxorubicin as previously demonstrated by  
 
other authors using rats (Hou et al., 2005, Brilhante et al., 2012).  
 
 
The results presented in this study provides firm evidence that doxorubicin  
 
can unfavourably damage the male germ cells and significantly increase  
 
DNA damage and apoptosis. Furthermore, the difference in DNA  
 
fragmentation between the treated and the control suggests reduced germ  
 
cells proliferation and increased apoptotic cells on the extremely proliferative  
 
germ cells, namely spermatogonia and spermatocytes.  
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Chapter 5. The development of an in vitro rat germ cell system to  
 
detect well-known in vivo germ cell mutagens  
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5.1 Introduction  
 
 
The single-cell gel electrophoresis assay has been widely used to measure  
 
DNA damage in male germ cells in a variety of physiological and pathological  
 
conditions (Haines et al., 2002, Baumgartner et al., 2009). This chapter  
 
examined the same methodology in chapter 4 to investigate six well known in  
 
vivo germ cells mutagenesis. N-ethyl-N-nitrosourea (ENU), N-methyl-N-  
 
nitrosourea (MNU), 6-mercaptopurine (6MP), 5-bromo-2'-deoxyuridine (5-  
 
BrdU), methyl methanesulfonate (MMS) and ethyl methanesulfonate (EMS)  
 
are potent male rodent germ cell mutagens and have been widely used  
 
historically to characterise the susceptibility of different types of germ cells to  
 
the induction of genetic damage. Numerous strategies for the assessment of  
 
genotoxicity of chemical compounds or chemotherapeutic agents have been  
 
proposed. In the present study, the effect of genotoxicants that are known to  
 
affect germ cells in vivo were tested in isolated germ cells in vitro using  
 
methods for isolation and culture of adult male rat cell.  
 
 
Genotoxicity testing is part of the legislative requirements for safety testing  
 
that have to be performed before a new compound can be released for  
 
human contact and/or the environment (Parasuraman, 2011). Many different  
 
experimental methods are in use for investigation of genotoxicity of  
 
chemicals in animals (Parasuraman, 2011). In vivo tests of genotoxicity can  
 
involve the use of large numbers of animals (Van der Jagt et al., 2004), take  
 
several weeks to perform, and often provide only a general indication of  
 
genotoxic hazards without information about the mechanisms of action of the  
 
tested compounds. In vitro test systems have been proposed as alternatives  
 
to whole animal testing for genotoxic toxicity (Makris et al., 2011). Therefore,  
 
 
123  
in vitro toxicity tests need to be recognized in order to decrease the number  
 
of test animals and expense, without compromising the safety of consumers.  
 
Furthermore, such in vitro approaches should be better suited to test a larger  
 
number of chemicals than those employed in vivo tests (Toppari et al., 1996,  
 
Genschow et al., 2002, Spielmann et al., 1997). The male reproductive  
 
system is particularly sensitive to the damage induced by anticancer agents  
 
targeting rapidly dividing cells (Clermont, 1972, Aguilar-Mahecha et al.,  
 
2002). Animal models have been extensively used to study spermatogenesis  
 
and have revealed various molecular mechanisms that are critical during this  
 
process (Jan et al., 2012). Faults in germ cell progress can result in infertility  
 
or DNA damage, and genetic alterations passed via germ cells might cause  
 
many disorders in the offspring (Li et al., 2014). Additionally, spermatogenic  
 
failure happens at different levels, involving defective migration of primordial  
 
germ cells, arrest during spermatogenesis, loss of spermatogonial stem cells  
 
and insufficient spermiogenesis or a disrupted micro-environment (Jan et al.,  
 
2012). All these complications can result to some common conditions such  
 
as  azoospermia,  severe  oligozoospermia  and  asthenozoospermia.  
 
Moreover, a number of studies have established the role of specific genes in  
 
the regulation of proliferation and differentiation in vitro (Jan et al., 2012).  
 
 
It is well known that ENU and MNU, which are direct acting alkylating agents  
 
(Seeley and Faustman, 1995, Beckwith et al., 2000), primarily affect  
 
spermatogonia in vivo (Hitotsumachi et al., 1985). These alkylating agents  
 
have been found to induce mutagenesis by transferring its ethyl/methyl  
 
groups to nucleophilic oxygen or nitrogen sites on deoxyribonucleotides,  
 
leading to base mismatch within DNA replication (van Boxtel et al., 2010,  
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Imai et al., 2000). Russell et al., (1979) reported that treating male mice with  
 
ENU causes mutations that affect the spermatogonial stem cells and they  
 
also found that the spermatogonia had the highest rate of mutation in all cell  
 
types examined. A high frequency of mutations was also found in  
 
spermatogonial cells after treatment with ENU (Katoh et al., 1994, Provost  
 
and Short, 1994, Russell et al., 2007). Previous studies showed that, most of  
 
the mutations were intragenic after treatment with ENU (Marker et al., 1997,  
 
Miltenberger et al., 2002). In addition, mutations induced by ENU in  
 
spermatogonia, were found to be single base pair changes (Miltenberger et  
 
al., 2002). MNU has been found to be highly mutagenic in differentiating  
 
spermatogonia (Russell and Hunsicker, 1983, Russell et al., 2007). 6-MP  
 
and 5-BrdU are considered as the major analog drugs for therapy of acute  
 
lymphoblastic leukemia and autoimmune diseases, and have been used for  
 
four decades. 6-MP is metabolized by enzyme activity of thiopurine  
 
methyltransferase (TPMT), and therefore is anabolized by several enzymes  
 
to form 6-thioguanine nucleotides, leading to the induction of cytotoxicity as a  
 
result of its incorporation into DNA (Kanemitsu et al., 2009). 6-MP has also  
 
been shown to cause chromosomal damage and aberrations in the  
 
spermatocytes of male mice (Mosesso and Palitti, 1993). Furthermore, it has  
 
been shown that germ cells treated with 6-MP have the greatest response in  
 
early meiotic spermatocytes (Generoso et al., 1975). The thymidine analog  
 
(5-BrdU) is a genotoxic compound that is incorporated into DNA, causing  
 
specific-locus mutations and inhibition of cell proliferation (Morris, 1991). 5-  
 
BrdU is a nucleoside nucleic acid base modified via halogen substitution, and  
 
its derivatives are widely used in antitumour agent studies (Kagawa et al.,  
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2008). Histological examination of cultured rat spermatocytes after injection  
 
with 5-BrdU has demonstrated that 5-BrdU mostly labelled spermatocytes  
 
(Hue et al., 1998).  
 
 
EMS and MMS are alkylating agents that represent one of the most  
 
important classes of anticancer agents and play a major role in the treatment  
 
of several types of cancers (Kondo et al., 2010, Chaney and Sancar, 1996).  
 
MMS and EMS have been studied in mature spermatozoa to examine  
 
mutagenesis in different phases of spermatogenesis in male mice (van Delft  
 
et al., 1997). It has been found that EMS and MMS induce a high incidence  
 
of dominant lethal mutations in spermatids (Ehling, 1971). They have also  
 
been found to be mutagenic in the last phase of spermatogenesis, i.e. late  
 
spermatids and spermatozoa (van Delft et al., 1997). There are two ways to  
 
carry out a dominant lethal assay in males treated once. The first method in  
 
which male animals are mated for eight weeks (mice) or ten weeks (rats) to  
 
virgin female mice over the spermatogenic cycle and mated once a week  
 
(Anderson et al., 1981), or every few days (Ehling et al., 1978) to determine  
 
at which stage of the spermatogenic cycle the chemical is at its most active.  
 
There is a second method where animals are mated after 2 doses, one non-  
 
toxic. The animals are mated for 8-10 weeks and sampled twice (Topham,  
 
1980) a similar approach has been used in vivo Comet assay (Hartmann et  
 
al., 2003b). The toxic dose will ensure that animal received the compound  
 
when a negative response is seen (Hartmann et al., 2003). The present  
 
study mimics the method of Anderson et al (1981). The three different types  
 
of isolated germ cells ( spermatogonia, spermatocytes and spermatids) are  
 
examined but all cells are only exposed to single dose in vitro Comet assay.  
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5.2 Materials and Methods  
 
 
All information relevant to the experiments reported in this study are  
 
presented in section 2.1. Germ cells isolation and preparation was described  
 
in section 2.2.1 and cell counting in section 2.2.1.5. The treatment time of  
 
isolated germ cells is reported in section 2.3.1.5.1 and evaluated using  
 
Comet assay parameters as reported in section 2.6 and 2.6.1. TUNEL assay  
 
in section 2.5 and 2.5.1 Data are expressed as mean ± SEM of at least three  
 
independent experiments with three replicates per experimental group.  
 
Statistical analyses were made by one-way ANOVA; for all experiments, a P  
 
value of < 0.05 was considered significant.  
 
 
The alkaline version of the single cell gel electrophoresis assay was  
 
conducted on separate cultures of spermatogonia, spermatocytes and  
 
spermatids of male rats treated with 0.05 mM, 0.5 mM, 1 mM, of all six  
 
compounds. Hundreds of cells were scored for each cell type examined per  
 
slide, and two measures of DNA damage were made for each sample: % Tail  
 
DNA and OTM. The mean values from all cell types per treatment group are  
 
presented in the Comet and TUNEL assays data tables along with the results  
 
of the statistical analyses.  
 
 
5.3 Results  
 
 
5.3.1 Effect of ENU and MNU treatment  
 
 
MNU and ENU displayed a dose-response curve in both assays used for this  
 
investigation. The lowest doses that induced a statistically significant  
 
increase in genetic damage were 0.05 mM ENU or 0.05 mM MNU for DNA  
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damage and 0.05 mM ENU or 0.05 mM MNU for  apoptos is .  In   
 
spermatogonia, both nitrosoureas ENU and MNU showed highly increased  
 
OTM, percentage tail DNA and the percentage of apoptotic cells. They were  
 
thus clearly much more potent as spermatogonial mutagens than 6-MP and  
 
5-BrdU or the methanesulfonates (Figure 5.1, 5.2, 5.3, 5.4, 5.5 and 5.6). The  
 
response to ENU and MNU treatment was also different in the three types of  
 
cells analyzed: spermatogonia, showed the highest levels of DNA damage  
 
and apoptosis in response to ENU and MNU treatment in comparison to the  
 
other types of cells. Spermatogonial cells showed a clear dose-dependent,  
 
statistically significant increase in comet parameters and apoptosis from the  
 
concentration of 0.05 mM ( Figures 5.3 and 5.6 ) upwards whereas the other  
 
compounds showed lower means at each dose with generally lower levels of  
 
significance and only significant at all from 0.5 mM upwards. The values of  
 
various comet measurements as quantified with Comet 6.0 software  
 
generated from ENU and MNU studies are given in Table 5.1.The results  
 
showed that OTM and %Tail DNA gave good correlations with the  
 
concentration/dose of ENU and MNU agents used.  
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Figure 5.1: The dose response of isolated germ cells with the Comet assay (OTM)  
after 1h treatment, at 37 ºC with ENU at different concentrations: 0.05 mM, 0.5 mM  
and 1 mM. The bars indicate the mean ± SEM for three independent experiments by 
comparison with untreated control value. Asterisks denote values that are 
significantly different from that of the respective control group (*P <0.05, **P <0.01  
and *** p <0.001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: The dose response effects of ENU on testicular DNA damage assessed  
by the Comet assay (% tail DNA), after 1h treatment at 37 ºC with ENU at different  
concentrations: 0.05 mM, 0.5 mM and 1 mM. Data shown represent means ± SEM. 
Asterisks denote values that are significantly different from that of the respective  
control group (*P <0.05, **P <0.01 and *** P <0.001).  
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Figure 5.3: The dose response of isolated germ cells treated with ENU at different  
concentrations (0.05 mM, 0.5 mM and 1 mM), after 1h treatment at 37 ºC, evaluated 
in the TUNEL assay. Columns represent the mean percentages ± SEM of apoptotic 
cells. Data were obtained from three independent experiments. Asterisks denote 
values that are significantly different from that of the respective control group (*P  
<0.05; **P <0.01; ***P <0.001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: The dose response of isolated germ cells with the Comet assay (OTM),  
after 1h treatment, at 37 ºC with MNU at different concentrations: 0.05 mM, 0.5 mM  
and 1 mM. The bars represent the mean ± SEM for three independent experiments 
by comparison with untreated control value. Asterisks denote values that are 
significantly different from that of the respective control group (*P <0.05, **P <0.01  
and *** P <0.001).  
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Figure 5.5: The dose response effects of MNU on testicular DNA damage assessed  
by the Comet assay (% tail DNA), after 1h treatment at 37 ºC with ENU at different  
concentrations: 0.05 mM, 0.5 mM and 1 mM. Data shown represent means ± SEM. 
Asterisks denote values that are significantly different from that of the respective  
control group (*P <0.05, **P <0.01 and *** P <0.001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: The dose response of isolated germ cells treated with MNU at different  
concentrations (0.05 mM, 0.5 mM and 1 mM), after 1h treatment at 37ºC, evaluated  
in the TUNEL assay. Columns represent the mean percentages ± SEM of apoptotic 
cells. Data were obtained from three independent experiments. Asterisks denote 
values that are significantly different from that of the respective control group ( *P  
<0.05; **P <0.01; ***P <0.001).  
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Table 5.1: Summary table presenting the individual data for the effects of  
 
ENU and MNU on isolated germ cells' Comet measurements: Olive tail  
 
moment, and % tail DNA; and percentage of apoptotic cells. Data shown  
 
represent group values are (mean ± SEM ) of three experiments (n=3) (100  
 
cells per experimental). (ns) = not significant, *p <0.05, **p <0.01 and *** p  
 
<0.001 versus control.  
 
 
 
Germ cells  Olive tail moment  (%)Tail DNA  Apoptotic cells (%)  
Spermatogonia     
Control  1.23 ± 0.06  9.19 ± 0.06  8.00 ± 0.58  
0.05mM ENU  2.33 ± 0.13**  11.45± 0.37**  13.67±0.33**  
0.5mM ENU  6.21± 0.49 ***  20.64 ± 0.52***  35.67±0.33***  
1mM  ENU  9.29 ± 0.20***  28.38 ± 0.81***  49.00±0.58***  
Control  1.03 ± 0.08  6.23 ± 0.33  7.33 ± 0.33  
0.05mM MNU  2.09 ±0.21*  6.86 ± 0.42*  10.00 ± 0.58*  
0.5mM MNU  5.87 ± 0.65**  20.29±1.51**  16.33 ± 1.20**  
1mM  MNU  8.34 ± 0.28***  25.10± 0.67**  37.67 ± 1.20***  
Spermatocytes     
Control  0.91 ± 0.08  3.58 ± 0.36  7.00 ± 0.58  
0.05mM ENU  1.35 ± 0.23 ns  5.74 ± 0.69 ns  10.00 ± 0.58 ns  
0.5mM  ENU  3.01 ± 0.15 *  10.71± 1.13 *  12.67 ± 0.88 *  
1mM  ENU  3.78 ± 0.21**  14.40 ± 1.12**  19.67 ± 0.67**  
Control  0.72 ± 0.09  3.97 ± 0.37  7.00 ± 0.58  
0.05mM MNU  1.19 ± 0.20 ns  6.28 ± 0.55 ns  9.33 ± 0.88 ns  
0.5mM  MNU  2.59 ± 0.53 *  11.73 ±1.16*  13.00 ± 0.58 *  
1mM  MNU  3.94 ± 0.43**  14.45 ±1.18*  20.00 ± 0.58 **  
Spermatids     
Control  0.59 ± 0.05  2.77 ± 0.31  6.67 ± 0.33  
0.05mM ENU  0.75 ± 0.09 ns  5.46 ± 0.95 ns  8.67 ± 0.33 ns  
0.5mM  ENU  1.87 ± 0.37 *  6.24 ± 0.92 *  12.00 ± 0.58*  
1mM  ENU  2.66 ± 0.28**  11.71± 1.20 **  17.67 ± 0.88**  
Control  0.79 ± 0.08  3.50 ± 0.35  6.67 ± 0.67  
0.05mM MNU  1.64 ± 0.20 ns  6.15 ± 0.61ns  8.67 ± 1.20 ns  
0.5mM  MNU  2.11± 0.24 *  8.82 ± 0.83 *  12.00 ± 0.58 *  
1mM  MNU  3.02 ± 0.28**  12.46 ±0.84**  17.33 ±0.88**  
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5.3.2  Effect of 6-MP and 5-BrdU treatment  
 
 
6-MP and 5-BrdU showed a dose-response curve in both assays used for  
 
this study. The lowest doses that induced a statistically significant increase in  
 
genetic damage were 0.05 mM ENU or 0.05 mM MNU for DNA damage and  
 
0.05 mM ENU or 0.05 mM MNU for apoptosis. In spermatocytes, both 6-MP  
 
and 5-Br-dU showed highly increased OTM, percentage tail DNA and the  
 
percentage of apoptotic cells. They were therefore clearly much more potent  
 
spermatocytes mutagens than MNU and ENU or the methanesulfonates  
 
(Figure 5.7, 5.8, 5.9, 5.10, 5.11 and 5.12). The response to 6-MP and 5-Br-  
 
dU treatment was also different for the three types of cells analyzed:  
 
spermatocytes, which showed the highest levels of DNA damage and  
 
apoptosis in response to 6-MP and 5-BrdU treatment than the other types of  
 
cells. Spermatocytes showed a clear dose-dependent, statistically significant  
 
increase in comet parameters and apoptosis from the concentration of 0.05  
 
mM ( Figure 5.9 and 5.12 ) upwards whereas the other compounds showed  
 
lower means at each dose with generally lower levels of significance and  
 
only signif icant from 0.5 mM upwards. Data for dif ferent Comet  
 
measurements/parameters are presented in Table 5.2. The results showed  
 
that OTM and %Tail DNA gave good correlations with the concentration/dose  
 
of 6-MP and 5-BrdU agents used.  
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Figure 5.7: The dose response of isolated germ cells with the Comet assay (OTM),  
after 1h treatment, at 37 ºC with 6-MP at different concentrations: 0.05 mM, 0.5 mM 
and 1 mM. The bars indicate the mean ± SEM for three independent experiments by 
comparison with untreated control value. Asterisks denote values that are 
significantly different from that of the respective control group (*P <0.05, **P <0.01  
and *** P <0.001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8: The dose response effects of 6-MP on testicular DNA damage  
assessed by the Comet assay (% tail DNA), after 1h treatment at 37 ºC with 6-MP 
at different concentrations: 0.05 mM, 0.5 mM and 1 mM. Data shown represent 
means ± SEM. Asterisks denote values that are significantly different from that of  
the respective control group (*P <0.05, **P <0.01 and *** P <0.001).  
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Figure 5.9: The dose response of isolated germ cells treated with 6-MP at different  
concentrations (0.05 mM, 0.5 mM and 1 mM), after 1hr treatment at 37ºC, evaluated  
in the TUNEL assay. Columns represent the mean percentages ± SEM of apoptotic 
cells. Data were obtained from three independent experiments. Asterisks denote 
values that are significantly different from that of the respective control group (*P  
<0.05; **P <0.01; ***P <0.001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10: The dose response of isolated germ cells with the Comet assay  
(OTM), after 1hr treatment, at 37ºC with 5-BrdU at different concentrations: 0.05 
mM, 0.5 mM and 1 mM. The bars indicate the standard error for three independent 
experiments by comparison with untreated control value. Asterisks denote values 
that are significantly different from that of the respective control group (*P <0.05, **P  
<0.01 and *** P <0.001).  
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Figure 5.11: The dose response effects of 5-BrdU on testicular DNA damage  
assessed by the Comet assay (% tail DNA), after 1hr treatment at 37 ºC with 5-  
BrdU at different concentrations: 0.05 mM, 0.5 mM and 1 mM. Data shown 
represent means ± SEM. Asterisks denote values that are significantly different from  
that of the respective control group (*P <0.05, **P <0.01 and *** P <0.001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12: The dose response of isolated germ cells treated with 5-BrdU at  
different concentrations (0.05 mM, 0.5 mM and 1 mM), after 1h treatment at 37 ºC, 
evaluated in the TUNEL assay. Columns represent the mean percentages ± SEM of 
apoptotic cells. Data were obtained from three independent experiments. Asterisks 
denote values that are significantly different from that of the respective control group  
(*P <0.05; **P <0.01; ***P <0.001).  
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Table 5.2: Summary table presenting the individual data for the effects of 6-  
 
MP and 5-BrdU on isolated germ cells' Comet measurements: Olive tail  
 
moment and % tail DNA; and percentage of apoptotic cells. Data shown  
 
represent group (means ± SEM) of three experiments (100 cells per  
 
experimental). Ns not significant, *p <0.05, **p <0.01 and *** p <0.001 versus  
 
control.  
 
 
Germ cells  Olive tail moment  (%)Tail DNA  Apoptotic cells (%)  
Spermatogonia     
Control  0.80 ± 0.06  3.35 ± 0.33  8.38 ± 0.72  
0.05mM 6-MP  1.20 ± 0.10ns  4.31± 0.30 ns  10.52 ± 1.56 ns  
0.5mM 6-MP  2.63 ± 0.48ns  7.20 ± 0.70 ns  11.14 ± 0.50ns  
1mM  6-MP  3.53 ± 0.38**  11.31± 0.64**  19.73 ±1.43**  
Control  0.80 ± 0.04  3.59 ± 0.13  7.67 ± 0.33  
0.05mM 5-BrdU  1.50 ±0.20ns  6.56 ± 0.89ns  11.00 ± 1.15ns  
0.5mM 5-BrdU  1.88 ± 0.16*  7.66 ± 0.65*  14.33 ± 0.88*  
1mM  5-BrdU  2.80 ± 0.23**  10.34 ± 1.01**  19.00 ± 1.15**  
Spermatocytes     
Control  0.87 ±0.06  3.91± 0.08  7.97 ± 0.50  
0.05mM 6-MP  2.22 ±0.15*  8.50 ±0.67 *  18.11 ± 1.69 *  
0.5mM  6-MP  5.63 ±0.55 **  12.41 ±0.88 **  23.47 ± 1.44**  
1mM  6-MP  7.63 ±0.36 ***  19.04 ±0.93 ***  35.33 ± 1.38***  
Control  0.69 ± 0.04  3.71± 0.35  7.33 ± 0.33  
0.05mM 5-BrdU  1.91± 0.22*  9.36 ± 0.63*  17.00± 1.73*  
0.5mM  5-BrdU  3.88 ± 0.36**  13.09 ± 0.66**  19.00 ± 1.15**  
1mM  5-BrdU  6.55 ± 0.29***  16.77± 0.79***  30.66± 1.37***  
Spermatids     
Control  0.75 ± 0.03  3.81 ± 0.17  6.19 ± 0.58  
0.05mM 6-MP  0.98 ± 0.28ns  5.58 ± 0.90ns  8.21 ± 0.62 ns  
0.5mM  6-MP  1.24 ± 0.13ns  5.87 ± 0.48ns  12.52 ± 1.28 ns  
1mM  6-MP  2.45 ±0.26**  8.60 ± 0.38**  16.27 ± 1.01**  
Control  0.78 ± 0.06  3.69 ± 0.34  5.00 ± 0.58  
0.05mM 5-BrdU  1.43 ± 0.29ns  5.77 ± 0.88 ns  7.00 ± 0.58 ns  
0.5mM  5-BrdU  1.62 ± 0.21*  7.43 ± 1.11*  11.00 ±1.15*  
1mM  5-BrdU  2.60 ± 0.16**  10.09 ± 0.61**  15.33 ± 0.88**  
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5.3.3  Effect of EMS and MMS treatment  
 
 
MMS and EMS showed a dose-response curve in both assays used for this  
 
study. The lowest doses that induced a statistically significant increase in  
 
genetic damage were 0.05 mM MMS or 0.05 mM EMS for DNA damage and  
 
0.05 mM MMS or 0.05 mM EMS for apoptosis. In spermatids, both  
 
methanesulfonates MMS and EMS showed highly increased OTM,  
 
percentage tail DNA and the percentage of apoptotic cells. They were  
 
therefore clearly much more potent spermatids mutagens than MNU and  
 
ENU or 6-MP and 5-Br-dU (Figure 5.13, 5.14, 5.15, 5.16, 5.17 and 5.18). The  
 
response to MMS and EMS treatment was also different for the three types  
 
of cells analyzed: Spermatids, which showed the highest levels of DNA  
 
damage and apoptosis in response to MMS and EMS treatment than the  
 
other types of cells. Spermatocytes showed a clear dose-dependent,  
 
statistically significant increase in comet parameters and apoptosis from the  
 
concentration of 0.05 mM ( Figure 5.15 and 5.18 ) upwards whereas the  
 
other compounds showed lower means at each dose with generally lower  
 
levels of significance and only significant at all from 0.5 mM upwards. The  
 
values of various Comet measurements as quantified with Comet 6.0  
 
software generated from MMS and EMS studies are presented in Table 5.3.  
 
The results showed that OTM and %Tail DNA gave good correlations with  
 
the concentration/dose of MMS and EMS agents used.  
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Figure 5.13: The dose response of isolated germ cells with MMS the Comet  
assay (OTM) after 1h treatment, at 37 ºC with MMS at different 
concentrations: 0.05 mM, 0.5 mM and 1 mM. The bars indicate the (mean ± 
SEM) for three independent experiments by comparison with untreated 
control value. Asterisks denote values that are significantly different from that  
of the respective control group (*P <0.05, **P <0.01 and *** P <0.001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.14: The dose response effects of MMS on testicular DNA damage,  
assessed by the Comet assay (% tail DNA) after 1hr treatment at 37ºC with MMS at  
different concentrations: 0.05 mM, 0.5 mM and 1 mM. Data shown represent means ± 
SEM. Asterisks denote values that are significantly different from that of the  
respective control group (*P <0.05, **P <0.01 and *** P <0.001).  
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Figure 5.15: The dose response curve of isolated germ cells was treated with MMS  
at different concentrations 0.05 mM, 0.5 mM and 1 mM, after 1h treatment, at 37ºC,  
evaluated in the TUNEL assay. Columns represent the mean percentages ± SEM of 
apoptotic cells for each of the three concentrations of MMS used (0, 0.05, 0.5 and 1 
mM). Data were obtained from three independent experiments. Each dose level 
within a cell type has been compared with its respective control group ( *p <0.05  
**p <0.01 ***p <0.001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.16: The dose response of isolated germ cells with the Comet assay (OTM)  
after 1hr treatment, at 37ºC with EMS at different concentrations: 0.05 mM, 0.5 mM  
and 1 mM. The bars indicate the means ± SEM for three independent experiments 
by comparison with untreated control value. Asterisks denote values that are 
significantly different from that of the respective control group (*P <0.05, **P <0.01  
and *** P <0.001).  
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Figure 5.17: The dose response effects of EMS on testicular DNA damage  
assessed by the Comet assay (% tail DNA), after 1h treatment at 37ºC with EMS at  
different concentrations: 0.05 mM, 0.5 mM and 1 mM. Data shown represent means ± 
SEM. Asterisks denote values that are significantly different from that of the  
respective control group (*P <0.05, **P <0.01 and *** P <0.001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.18: The dose response of isolated germ cells treated with EMS at different  
concentrations (0.05 mM, 0.5 mM and 1 mM), after 1h treatment at 37 ºC, evaluated  
in the TUNEL assay. Columns represent the mean percentages ± SEM of apoptotic 
cells. Data were obtained from three independent experiments. Asterisks denote 
values that are significantly different from that of the respective control group (*P  
<0.05; **P <0.01; ***P <0.001).  
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Table 5.3 : Summary table presenting the individual data for the effects of  
 
MMS and EMS on isolated germ cells' Comet measurements: Olive tail  
 
moment and % tail DNA; and percentage of apoptotic cells. Data shown  
 
represent group (means ± SEM) of three experiments (100 cells per  
 
experimental). Ns not significant, *p <0.05, **p <0.01 and *** p <0.001 versus  
 
control.  
 
 
Germ cells  Olive tail moment  (%)Tail DNA  Apoptotic cells (%)  
 
Spermatogonia     
Control  0.92 ± 0.06  3.96 ± 0.24  8.33 ± 0.33  
0.05mM MMS  1.69 ± 0.19ns  6.98 ± 1.26ns  11.00 ± 0.58ns  
0.5mM  MMS  2.98 ± 0.53*  9.95 ± 1.37*  13.67 ± 0.6*  
1mM  MMS  4.91 ± 0.48**  16.96 ± 2.04**  21.00 ±1.53**  
Control  1.11 ± 0.16  3.99 ± 0.38  7.33 ± 0.33  
0.05mM EMS  1.37 ± 0.35 ns  6.15 ± 0.99ns  10.33 ± 0.88ns  
0.5mM  EMS  2.95 ± 0.21*  8.87 ± 0.92*  12.33 ± 0.88*  
1mM  EMS  4.36 ± 0.31**  14.09 ± 1.17**  20.33 ±1.33**  
Spermatocytes     
Control  1.03 ± 0.13  4.59 ± 0.46  7.67 ± 0.67  
0.05mM MMS  1.77 ± 0.09ns  9.35 ± 0.88 ns  11.33 ± 0.88 ns  
0.5mM  MMS  4.32 ± 0.41*  10.93 ± 0.97*  17.33 ± 0.88*  
1mM  MMS  6.15 ± 0.54**  18.36 ± 1.15**  22.00 ± 1.53**  
Control  0.90 ± 0.09  4.12 ± 0.25  8.00 ± 0.58  
0.05mM EMS  2.32 ± 0.31ns  9.12 ± 1.18ns  11.33 ± 0.67ns  
0.5mM  EMS  3.44 ± 0.49*  11.41 ± 0.91*  16.67 ± 0.88*  
1mM  EMS  5.17 ± 0.42**  21.81 ± 1.73**  20.67± 0.88**  
Spermatids     
Control  0.89 ± 0.06  4.58± 0.37  7.67 ± 0.67  
0.05mM MMS  2.65 ± 0.35*  12.34± 0.86*  14.00 ± 0.58*  
0.5mM  MMS  8.02 ± 0.76**  25.44± 0.94**  27.67 ± 1.20**  
1mM  MMS  11.66 ± 1.04***  36.63 ±0.75***  35.67 ± 0.88***  
Control  0.92± 0.03  4.58 ± 0.22  8.00 ± 1.00  
0.05mM EMS  3.04 ±0.32*  11.06 ± 1.04*  14.00 ± 0.58 *  
0.5mM  EMS  6.80 ±0.85**  24.49 ± 2.10**  20.33 ± 1.86**  
1mM  EMS  9.89 ±0.36***  33.64 ± 0.76***  34.00± 1.15***  
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5.4 Discussion  
 
 
Genotoxicity assessment after exposure to N-ethyl-N-nitrosourea, N-methyl-  
 
N-nitrosourea, 6-mercaptopurine, 5-bromo-2'-deoxyuridine and , ethyl  
 
methanesulfonate  or methyl methanesulfonate was conducted on three  
 
types of rat germ cells (spermatogonia, spermatocytes and spermatids). The  
 
alkali version of the Comet assay was used to detect DNA strand breaks.  
 
Spermatogonia were the most sensitive to ENU and MNU; spermatocytes  
 
were most sensitive to 6-MP and 5-BrdU while spermatids were found to be  
 
the most sensitive cell type to MMS and EMS. Parallel results were found  
 
using the TUNEL assay, which also showed highly significant, dose-  
 
dependent effects of these 6 genotoxins on spermatogonia, spermatocytes  
 
and spermatids in the same way as for DNA damage. Crucially, the  
 
specificity of effects on different germ cell types matches those found in vivo.  
 
 
The results for ENU and MNU are similar to findings by (Russell et al., 2007)  
 
who also found genetic damage in spermatogonia when treated with ENU  
 
and MNU. In the present study, comparing the chemicals for the endpoints  
 
studied (i.e., Comet assay and TUNEL assay) revealed that ENU and MNU  
 
are much more effective on spermatogonia than spermatocytes and  
 
spermatids. These results suggest that both chemicals are highly mutagenic  
 
in differentiating spermatogonia (Russell et al., 2007, Russell and Hunsicker,  
 
1983, Guenet, 2004, Siepka and Takahashi, 2005). In addition, increased  
 
spontaneous frequency of gene mutations and chromosome damage has  
 
been reported (O'Brien et al., 2013).  
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A similar trend was observed on spermatocytes when 6-MP and 5-BrdU  
 
induced Comet parameters were compared with those of ENU, MNU, MMS  
 
and EMS at 0.05, 0.5 and 1.0 mM. Spermatocytes showed a highly  
 
significant increase in DNA damage and apoptosis to 6-MP, 5-BrdU. This  
 
increase was dramatically greater in spermatids and spermatogonia. Thus,  
 
spermatocytes are the most sensitive to 6-MP and 5-BrdU in agreement with  
 
the findings in vivo that showed 6-MP to be a potent chemical for inducing  
 
DNA damage in spermatocytes (Mosesso and Palitti, 1993) along with 5-  
 
BrdU (Perrard et al., 2003).  
 
 
Spermatids were found to be the most sensitive to MMS and EMS in the  
 
induction of genetic damage and apoptosis in agreement with in vivo studies  
 
that showed decrease in the number of spermatids and high frequency of  
 
chromosome aberrations induced by methanesulfonates in spermatids  
 
(Kuriyama et al., 2005, Matsuda et al., 1989).  
 
 
This experiment using these chemicals also suggested that OTM and %Tail  
 
DNA give good correlations with the dose of genotoxic agents used.  
 
Statistically, our results did not find much difference between OTM and  
 
%DNA in the tail. Although Olive Tail moment appeared to be the most  
 
statistically significant measurement, it provides an estimate of DNA damage  
 
in arbitrary units. Moreover, the level of DNA damage is dependent on both  
 
the toxicant dose and the type of germ cell, and occurs at doses known to be  
 
relevant to testicular and reproductive toxicity. Furthermore, these results  
 
indicate that Staput-isolated rat testicular germ cells provide suitable model  
 
in vitro to study DNA damage in different phases of spermatogenesis.  
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Chapter 6. Effect of ENU and MMS on Tbpl1, FHL5 and Gtf2a1l  
 
expression in male mouse germ cells  
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6.1 Introduction  
 
 
Loss of germ cells is common during mammalian spermatogenic  
 
development although different cell types have different capacities for  
 
apoptosis and different susceptibilities to apoptosis after toxin exposure. As a  
 
result, understanding of the mechanisms underlying germ cell death is still  
 
limited. This due to a number of factors: lack of availability of in vitro  
 
techniques  to  successfully  achieve  fully  functional  mammalian  
 
spermatogenesis outside the body; presence of numerous spermatogenesis-  
 
specific genes or isoforms; the difficulty of using microarrays in studies of  
 
pathological states because of cell ratio distortion; etc. Very often, the study  
 
of the function of genes involved in sperm production needs expensive  
 
animal models (Kennedy et al., 2005). All this makes the specific diagnosis  
 
and treatment of infertility in males difficult and highlights the importance of  
 
identifying and characterization of new genes and proteins involved in the  
 
production of functional male germ cells (Kennedy et al., 2005).  
 
 
Because the similarities and differences between the mouse and human  
 
genomes are so well understood (relative to other animal species), the  
 
mouse has historically been the main model system to identify the genetic  
 
basis and mechanisms of the pathogenesis of many human diseases.  
 
Although the current mouse mutant databases are composed of a massive  
 
number of different knockout animals, which are a valuable source of  
 
models, only a minor amount of the probable total number of mammalian  
 
genes is covered.  
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The establishment of novel mutagenesis programmes using potent  
 
mammalian mutagens and carcinogens such as N-ethyl-N-nitrosourea (ENU)  
 
and methyl methanesulfonate (MMS) has started to fill this gap but is a rather  
 
laborious and very animal intensive process (Kennedy and O'Bryan, 2006,  
 
Cordes, 2005). N-ethyl-N-nitrosourea (ENU) is a potent monofunctional  
 
ethylating agent which has been found to be mutagenic and carcinogen in a  
 
wide variety of organisms from viruses to mammalian germ cells (Justice et  
 
al., 2000, Chen et al., 2002). ENU is a synthetic compound that causes  
 
random, single base pair mutations, acting directly on nucleic acids without  
 
any metabolic processing needed for its activation (Noveroske et al., 2000,  
 
Singer and Dosanjh, 1990). In the mouse testis, the most commonly studied  
 
mutations are AT-to-TA transversions or AT-to-GC transitions (Noveroske et  
 
al., 2000). The single base pair alterations induced by ENU can be  
 
invaluable for dissecting the fine structure of a protein (Justice, 2000).  
 
 
Male germ cell development consists of a variety of unique processes,  
 
including genetic recombination and haploid gene expression. This  
 
processes are intricate, highly ordered, and require novel gene products and  
 
a precise and well-coordinated programme of gene expression to occur  
 
(Eddy,  2002).  Other  factors  essential  f or  postmeiotic  stages  of  
 
spermatogenesis include transcription factors (Eddy, 2002). Moreover, the  
 
most uncomplicated strategy to clarify differentiation mechanisms of male  
 
germ cell is to identify and characterize differentiation-specific molecules and  
 
their associated genes in germ cells. Yet, only a few genes specifically  
 
involved in spermatogenesis have been studied (Guo et al., 2004).  
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TATA box binding protein-like 1 (Tbpl1), also called TLF (Chong et al., 2005)  
 
is a protein commonly thought to belong to the general transcription initiation  
 
complex and it has been considered as a substitution factor for TATA-binding  
 
protein (TBP) in the basal transcriptional machinery of RNA polymerase II  
 
(Zhang et al., 2001, Ohbayashi et al., 1999). It also has a specialised  
 
function in spermatogenesis, as revealed by targeted mutation of the gene in  
 
both somatic and germ cells. The Tbpl1 mutation obtained leads to a  
 
complete arrest of late spermiogenesis and increased haploid cell apoptosis  
 
(Martianov et al., 2001). Four and a half LIM domains protein 5 (FHL5) is a  
 
LIM domain protein that interacts with transcription factor CREM in  
 
postmeiotic male germ cells and enhances CREM-dependent transcription  
 
(Lardenois et al., 2009). CREM regulates many crucial genes required for  
 
spermatid maturation, and targeted mutation of the Crem gene in the mouse  
 
germ-line blocks spermatogenesis (Fimia et al., 1999, Kotaja et al., 2004).  
 
General transcription factor IIA, 1-like (Gtf2a1l) is a germ cell-specific  
 
counterpart of the large (/) subunit of general transcription factor  
 
TFIIA. This factor is able to interact with the small TFIIA subunit () to form a  
 
heterodimeric complex that stabilizes binding of TBP to promoter DNA  
 
(Upadhyaya et al., 2002). The selected genes (Tbpl1, FHL5 and Gtf2a1l) are  
 
known to be highly expressed in spermatocytes and spermatids as well as  
 
being thought to play a role in germ cells (Martianov et al., 2002, Han et al.,  
 
2001, Lardenois et al., 2009).  
 
 
The  previous  chapter  was  able  to  determine  DNA  damage  on  
 
spermatogonia, spermatocytes and spermatids using the Comet assay. In  
 
the present study, two different types of spermatogenic cells (spermatocytes  
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and spermatids) were isolated from mice testes using Staput. The  
 
expression of Tbpl1, FHL5 and Gtf2a1l genes were detected in two different  
 
stages of spermatogenic cells, suggesting that Tbpl1, FHL5 and Gtf2a1l  
 
genes were differentially expressed. The Tbpl1, FHL5 and Gtf2a1l  
 
differentially expressed genes were further analysed by reverse transcription  
 
polymerase chain reaction (RT-PCR) for stage and tissue specific expression  
 
characteristics. Based on the results of RT-PCR, Tbpl1, FHL5 and Gtf2a1l  
 
genes were highly expressed in both spermatocytes and spermatids. This  
 
was further clarified using Tbpl1, FHL5 and Gtf2a1l genes to quantify mRNA  
 
level expression in each cell types (spermatocytes and spermatids). Finally,  
 
spermatocytes, spermatids and most utilized mutagens (ENU and MMS)  
 
where analysed for protein levels of Tbpl1, FHL5 and Gtf2a1l using their  
 
specific antibodies.  
 
 
6.2 Materials and Methods  
 
 
All relevant information is shown in section (2.1). RNA extraction and  
 
preparation was described in section 2.8.1 and 2.8.2. Measurement of  
 
quantity and purity of total RNA is described in section 2.8.5. DNase I  
 
treatment is described in section 2.8.6, cDNA synthesis in section 2.8.7.  
 
Polymerase chain reaction (PCR) is described in section was described in  
 
section 2.8.9 and quantitative real-time PCR assay shown in section 2.8.9.2  
 
Western Blot analysis is described in section 2.12.  
 
 
 
 
 
 
 
 
 
 
 
149  
6.3 Results  
 
 
6.3.1 Quality of RNA Extraction  
 
 
Total RNA was isolated from germ cell fractions (spermatocytes and  
 
spermatids) using Trizol Reagent, followed by incubation with RNase-free  
 
DNase I, for 1 h at 37°C, to avoid contamination by genomic DNA. The RNA  
 
quality was assessed by gel electrophoresis and spectrophotometric reading:  
 
see Figure 6.1  
 
 
RT-PCR was performed on first strand cDNA for detection of the -actin; a  
 
housekeeping gene constitutively expressed in mouse testis. This gene is  
 
regularly amplified to ensure synthesis of the first strand of cDNA had been  
 
successful and validation of PCR conditions. Gene expression studies  
 
require that the expression profiles of the various genes being studied should  
 
be normalized against a suitable internal control: see Figure 6.2  
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Figure 6.1:  Two bands which represented the two ribosomal RNA  
components 28S and 18S. The intensity of 28S was higher than 18S with a  
ratio that confirmed the satisfactory purity of the RNA.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2: PCR detection of -actin (149 bp). The samples were subjected  
to electrophoresis through a 1.5 % w/v agarose gel in 1 X TBE with 1 g/ml  
ethidium bromide. The PCR conditions were 95°C (30sec), 60°C (30sec), 72  
°C (30sec) for 30 cycles. Lane 1 shows the negative control with -actin 
DNA. Lanes 2, 3 and 4 show an amplified fragment of -actin from DNA of 
cells (spermatocytes and spermatids) treated with different concentration  
0.05, 0.5 and 1 mM of ENU or MMS.  
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6.3.2 Effect of N-ethyl-N-nitrosourea (ENU) treatment on spermatocytes  
 
and spermatids.  
 
 
6.3.2.1 Tbpl1  
 
 
QPCR was chosen as the technique to provide confirmation of the changes  
 
in Tbpl1 gene expression that was seen after cells were treated with different  
 
concentrations of ENU. The samples were taken at 1 h following ENU  
 
treatment for both treated and untreated control cultures, and the expression  
 
levels of Tbpl1 were normalised with those of -actin and statistically  
 
compared against the control level.  
 
 
There was no statistically significant difference in the levels of Tbpl1 mRNA  
 
in spermatocytes after 1h of treatment with ENU (0.05 mM, 0.5 mM)  
 
compared with -actin but there was with 1mM (*p<0.05) (Figures 6.3). A.  
 
Statistical analysis showed a significant decrease in the level of expression  
 
of Tbpl1 when spermatids were treated with 0.5 mM ENU (*p<0.05) and a  
 
further decrease was found with ENU 1 mM (**p<0.01). These results are  
 
shown in Figures 6.3. B.  
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Figure 6.3: Effect of ENU on the Tbpl1 mRNA expression in spermatocytes  
and spermatids by qPCR. A. spermatocytes and B. spermatids after 1 h 
treatment, at 37 ºC with ENU at different concentrations: 0.05 mM, 0.5 mM 
and 1 mM. Non-treated cells' values were defined as 100% and other values 
were adjusted accordingly. Data are expressed as the mean ± SEM n=3 
different biological replicates performed on three different occasions and 
analysed by one-way ANOVA followed by Data were analysed by One-way- 
ANOVA followed by Bonferroni's post-hoc comparisons tests, comparing  
each exposure level against the control level: (*p<0.05, **p<0.01).  
 
 
 
 
 
 
153  
The relative level of Tbpl1 expression in protein extracted from isolated germ  
 
cells of both spermatocytes and spermatids was determined by semi-  
 
quantitative western blotting. The samples were taken at 1 h following ENU  
 
treatment for both treated and untreated control cultures, and the expression  
 
levels of Tbpl1 were normalised to those of GAPDH before being compared  
 
with the control level.  
 
 
There was no statistically significant difference in the levels of Tbpl1 protein  
 
at 0.05 mM and 0.5 mM ENU in spermatocytes. In contrast, spermatids  
 
showed a significant decrease (*p<0.05) at 0.5 mM. A further decrease was  
 
shown when the spermatocytes were treated with ENU 1 mM (*p<0.05) and  
 
spermatids treated with ENU 1 mM (**p<0.01). These results are shown in  
 
Figure 6.4 A and B.  
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Figure 6.4: Spermatocytes were treated with ENU and the level of TbpI1  
 
protein was examined 1 h after treatment. Sample Western blots of TbpI1  
 
and GAPDH proteins are shown in (A) and quantified summary data are  
 
shown in (B). ENU treatment appeared to decrease the TbpI1 protein level at  
 
all doses but the decrease was only significant at 1 mM. The density of each  
 
band was quantified by the use of Image 1.45 software. The relative  
 
expression level of TbpI1 was measured by TbpI1/GAPDH ratio. Results are  
 
the mean ± SEM. From three independent experiments and statistical  
 
comparisons were made using one-way ANOVA followed by Bonferroni's  
 
post-hoc comparisons tests, comparing each dose against the control ( *P  
 
<0.05).  
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Figure 6.5: Spermatids were treated with ENU and the level of mature TbpI1  
 
protein was examined 1 h after treatment. Sample Western blots of TbpI1  
 
and GAPDH proteins are shown in (A) and quantified summary data are  
 
shown in (B). ENU treatment appeared to decrease the TbpI1 protein level at  
 
all doses and the decrease was significant at 0.5 and 1 mM. The density of  
 
each band was quantified by the use of Image 1.45 software. The relative  
 
expression level of TbpI1 was measured by TbpI1 / GAPDH ratio. Results  
 
are the mean ± SEM. From three independent experiments and statistical  
 
comparisons were made using one-way ANOVA followed by Bonferroni's  
 
post-hoc comparisons tests, comparing each dose against the control (*P  
 
<0.05; **P <0.01).  
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6.3.2.2 FHL5  
 
 
QPCR was conducted on mRNA isolated from untreated and treated (0.05  
 
mM, 0.5 mM and 1 mM ENU) spermatocytes and spermatids. Statistical  
 
analysis showed no significant effect on level expression of FHL5 gene when  
 
spermatocytes were treated with 0.05 and 0.5 mM ENU. However, a  
 
significant decrease was shown when spermatocytes treated with 1 mM  
 
(*p<0.05) as shown in Figure 6.6 A. In contrast, spermatids showed  
 
significant decrease when treated with 0.5 mM (*p<0.05) and 1mM ENU  
 
(**p<0.01) respectively as shown in Figure 6.6 B.  
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Figure 6.6: Effect of ENU on the FHL5 mRNA expression in spermatocytes  
 
and spermatids by qPCR A. Spermatocytes and B. Spermatids after 1 h  
 
treatment, at 37 ºC with ENU at different concentrations: 0.05 mM, 0.5 mM  
 
and 1 mM. Data are expressed as the mean ± SEM. n=3 different biological  
 
replicates performed on three different occasions and analysed by one-way  
 
ANOVA followed by Bonferroni's post-hoc, comparisons tests, comparing  
 
each exposure level against the control level ( *p<0.05, **p<0.01).  
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Protein extracted from isolated germ cells of both spermatocytes and  
 
spermatids was determined by Western blotting to measure FHL5 protein  
 
expression. The samples were taken at 1 h following ENU treatment for both  
 
treated and untreated control cultures, and the expression levels of FHL5  
 
normalised against those of GAPDH and compared with the normalised  
 
control  value.  FHL5  protein  was  differentially  expressed  between  
 
spermatocytes and spermatids when treated with ENU and was found to be  
 
down-regulated by ENU treatment.  
 
 
There was no statistically significant difference in the levels of Fhl5 protein,  
 
at 0.5 mM concentrations of ENU on spermatocytes while spermatids  
 
showed significant decrease (*p<0.05). Moreover, further decrease was  
 
shown when spermatocytes treated with 1 mM (*p<0.05) as shown in Figure  
 
6.7 A and B. In contrast, spermatids showed significant decrease when  
 
treated with 0.5 mM and 1mM ENU (*p<0.05) and (**p<0.01) respectively as  
 
shown in Figure 6.8 A and B.  
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Figure 6.7: Spermatocytes were treated with ENU and the level of mature  
 
FHL5 protein was examined 1 h after treatment. Sample Western blots of  
 
FHL5 and GAPDH proteins are shown in (A) and quantified summary data  
 
are shown in (B). ENU treatment appeared to decrease the FHL5 protein  
 
level at all doses but the decrease was only significant at 1 mM. The density  
 
of each band was quantified by the use of Image 1.45 software. The relative  
 
expression level of FHL5 was measured by FHL5 / GAPDH ratio. Results are  
 
the mean ± SEM. From three independent experiments and statistical  
 
comparisons were made using one-way ANOVA followed by One-way-  
 
ANOVA followed by Bonferroni's post-hoc, comparing each dose against the  
 
control (*P <0.05).  
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Figure 6.8: Spermatids were treated with ENU and the level of FHL5 protein  
 
was examined 1 h after treatment. Sample Western blots of FHL5 and  
 
GAPDH proteins are shown in (A) and quantified summary data are shown in  
 
(B). ENU treatment appeared to decrease the FHL5 protein level at all doses  
 
and the decrease was significant at 0.5 and 1mM. The density of each band  
 
was quantified by the use of Image 1.45 software. The relative expression  
 
level of FHL5 was measured by TbpI1 / GAPDH ratio. Results are the mean  
 
± SEM From three independent experiments and statistical comparisons  
 
were made using one-way ANOVA followed by Bonferroni's post-hoc  
 
comparisons tests, comparing each dose against the control (*P <0.05; **P  
 
<0.01).  
 
 
161  
Different levels of expression of Gtf2a1I mRNA between spermatocytes and  
 
spermatids were seen after treatment with different concentrations of ENU.  
 
The samples were taken at 1 h following ENU treatment for both treated and  
 
untreated control cultures, and the expression levels of Gtf2a1I were  
 
normalised against those of -actin and compared with the equivalent control  
 
 
value.  
 
 
There was no statistically significant difference on the levels of Gtf2a1I after  
 
1 h of treatment with 0.05 mM ENU in either spermatids or spermatocytes.  
 
However, a significant decrease in the level of expression of Gtf2a1I in  
 
spermatocytes treated with 0.5 mM and 1 mM ENU (*p<0.05) and (**p<0.01)  
 
respectively as shown in Figure 6.9 A and B. In contrast, spermatids treated  
 
with 0.5 mM and 1 mM ENU (*p<0.01) and (**p<0.001) respectively as  
 
shown in Figure 6.9 A and B.  
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Figure 6.9: Effect of ENU on the Gtf2a1l mRNA expression in spermatocytes  
 
and spermatids by qPCR. A. spermatocytes and spermatids by qPCR  
 
Spermatocytes and B. spermatids after 1 h treatment, at 37 ºC with ENU at  
 
different concentrations: 0.05mM, 0.5mM and 1mM. Non-treated cells' values  
 
were defined as 100 % and other values were adjusted accordingly. Data are  
 
expressed as the mean ± SEM. n=3 different biological replicates performed  
 
on three different occasions and analysed by one-way ANOVA followed by  
 
Bonferroni's post-hoc comparisons tests, comparing each exposure level  
 
against the control level ( *p<0.05, **p<0.01, **p<0.01).  
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The relative expression level of Gtf2a1I was measured by quantitative  
 
western blotting. The samples were taken at 1 h following ENU treatment for  
 
both treated and untreated control cultures, and the expression levels of Fhl5  
 
were compared to GAPDH. A Gtf2a1I protein was differentially expressed  
 
between spermatocytes and spermatids when treated with ENU compared  
 
with the controls (ENU untreated cells) was considered to be expressively  
 
down-regulated by ENU treatment.  
 
 
The relative expression level of Gtf2a1I protein was measured by semi-  
 
quantitative Western blotting. Again, the protein was differentially expressed  
 
between spermatocytes and spermatids when treated with ENU compared  
 
with the controls.  
 
 
There was no statistically significant difference in the levels of Gtf2a1I  
 
protein, at 0.5 mM ENU on spermatocytes while in contrast, spermatids  
 
showed a significant decrease (*p<0.05). A further decrease was shown  
 
when the spermatocytes (*p<0.05) and spermatids (**p<0.01) were treated  
 
with 1 mM ENU. These results are shown in Figure 6.10 A and B and 6.11 A  
 
a n d B.  
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Figure 6.10: Spermatocytes were treated with ENU and the level of Gtf2a1l  
 
protein was examined 1 h after treatment. Sample Western blots of Gtf2a1l  
 
and GAPDH proteins are shown in (A) and quantified summary data are  
 
shown in (B). ENU treatment appeared to decrease the Gtf2a1l protein level  
 
at all doses but the decrease was only significant at 1 mM. The density of  
 
each band was quantified by the use of Image 1.45 software. The relative  
 
expression level of Gtf2a1l was measured by Gtf2a1l / GAPDH ratio. Results  
 
are the mean ± SEM From three independent experiments and statistical  
 
comparisons were made using one-way ANOVA followed by Bonferroni's  
 
post-hoc comparisons tests, comparing each dose against the control ( *P  
 
<0.05).  
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Figure 6.11: Spermatids were treated with ENU and the level of Gtf2a1l  
 
protein was examined 1 h after treatment. Sample Western blots of Gtf2a1l  
 
and GAPDH proteins are shown in (A) and quantified summary data are  
 
shown in (B). ENU treatment appeared to decrease the Gtf2a1l protein level  
 
at all doses and the decrease was significant at 0.5 and 1 mM. The density  
 
of each band was quantified by the use of Image 1.45 software. The relative  
 
expression level of Gtf2a1l was measured by Gtf2a1l / GAPDH ratio. Results  
 
are the mean ± SEM From three independent experiments and statistical  
 
comparisons were made using one-way ANOVA followed by Bonferroni's  
 
post-hoc comparisons tests, comparing each dose against the control ( *P  
 
<0.05; **P <0.01).  
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6.3.3  Effect  of  methyl  methanesulfonate  (MMS)  treatment  on  
 
spermatocytes and spermatids.  
 
 
6.3.3.1 Tbpl1  
 
 
Spermatocytes and spermatids were treated with MMS at different  
 
concentrations: 0.05 mM, 0.5 mM and 1 mM. The samples were taken at 1 h  
 
following MMS treatment for both treated and untreated control cultures, the  
 
expression levels of Tbpl1 were normalised against -actin and compared  
 
 
with the untreated control.  
 
 
All treatments yielded progressive decreases in the levels of Tbpl1 mRNA  
 
after 1h of treatment with MMS but they were only significant at 0.5 and 1  
 
mM. (Spermatocytes: *P <0.05 at 0.5 mM and **P <0.01 at 1mM;  
 
spermatids: **P <0.01 at 0.5 mM and ***P <0.001 at 1 mM). These results  
 
are shown in Figure 6.12 A and B.  
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Figure 6.12:  Ef fect  of  MMS on the Tbpl1 mRNA expression in  
 
spermatocytes and spermatids by qPCR. A. spermatocytes and B.  
 
spermat ids af ter 1 h t reatment, at  37 ºC with MMS at d if ferent   
 
concentrations: 0.05mM, 0.5mM and 1mM. Non-treated cells' values were  
 
defined as 100% and other values were adjusted accordingly. Data are  
 
expressed as the mean ± SEM n=3 different biological replicates performed  
 
on three different occasions and analysed by one-way ANOVA followed by  
 
Bonferroni's post-hoc comparisons tests, comparing each exposure level  
 
against the control level ( *p<0.05, **p<0.01, ***p<0.01).  
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The relative protein expression level of TbpI1 was measured by quantitative  
 
western blotting. The samples were taken at 1 h following MMS treatment  
 
for both treated and -untreated control cultures, and the expression levels of  
 
TbpI1 were normalised against GAPDH and compared with the value for the  
 
untreated control. TbpI1 protein was differentially expressed between  
 
spermatocytes and spermatids but was down-regulated by MMS treatment in  
 
both cases.  
 
 
Statistically significance was shown in the decreased levels of TbpI1 protein  
 
with 0.5 mM MMS (spermatocytes *P <0.05, spermatids **P <0.01). A further  
 
decrease was shown at 1 mM (spermatocytes **P <0.01, spermatids ***P  
 
<0.001). These results are shown in Figure 6.13 A and B and 6.14 A and B.  
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Figure 6.13: Spermatocytes were treated with MMS and the level of TbpI1  
 
protein was examined 1 h after treatment. Sample Western blots of TbpI1  
 
and GAPDH proteins are shown in (A) and quantified summary data are  
 
shown in (B). MMS treatment appeared to decrease the TbpI1 protein level  
 
at all doses and the decrease was significant at 0.5 and 1mM. The density of  
 
each band was quantified by the use of Image 1.45 software. The relative  
 
expression level of TbpI1 was measured by TbpI1 / GAPDH ratio. Results  
 
are the mean ± SEM. From three independent experiments and statistical  
 
comparisons were made using one-way ANOVA followed Bonferroni's post-  
 
hoc comparisons tests, comparing each dose against the control (*P <0.05;  
 
**P <0.01).  
 
 
 
 
 
 
 
 
170  
  
Figure 6.14: Spermatids were treated with MMS and the level of TbpI1  
 
protein was examined 1 h after the treatment. Sample Western blots of TbpI1  
 
and GAPDH proteins are shown in (A) and quantified summary data are  
 
shown in (B). MMS treatment decreased TbpI1 protein level. The density of  
 
each band was quantified by the use of Image 1.45 software. The relative  
 
expression level of TbpI1 was measured by TbpI1 / GAPDH ratio. Results  
 
are the mean ± SEM. from three independent experiments ( **P < 0.01 and  
 
***P < 0.001).  
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6.3.3.2 FHL5  
 
 
mRNA levels of the FHL5 gene also showed different mRNA expression in  
 
spermatocytes  and  spermatids  after  being  treated  with  different  
 
concentrations of MMS (as above). The samples were taken at 1 h following  
 
MMS treatment for both treated and untreated control cultures, and the  
 
expression levels of FHL5 were normalised against those of -actin and  
 
compared with the control values.  
 
 
There was no statistically significant difference on the levels of FHL5 after 1  
 
h of treatment with 0.05 mM MMS in either spermatids or spermatocytes.  
 
However, a significant decrease in the level of expression of FHL5 in  
 
spermatocytes treated with 0.5 mM and 1 mM MMS (*p<0.05) and (**p<0.01)  
 
respectively as shown in Figure 6.15 A and B. In contrast, spermatids treated  
 
with 0.5 mM and 1 mM MMS (**p<0.01) and (***p<0.001) respectively as  
 
shown in Figure 6.15 A and B.  
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Figure 6.15: Effect of MMS on the Fhl5 mRNA expression in spermatocytes  
 
and spermatids by qPCR. A. spermatocytes and B. spermatids after 1 h  
 
treatment, at 37º C with MMS at different concentrations: 0.05 mM, 0.5 mM  
 
and 1 mM. Non-treated cells' values were defined as 100% and other values  
 
were adjusted accordingly. Data are expressed as the mean ± SEM. n=3  
 
different biological replicates performed on three different occasions and  
 
analysed by one-way ANOVA followed by Bonferroni's post-hoc comparisons  
 
tests, comparing each exposure level against the control level (*P <0.05, **P  
 
<0.01, ***P <0.001).  
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The relative expression level of FHL5 was measured by quantitative Western  
 
blotting. The samples were taken at 1 h following MMS treatment for both  
 
treated and untreated control cultures, and the expression levels of FHL5  
 
were normalised against GAPDH and compared with the control values. The  
 
same pattern of results was obtained with protein expression as with mRNA  
 
with statistically significant effects shown on the levels of FHL5 protein when  
 
spermatocytes treated with 0.5 mM and 1 mM MMS (*p<0.05) and (**p<0.01)  
 
respectively as shown in Figure 6.16 A and B. In contrast, spermatids treated  
 
with 0.5 mM and 1 mM MMS (**p<0.01) and (***p<0.001) respectively as  
 
shown in Figure 6.17 A and B.  
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Figure 6.16: Spermatocytes were treated with MMS and the level of FHL5  
 
protein was examined 1 h after treatment. Sample Western blots of FHL5  
 
and GAPDH proteins are shown in (A) and quantified summary data are  
 
shown in (B). MMS treatment appeared to decrease the FHL5 protein level at  
 
all doses and the decrease was significant at 0.5 and 1 mM. The density of  
 
each band was quantified by the use of Image 1.45 software. The relative  
 
expression level of FHL5 was measured by FHL5 / GAPDH ratio. Results are  
 
the mean ± SEM From three independent experiments and statistical  
 
comparisons were made using one-way ANOVA followed by Bonferroni's  
 
post-hoc comparisons tests, comparing each dose against the control ( *P  
 
<0.05; **P <0.01).  
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Figure 6.17: Spermatids were treated with MMS  and the level of FHL5  
 
protein was examined 1 h after treatment. Sample Western blots of FHL5  
 
and GAPDH proteins are shown in (A) and quantified summary data are  
 
shown in (B). MMS treatment appeared to decrease the FHL5 protein level at  
 
all doses and the decrease was significant at 0.5 and 1mM. The density of  
 
each band was quantified by the use of Image 1.45 software. The relative  
 
expression level of FHL5 was measured by FHL5 / GAPDH ratio. Results are  
 
the mean ± SEM. from three independent experiments and statistical  
 
comparisons were made using one-way ANOVA followed by Bonferroni's  
 
post-hoc comparisons tests, comparing each dose against the control ( **P  
 
<0.01; ***P <0.001).  
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6.3.3.3 Gtf2a1l  
 
 
As with the other two transcription factors studied, the expression of the  
 
Gtf2a1I gene showed a different pattern of expression of mRNA between  
 
spermatocytes and spermatids after treatment with different concentrations  
 
of MMS. The samples were taken at 1 h following MMS treatment for both  
 
treated and untreated control cultures, and the expression levels of Gtf2a1I  
 
were normalised against -actin and compared with the corresponding  
 
 
control value.  
 
 
There was no statistically significant difference on the levels of Gtf2a1I after  
 
1 h of treatment with 0.05 mM MMS in both spermatocytes and spermatids.  
 
However, a significant decrease in the level of expression of Gtf2a1I in  
 
spermatocytes treated with 0.5 mM and 1 mM MMS (*p<0.05) and (**p<0.01)  
 
respectively. In contrast, spermatids treated with 0.5 mM and 1 mM MMS  
 
(**p<0.01) and (***p<0.001) respectively. These results are shown in Figure  
 
6.18 A and B.  
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Figure 6.18:  Effect of MMS on the Gtf2a1l mRNA expression in  
 
spermatocytes and spermatids by qPCR. A. spermatocytes and B.  
 
spermat ids af ter 1 h t reatment, at  37º C with MMS at d if ferent   
 
concentrations: 0.05 mM, 0.5 mM and 1 mM. Non-treated cells' values were  
 
defined as 100% and other values were adjusted accordingly. Data are  
 
expressed as the mean ± SEM. n=3 different biological replicates performed  
 
on three different occasions and analysed by one-way ANOVA followed by  
 
Bonferroni's post-hoc comparisons tests, comparing each exposure level  
 
against the control level (*p<0.05, **p<0.01, ***p<0.001).  
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The relative expression level of Gtf2a1I protein was measured by  
 
quantitative western blotting. The samples were taken at 1 h following MMS  
 
treatment for both treated and -untreated control cultures, and the expression  
 
levels of Gtf2a1I were normalised against those of GAPDH and compared  
 
with the appropriate control.  
 
 
A statistically significant decrease was shown in the levels of Gtf2a1I protein  
 
when protein when spermatocytes treated with 0.5 mM and 1 mM MMS  
 
(*p<0.05) and (**p<0.01) respectively as shown in Figure 6.19 A and B. In  
 
contrast, spermatids treated with 0.5 mM and 1 mM MMS (**p<0.01) and  
 
(***p<0.001) respectively as shown in Figure 6.20 A and B.  
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Figure 6.19: Spermatocytes were treated with MMS and the level of Gtf2a1l  
 
protein was examined 1 h after treatment. Sample Western blots of Gtf2a1l  
 
and GAPDH proteins are shown in (A) and quantified summary data are  
 
shown in (B). MMS treatment appeared to decrease the Gtf2a1l protein level  
 
at all doses and the decrease was significant at 0.5 and 1mM. The density of  
 
each band was quantified by the use of Image 1.45 software. The relative  
 
expression level of Gtf2a1l was measured by Gtf2a1l / GAPDH ratio. Results  
 
are the mean ± SEM From three independent experiments and statistical  
 
comparisons were made using one-way ANOVA followed by Bonferroni's  
 
post-hoc comparisons tests, comparing each dose against the control ( *P  
 
<0.05; **P <0.01).  
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Figure 6.20: Spermatids were treated with MMS and the level of Gtf2a1l  
 
protein was examined 1 h after treatment. Sample Western blots of Gtf2a1l  
 
and GAPDH proteins are shown in (A) and quantified summary data are  
 
shown in (B). MMS treatment appeared to decrease the Gtf2a1l protein level  
 
at all doses and the decrease was significant at 0.5 and 1mM. The density of  
 
each band was quantified by the use of Image 1.45 software. The relative  
 
expression level of Gtf2a1l was measured by Gtf2a1l / GAPDH ratio. Results  
 
are the mean ± SEM From three independent experiments and statistical  
 
comparisons were made using one-way ANOVA followed by Bonferroni's  
 
post-hoc comparisons tests, comparing each dose against the control ( **P  
 
<0.01; ***P <0.001).  
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6.4 Discussion  
 
 
To investigate the ENU and MMS induced damage on mRNA, the  
 
expression level of TbpI1, Fhl5 and Gtf2a1I selected mRNA transcription  
 
factors in spermatocytes and spermatids were compared under control and  
 
treatment conditions. The selected genes are known to be highly expressed  
 
in spermatocytes and spermatids. Expression was measured by qPCR  
 
analysis. The PCR exponential phase was obtained and the optimal number  
 
of PCR cycles, which was 30 cycles, was determined. QPCR analysis  
 
showed that TbpI1 is present in spermatocytes and spermatids in male adult  
 
mouse and observed by a product band at 136 bp. The Fhl5 gene was  
 
represented by a product band at 102 bp and Gtf2a1I by a product band at  
 
109 bp.  
 
 
Mammalian spermatogenesis seems to be controlled via the organized stage  
 
and cell specific gene expression in both the germ cells and the supporting  
 
somatic cells. The molecular mechanisms of this process are believed to  
 
include the selective modulation of defined sets of genes that facilitate  
 
spermatogenic cell differentiation (Guo et al., 2004). The dynamic pattern of  
 
TLF expression is essential for the development and differentiation of male  
 
germ cells (Martianov et al., 2001, Akhtar and Veenstra, 2011). The  
 
expression of the FHL5 gene is highly specific to spermatocytes and  
 
spermatids (Steger et al., 2004, De Cesare et al., 2003). FHL5 is regulated  
 
via interaction with CREM, a main factor for the regulation of many  
 
postmeiotic genes in spermatid maturation (De Cesare et al., 2003). FHL5  
 
expression is limited to late male germ cells (Fimia et al., 1999). A  
 
homozygous deletion of the FHL5 gene results in severe oligozoospermia,  
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though germ cells progress in FHL5-deficient mice seems normal. This result  
 
suggests that FHL5 is included in regulating genes for physical mechanisms  
 
involved in post-testicular sperm development (Kotaja et al., 2004). In  
 
agreement with the observations of Han et al. and Huang et al., (2001 and  
 
2006) who showed that Gtf2a1I mRNA is present in spermatocytes and  
 
spermatids (Han et al., 2001, Huang et al., 2006), this gene was also found  
 
to be expressed in these cell types in the present study. Gtf2a1I is encoded  
 
by a germ cell-specific gene whose expression is up-regulated with other  
 
general transcription factors during male germ cell development in the  
 
mouse (Han et al., 2001, De Cesare et al., 2003). Recently, an endogenous  
 
homolog of Gtf2a1I has been found as a 52 kDa protein in human testis  
 
extracts (Ozer et al., 2000, Huang et al., 2006). It is therefore possible that  
 
the function of Gtf2a1I is the morphological development of the sperm. If so,  
 
a lack of Gtf2a1I protein could result in abnormal sperm formation (Huang et  
 
al., 2006).  
 
 
The results presented in this chapter show that treating spermatocytes and  
 
spermatids isolated by Staput with ENU or MMS had a very marked effect on  
 
the mRNA and protein levels of these genes. Furthermore, it was found that  
 
the mRNA and protein levels were more affected in spermatids than in  
 
spermatocytes. This might be due to the mutational susceptibility of the  
 
different germ cell stages as a function of the chemical agent used. It is well  
 
known that the postmeiotic phase of mouse male germ cells is extremely  
 
sensitive to the induction of heritable genomic damage (Marchetti and  
 
Wyrobek, 2008). The high sensitivity of the postmeiotic period to mutagenic  
 
exposure has been associated with the reduced DNA repair capacity,  
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recombination and the types of chromosome-associated proteins and the  
 
extent of chromosomal condensation of late spermatids and sperm as  
 
compared other spermatogenic cell types (Singer et al., 2006, Sega, 1974,  
 
Olsen et al., 2005). All main DNA repair pathways appear to be less  
 
functional in late spermatids and sperm (Olsen et al., 2005, Hamer et al.,  
 
2003, Xu et al., 2005). This incapability of sperm to repair DNA lesions as  
 
they happen might make them mainly vulnerable to repeated exposures that  
 
take place because of environmental mutagens and occupational or life style  
 
reasons (Marchetti and Wyrobek, 2008). These clarifications suggest that  
 
genomic damage induced in late spermatids and sperm might accumulate in  
 
the fertilizing sperm and be transmitted to the embryo (Marchetti and  
 
Wyrobek, 2008). The qRT-PCR and Western blot analyses illustrated that  
 
the levels of TbpI1, FHL5 and Gtf2a1I expression in cells treated with ENU  
 
and MMS were highly down-regulated. This could suggest that these genes  
 
are essential for the progression of meiosis during germ cells development  
 
and in spermiogenesis.  
 
 
This study briefly outlines the current hypotheses regarding possible  
 
mechanisms during the haploid phase of spermatogenesis that may lead to  
 
such decreased level mRNA and proteins expression, which could be  
 
including enzyme induced breaks, apoptosis-like processes or oxidative  
 
stress of DNA. A better understanding of the origin of these mechanisms will  
 
lead to further investigations on the genetic instability of TbpI1, FHL5 and  
 
Gtf2a1I and mutagenic potential induced by the mutagenesis of ENU and  
 
MMS.  
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Chapter 7. Cloning  and  characterisation  of  the  post-meiotically  
 
expressed genes Tbpl1, FHL5 and Gtf2a1l for assessment of effects of  
 
ENU and MMS  
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7.1 Introduction  
 
 
A number of stresses such as DNA damage can lead not only to mutation  
 
but also to alterations in gene expression patterns caused via a universal  
 
shutdown and reprogramming of protein synthesis (Spriggs et al., 2010). A  
 
selective recruitment of ribosomes to mRNA which contain protein products  
 
that are needed for stress responding, can occur as a result of DNA damage.  
 
This recruitment can be regulated via elements in the 5′ and 3′ untranslated  
 
regions of mRNAs, involving interior ribosome entry segments, upstream  
 
open-reading frames, and microRNA target sites (Spriggs et al., 2010).  
 
Exogenous DNA damage can occur from physical or chemical sources.  
 
Among the most potent of these are radiotherapy and chemical agents used  
 
in cancer therapy, which can cause a diversity of DNA lesions, alkylating  
 
agents such as MMS and ENU, which attach alkyl groups to DNA bases  
 
(Ciccia and Elledge, 2010). Bases modified by alkylation can be misrepaired  
 
leading to misincorporation and hence mutation (Lindahl and Barnes, 2000).  
 
 
Spontaneous DNA mutation also occurs and can be due to dNTP  
 
misincorporation during DNA replication or interconversion among DNA  
 
bases produced by deamination. Alternatively, it can be due to loss of DNA  
 
bases resulting from DNA depurination (Lindahl and Barnes, 2000). In order  
 
to detect mutations caused in these ways, there is a range of genetic  
 
toxicology tests available for their detection. However, it is important to  
 
continue to develop new in vitro tests, especially those that can be used for  
 
high throughput testing.  
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The purpose of this study was to clone cDNA derived from testicular mRNA  
 
of the meiosis/spermiogenesis-specific transcription factors Tbpl1, FHL5 and  
 
Gtf2a1l respectively, given their apparent importance as targets described in  
 
Chapter 6. This will then enable the assessment of the toxicity of various  
 
doses of ENU and MMS on purified DNA plasmid by qPCR to evaluate the  
 
level expression of these genes in the in vitro model system of E.coli. The  
 
recombinant Tbpl1, FHL5 and Gtf2a1l proteins will be expressed, isolated  
 
using his-select spin columns and detected by Western blotting using a  
 
histidine Tag and Tbpl1-, FHL5- and Gtf2a1l-specific primary antibodies.  
 
 
7.2 Materials and Methods  
 
 
All relevant information is shown in section 2.1 RNA extraction and  
 
preparation is described in section 2.8.1. Measurement of quantity and purity  
 
of total RNA is described in section 2.8.5. DNase-I treatment is described in  
 
section 2.8.6 and cDNA synthesis in section 2.8.9 Plasmid DNA isolation is  
 
described in section 2.9.3. Restriction endonuclease digestion of plasmid  
 
DNA is described in section 2.9.4. Web-based genome databases  
 
(www.ensembl.org, www.bioinformatics.nl and www.ncbi.nlm.nih.gov) were  
 
used to analyse the genomic sequences and protein of the target genes to  
 
facilitate the design primers for qPCR. Full details of primer design are  
 
described in section 2.8.8. Polymerase chain reaction (PCR) is described in  
 
section 2.8.9. Cloning of the PCR Product into PET100/D is described in  
 
section 2.10.15. Protein expression is described in section 2.10.2 and  
 
Western Blot analysis was performed as described in section 2.12.  
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7.3 Results  
 
 
7.3.1 RNA isolation  
 
 
Total RNA was extracted from mouse testis using the GenElute™  
 
Mammalian Total RNA Miniprep Kit (Sigma Aldrich) according to the  
 
manufacturer's instructions. The quality of RNA was analysed by using gel  
 
electrophoresis (1 % agarose gel in 1x TBE) and ethidium bromide staining.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1: Optimised RNA extraction from mouse testis. Total RNA was  
 
extracted from 30mg testis tissue removed from 12 week old male NMRI  
 
mice. The samples were subjected to electrophoresis through a 1% w/v  
 
agarose gel in 1 X TBE with 1µg/ml ethidium bromide staining. Two sharp  
 
bands appeared on the gel which represents 28S and 18S ribosomal RNA  
 
bands with an approximate ratio of 2:1 indicating good quality RNA. In  
 
addition, there is a streak of mRNA from 200-2000 bp whose evenness in  
 
turn also reflects its quality.  
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7.3.2  -Actin PCR  
 
 
RT-PCR was performed on first strand cDNA for detection of -actin; a  
 
housekeeping gene constitutively expressed in mouse testis. This gene is  
 
regularly amplified to ensure synthesis of the first strand of cDNA had been  
 
successful and to validate the PCR conditions. Gene expression studies  
 
require that the expression profiles of the various genes being studied should  
 
be normalized against a suitable internal control.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2: PCR amplification of -actin product (327bp). The samples were  
 
subjected to electrophoresis through a 1.5% w/v agarose gel in 1X TBE with  
 
1µg/ml ethidium bromide staining. The PCR conditions were 95°C (30sec),  
 
59°C (30sec), 72 °C (30sec) for 30 cycles. The primers were forward 5-  
 
TATCCCGGGTAACCCTTCTC-3  and  reverse  5-  
 
TGCTGGGAGTCTCAGGACAG-3. Lanes 1 shows DNA ladder. Lane 2 is a  
 
negative control containing no cDNA and lanes 3 and 4 show positive  
 
amplification of -actin (327bp) product template.  
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Normalization ensures that the results have been corrected for discrepancies  
 
in concentration measurements, reaction inhibition and other extraneous  
 
errors. In these studies, the expression of the housekeeping gene actin was  
 
used as the RT-qPCR internal control standard. Figure 7.2 shows a clear  
 
single band of -actin against the marker ladder and a control run without  
 
cDNA. The detection of -actin (327bp) gave the expected size product,  
 
indicated it to be correct and, especially important, with no signs of  
 
contamination.  
 
 
7.3.3  TATA box binding protein-like 1 (Tbpl1)  
 
 
The full genomic sequence of the TATA box binding protein-like 1 is located  
 
on chromosome 10 at location 22,703,879-22,731,938, spanning over 27.57  
 
kb. Tbpl1 has 7 exons with a transcribed length 2,873 bps, which encodes a  
 
peptide 186 amino acids in size. The Tbpl1 protein is a 20,886.52 g/mol (21  
 
KDa).  
 
 
1 GAGAACCGGAAGTGAGTGGCTAGCCGGGATCCCCGGAGCTCCTGGGTCCGGCGGCGCTCT  
 
61 AGCCGCCTCGTGCCGCCTCTATGCCCCCGTGCGTCTAGTCTATTTATTGTCGCGGGGGAA  
 
121 GCGGCGGCCGCCCTGTACCCGGAACAACAAAGCGAGAAACCGAGCTCGAGCCTTGGGGGG  
 
181 CTCCTAGCAACGGGCCTGGGCGGGAGTTCCATGGAGACTGGGGAGCGGACCCGTTTTATC  
 
241 TTCATCCTTGTCCTCCAGCTTCTTCTCCGCGTCCGACGCAACCAGCAGCAGCGCTGCCGC  
 
301 CGTGTCCTTTACGACCGCCCCGTCTTCCCACGGATGTGATCTTCGTGGTGGGAACCAAGT  
 
361 TTCTAAACTACCCCAATGGATGCAGACAGTGATGTTGCATTGGACATTTTAATTACAAAT  
...............ATGGATGCAGACAGTGATGTTGCATTGGACATTTTAATTACAAAT  
...............-M--D--A--D--S--D--V--A--L--D--I--L--I--T--N-  
 
421 GTAGTCTGTGTTTTTAGAACAAGATGCCATTTGAACTTAAGGAAGATTGCTTTGGAGGGA  
46 GTAGTCTGTGTTTTTAGAACAAGATGCCATTTGAACTTAAGGAAGATTGCTTTGGAGGGA  
16 -V--V--C--V--F--R--T--R--C--H--L--N--L--R--K--I--A--L--E--G-  
 
481 GCAAATGTAATTTATAAGCGTGATGTTGGGAAAGTATTAATGAAGCTTAGAAAACCTAGA  
106 GCAAATGTAATTTATAAGCGTGATGTTGGGAAAGTATTAATGAAGCTTAGAAAACCTAGA  
36 -A--N--V--I--Y--K--R--D--V--G--K--V--L--M--K--L--R--K--P--R-  
541 ATTACAGCTACAATTTGGTCCTCAGGAAAAATTATTTGCACTGGAGCAACAAGTGAAGAA 166 
ATTACAGCTACAATTTGGTCCTCAGGAAAAATTATTTGCACTGGAGCAACAAGTGAAGAA  
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56 -I--T--A--T--I--W--S--S--G--K--I--I--C--T--G--A--T--S--E--E-  
 
601 GAAGCTAAATTTGGTGCCAGACGTTTAGCCCGTAGTCTGCAGAAACTAGGTTTTCAGGTC  
226 GAAGCTAAATTTGGTGCCAGACGTTTAGCCCGTAGTCTGCAGAAACTAGGTTTTCAGGTC  
76 -E--A--K--F--G--A--R--R--L--A--R--S--L--Q--K--L--G--F--Q--V-  
 
661 ATCTTCACAGATTTTAAGGTGGTGAATGTTTTGGCAGTGTGTAACATGCCCTTTGAGATC  
286 ATCTTCACAGATTTTAAGGTGGTGAATGTTTTGGCAGTGTGTAACATGCCCTTTGAGATC  
96 -I--F--T--D--F--K--V--V--N--V--L--A--V--C--N--M--P--F--E--I-  
 
721 CGTTTGCCAGAATTTACAAAGAACAATAGACCTCATGCCAGCTATGAACCTGAACTTCAT  
346 CGTTTGCCAGAATTTACAAAGAACAATAGACCTCATGCCAGCTATGAACCTGAACTTCAT 116 
-R--L--P--E--F--T--K--N--N--R--P--H--A--S--Y--E--P--E--L--H-  
 
781 CCTGCCGTGTGCTATCGGATAAAGTCTCTAAGAGCTACATTACAGATATTTTCAACAGGA  
406 CCTGCCGTGTGCTATCGGATAAAGTCTCTAAGAGCTACATTACAGATATTTTCAACAGGA 136 
-P--A--V--C--Y--R--I--K--S--L--R--A--T--L--Q--I--F--S--T--G-  
 
841 AGCATCACAGTGACAGGGCCCAATGTAAAGGCTGTGGCGACTGCCGTGGAACAGATCTAC  
466 AGCATCACAGTGACAGGGCCCAATGTAAAGGCTGTGGCGACTGCCGTGGAACAGATCTAC 156 
-S--I--T--V--T--G--P--N--V--K--A--V--A--T--A--V--E--Q--I--Y-  
 
901 CCGTTCGTGTTTGAAAGCAGGAAGGAGATTTTATAA  
526 CCGTTCGTGTTTGAAAGCAGGAAGGAGATTTTATAA 176 
-P--F--V--F--E--S--R--K--E--I--L--*-  
 
 
 
Figure 7.3: DNA (top line) and transcript (middle line) sequences of Tbpl1  
 
gene and its corresponding peptide sequences (bottom line). The  
 
untranslated region of the transcript is highlighted yellow, exons are  
 
alternately coloured black and blue (and codons are alternately coloured pale  
 
yellow/black or blue). Taken from www.ensembl.org.  
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7.3.3.1 Tbpl1  
 
 
7.3.3.1.1 Tbpl1 PCR  
 
 
Following RNA isolation from mouse testis, the gene of interest, Tbpl1, was  
 
amplified by RT-PCR. Custom primers were designed to amplify the 558 bp  
 
gene using the genomic DNA sequences of mus-musculus ATCC 2873  
 
obtained at the Ensembl website, gene ID # ENSMUSG00000071359.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.4: PCR amplification of Tbpl1 product (558 bp). The samples were  
 
subjected to electrophoresis through a 1.5 % w/v agarose gel in 1XTBE with  
 
1µg/ml ethidium bromide staining. The PCR amplification conditions were  
 
94°C (30sec), 61°C (30sec), 72 ºC (30sec) for 30 cycles. The primers were  
 
forward  5'  CACCATGGATGCAGACATGAT-GTT-3'  and  reverse  5'-  
 
TAAAATCTCCTTCCTGCTTTCA-3´. Lane 1 shows DNA ladder. Lane 2 is a  
 
negative control containing no cDNA template. Lane 3 shows positive  
 
amplification of Tbpl1 (558bp) product.  
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Due to the fact that pET100/D is a eukaryotic expression vector, DNA from  
 
Tbpl1 was amplified using Pfu DNA polymerase for integration into  
 
pET100/D-TOPO (Figure 7.4) to produce a PCR product with blunt ends.  
 
Ligation of the PCR product into this TOPO vector inserted the sequences  
 
CACC via the forward primer of Tbpl1. The linearized vector contains a  
 
region complementary to this sequence, thus allowing directional binding of  
 
the PCR product to the vector that is also in frame with other genes on the  
 
vector. Primers were designed with the CACC located in the forward primer  
 
(Tbpl1 forward) without a stop codon following the sequences that allowed  
 
expression of a fusion protein containing the N-terminal polyhistidine tag  
 
and Xpress epitope, while the reverse primer (Tbpl1 reverse) contained the  
 
native stop codon. Once the PCR product was obtained, it was ligated into  
 
the vector and transformed into E. coli TOPO 10 cells for propagation.  
 
 
7.3.3.1.2 PET100/D-TOPO vector  
 
 
Following the production of mouse testicular cDNA, the gene of interest  
 
(Tbpl1) was amplified by PCR. The primers were based on the DNA  
 
sequence of Tbpl1. The aim was to amplify the gene from the start codon  
 
(ATG) through to the stop codon (TAA). Once the 558 bp amplicon was  
 
obtained and confirmed by agarose gel electrophoresis (Figure 7.4), the  
 
gene was cloned into PET100/D-TOPO vector for sequence analysis.  
 
ThePET100/D-TOPO vector (Invitrogen) is an easy and efficient way to clone  
 
PCR products. This resulted in blunt ended PCR products added by Pfu taq  
 
polymerase to the 3' end of PCR products. The recombinant plasmid was  
 
identified by a chance screening for the plated bacterial transformants as  
 
there is no selective manner of choosing positive recombinants. Fifteen  
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colonies were selected and analyzed for the presence of the Tbpl1 gene.  
 
The cloning efficiency was as high as 80%. Only one positive clone was  
 
used for further analyses. After plasmid isolation, the recombinant plasmid  
 
(Tbpl1-pET) was subjected to restriction enzyme digestion by EcoRV, HindIII  
 
and PCR analysis. As anticipated, restriction enzyme digestion gave two  
 
distinct bands around (4926bp) and (838bp) (Figure 7.7) corresponding to  
 
the linearized vector and the Tbpl1 insert, respectively. PCR amplification  
 
using 20 ng of the Tbpl1-pET as a template and T7 forward primer (vector)  
 
and Tbpl1 complementary R1 reverse primer confirmed these results as a  
 
single discrete band of approximately 558bp was obtained (Figure 7.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.5: Confirmation of successful insertion of the Tbpl1 gene into  
 
pET100/D-TOPO. The samples were subjected to electrophoresis through a  
 
1% w/v agarose gel in 1X TBE with 1µg/ml ethidium bromide staining. The  
 
PCR conditions were 98°C (1sec), 61°C (30sec), 72 °C (30sec) for 30 cycles.  
 
Lane 1 shows DNA ladder. Lane 2, 3, 4 and 5 shows PCR products  
 
generated by different primer sets and confirmed as successful the correct  
 
orientation of the insert.  
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Figure 7.6: Map of pET 100/D-TOPO with Tbpl1 insert. The 5'-CACC-3' in  
 
the 5' end of the insert provides directional and in-frame cloning of the gene  
 
with the 6x His fusion tag. Ampicillin resistant positive clones were selected  
 
and the recombinant plasmid was subjected to sequence analysis.T7  
 
promoter was IPTG induced for high expression of the gene.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.7: Restriction enzyme digestion of pET100 and pET100- Tbpl1  
 
clone. The samples were subjected through a 1.5% w/v agarose gel in 1x  
 
TBE buffer with 1µg/ml ethidium bromide staining. . Lane 1 shows DNA  
 
ladder. Lane 2 shows positive control cut with HindIII. Lane 3 shows pET100-  
 
Tbpl1 cut with HindIII. Lane 4 shows pET100- Tbpl1 cut with EcoRV. Lanes  
 
5, 6 show negative control (non-recombinant plasmid).  
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7.3.3.1.3 Effect of ENU and MMS treatment on the DNA plasmid of TbpI1  
 
 
This experiment was performed in order to assess the effect of ENU and  
 
MMS on the untreated or treated DNA plasmid isolated from the host cells  
 
BL21 (DE3).The cells were cultured and treated with ENU and MMS (0.05  
 
mM, 0.5 mM and 1 mM) for 1h as described earlier (sections 2.10.2).  
 
Untreated cells were chosen as a control for the experiment. After that the  
 
cells were collected and DNA plasmid of TbpI1 was extracted and analyzed  
 
by qRT-PCR to quantify DNA expression of TbpI1. There was no statistically  
 
significant difference on the level of TbpI1, after 1h of treatment with ENU  
 
and MMS (0.05 mM) compared with non-treated control cells.  
 
 
When the cells were treated with ENU and MMS 0.5 mM there was a  
 
statistically significant decrease on the TbpI1level expression (P <0.05) and  
 
a further decrease in the level of TbpI1 was shown when the cells were  
 
treated with ENU and MMS 1 mM (P < 0.01). These results are shown in  
 
Figure 7.8 and 7.9 respectively. Moreover, this result showed that ENU and  
 
MMS showed down-regulation of TbpI1 expression.  
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Figure 7.8: Effect of ENU on the TbpI1 expression in DNA plasmid purified  
 
from the host cells BL21 (DE3) by qPCR after 1 h treatment at 37 ºC with  
 
ENU at different concentrations: 0.05 mM, 0.5 mM and 1 mM. Non-treated  
 
cells values were defined as 100% and other values were adjusted  
 
accordingly. Data are expressed as the mean ± SEM. n=3 different biological  
 
replicates performed on three different occasions ( *p<0.05, **p<0.01).  
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Figure 7.9: Effect of MMS on the TbpI1 expression in DNA plasmid purified  
 
from the host cells BL21 (DE3) by qPCR after 1 h treatment at 37 ºC with  
 
MMS at different concentrations: 0.05 mM, 0.5 mM and 1 mM. Non-treated  
 
cells values were defined as 100% and other values were adjusted  
 
accordingly. Data are expressed as the mean ± SEM. n=3 different biological  
 
replicates performed on three different occasions (*p<0.05, **p<0.01).  
 
 
 
7.3.3.1.4 Western Blot analysis of Purified Recombinant Protein of  
 
TbpI1  
 
 
The Western blot of the purified TbpI1 His-tagged protein isolated under  
 
native conditions was free of degradation products and showed distinctive  
 
and thick bands at a molecular mass of approximately 24 kDa that was  
 
confirmed using an antibody directed at the histidine tag as shown in Figure  
 
7.10. Furthermore, it showed a distinctive band at molecular masses of  
 
approximately 21 kDa that was confirmed using anti-TBPL1 antibody as  
 
shown in Figure 7.11. The purification of protein from uninduced cells  
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containing the pET100-TbpI1plasimd shows no expression of the TbpI1  
 
protein showing that expression is controlled.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.10: Western blotting analysis of his tagged Tbpl1 protein expressed  
 
in the pET vector system. Lane 1 shows a biotinylated protein ladder. Lane 2  
 
shows negative control of host strain without protein expression. Lane 3  
 
show purified recombinant protein using his select spin column under native  
 
condition from a 10 ml culture of expressed from the PET100- Tbpl1 induced  
 
with 1 mM IPTG for 4 hours at 37 ºC. Expression of the fusion protein was  
 
tested by western blot analysis using a mouse specific antibody to his-tag as  
 
a primary antibody and HRP conjugated mouse as a secondary antibody.  
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Figure 7.11: Western blotting analysis of (untagged) Tbpl1 protein  
 
expressed in the pET vector system. Lane 1 shows a biotinylated protein  
 
Ladder. Lane 2 shows negative control of host strain without protein  
 
expression. Lane 3 shows purified recombinant protein using his select spin  
 
column under native condition. From a 10 ml culture of expressed from the  
 
PET100- Tbpl1 induced with 1 mM IPTG for 4 hours at 37 C. Expression of  
 
the fusion protein was tested by Western blot analysis using a rabbit anti-  
 
TBPL1 antibody as a primary antibody and HRP conjugated rabbit as a  
 
secondary antibody.  
 
 
The relative level of Tbpl1 expression in exponentially growing E.coli was  
 
determined. Presence of Tbpl1 protein was determined by quantitative  
 
western blotting. The samples were taken at 1 h following ENU and MMS  
 
treatment for both treated and untreated-control cultures, and the expression  
 
levels of Tbpl1 were compared to GAPDH. Tbpl1protein was differentially  
 
expressed in ENU and MMS-treated cells compared with the controls and  
 
were therefore considered to have been down-regulated by both compounds  
 
ENU and MMS treatment.  
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There was no statistically significant different in the levels of Tbpl1 protein at  
 
0.5 mM concentration of both ENU and MMS. Moreover, further decrease  
 
was shown when the cells were treated with ENU and MMS 0.5 mM and 1  
 
mM (*p<0.05, ***p<0.001 respectively). These results are shown in Figures  
 
7.12 A and B and 7.13 A and B.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.12: Western blot analysis of purified recombinant TbpI1 protein  
 
expression after treatment with ENU at different concentrations and 1 h  
 
treatment. Sample Western blots of TbpI1 and GAPDH proteins are shown in  
 
(A) and quantified summary data are shown in (B). The density of each band  
 
was quantified by the use of Image 1.45 software. The relative expression  
 
level of TbpI1 was measured by TbpI1 / GAPDH ratio. Data are expressed  
 
as the mean ± SEM. n=3 biological replicates performed on three different  
 
occasions (*P <0.05, **P <0.01).  
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Figure 7.13: Western blot analysis of purified recombinant TbpI1 protein with  
 
TbpI1 antibody treated with MMS at different concentrations and 1 h of  
 
treatment. Sample Western blots of TbpI1 and GAPDH proteins are shown in  
 
(A) and quantified summary data are shown in (B). The density of each band  
 
was quantified by the use of Image 1.45 software. The relative expression  
 
level of TbpI1 was measured by TbpI1 / GAPDH ratio. Data are expressed  
 
as the mean ± SEM. n=3 different biological replicates performed on three  
 
different occasions (*p<0.05, ***p<0.001).  
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7.3.4  Four and a half LIM domains 5 (FHL5)  
 
 
The full genomic sequence of the FHL5 protein is located on chromosome 4  
 
at location 25,199,908-25,242,876 the genomic sequence spanning over  
 
42.97 kb. FHL5 has 6 exons with a transcription length 1,106 bps, which  
 
encodes a peptide 186 amino acids in size.  The protein of FHL5 is  
 
32,906.78 g/mol (32 kda).  
 
 
1 GGGGACCCAGGCAGAAGTCCAAGCACACTGAGAGTACAGAAAGCAGGTAACAATCCTGAG  
61 TTATTTTCTTCAAAGCCAACACTACTCAGAGTTCTCAAATTTCCCAAGAAAGAACTGAAG  
121 AGTGGCAACAAAGAACACTTCATCCGCTGCTCTACAAAGAACTCCAAAGGATAAAACTGA  
181 AATGACAAGTAGTCAATTTGATTGTCAATACTGCACTTCATCCCTGATTGGGAAGAAATA  
.ATGACAAGTAGTCAATTTGATTGTCAATACTGCACTTCATCCCTGATTGGGAAGAAATA  
.-M--T--S--S--Q--F--D--C--Q--Y--C--T--S--S--L--I--G--K--K--Y  
241 TGTACTCAAGGATGATAATCTATACTGCATCTCCTGCTACGATCGTATCTTTTCTAACTA  
60 TGTACTCAAGGATGATAATCTATACTGCATCTCCTGCTACGATCGTATCTTTTCTAACTA  
20 --V--L--K--D--D--N--L--Y--C--I--S--C--Y--D--R--I--F--S--N--Y  
301 TTGTGAGCAGTGTAAAGAACCAATTGAATCAGATTCTAAGGATCTTTGCTACAAAAACCG  
120 TTGTGAGCAGTGTAAAGAACCAATTGAATCAGATTCTAAGGATCTTTGCTACAAAAACCG  
40 --C--E--Q--C--K--E--P--I--E--S--D--S--K--D--L--C--Y--K--N--R  
361 TCACTGGCATGAAGGATGCTTCAGGTGCAACAAATGCCATCACTCTTTGGTGGAAAAGCC  
180 TCACTGGCATGAAGGATGCTTCAGGTGCAACAAATGCCATCACTCTTTGGTGGAAAAGCC  
60 --H--W--H--E--G--C--F--R--C--N--K--C--H--H--S--L--V--E--K--P  
421 TTTCGTTGCCAAGGATGATCGCCTGCTGTGCACAGACTGCTATTCCAACGAGTGTTCCTC  
240 TTTCGTTGCCAAGGATGATCGCCTGCTGTGCACAGACTGCTATTCCAACGAGTGTTCCTC  
80 --F--V--A--K--D--D--R--L--L--C--T--D--C--Y--S--N--E--C--S--S  
481 CAAGTGCTTCCACTGCAAGAGAACCATCATGCCAGGTTCTCGGAAAATGGAATTTAAGGG  
300 CAAGTGCTTCCACTGCAAGAGAACCATCATGCCAGGTTCTCGGAAAATGGAATTTAAGGG  
100 --K--C--F--H--C--K--R--T--I--M--P--G--S--R--K--M--E--F--K--G  
541 CAATTACTGGCATGAAACCTGCTTTGTGTGTGAGCACTGCCGACAGCCAATAGGAACCAA  
360 CAATTACTGGCATGAAACCTGCTTTGTGTGTGAGCACTGCCGACAGCCAATAGGAACCAA  
120 --N--Y--W--H--E--T--C--F--V--C--E--H--C--R--Q--P--I--G--T--K  
601 GCCTTTGATCTCCAAAGAGAGTGGCAATTATTGTGTGCCATGTTTTGAGAAGGAGTTTGC  
420 GCCTTTGATCTCCAAAGAGAGTGGCAATTATTGTGTGCCATGTTTTGAGAAGGAGTTTGC  
140 --P--L--I--S--K--E--S--G--N--Y--C--V--P--C--F--E--K--E--F--A  
661 TCATTACTGCAACTTCTGTAAGAAGGTGATAACTTCCGGTGGGATAACCTTCCGTGATCA  
480 TCATTACTGCAACTTCTGTAAGAAGGTGATAACTTCCGGTGGGATAACCTTCCGTGATCA  
160 --H--Y--C--N--F--C--K--K--V--I--T--S--G--G--I--T--F--R--D--Q  
721 GATATGGCATAAAGAGTGTTTTCTGTGCAGCGGCTGCAGGAAAGAGCTTTATGAGGAGGC  
540 GATATGGCATAAAGAGTGTTTTCTGTGCAGCGGCTGCAGGAAAGAGCTTTATGAGGAGGC  
180 --I--W--H--K--E--C--F--L--C--S--G--C--R--K--E--L--Y--E--E--A  
781 ATTTATGTCAAAGGATGATTTCCCATTCTGCCTGGATTGCTACAACCATCTTTATGCTAA  
600 ATTTATGTCAAAGGATGATTTCCCATTCTGCCTGGATTGCTACAACCATCTTTATGCTAA  
200 --F--M--S--K--D--D--F--P--F--C--L--D--C--Y--N--H--L--Y--A--K  
841 AAAGTGTGCAGCCTGCACCAAACCCATCACTGGCCTCAGAGGTGCCAAGTTCATCTGCTT  
660 AAAGTGTGCAGCCTGCACCAAACCCATCACTGGCCTCAGAGGTGCCAAGTTCATCTGCTT  
220 --K--C--A--A--C--T--K--P--I--T--G--L--R--G--A--K--F--I--C--F  
901 TCAAGACCGCCAGTGGCACAGTGAGTGCTTCAACTGCGGAAAGTGCTCGGTCTCCTTGGT  
720 TCAAGACCGCCAGTGGCACAGTGAGTGCTTCAACTGCGGAAAGTGCTCGGTCTCCTTGGT  
240 --Q--D--R--Q--W--H--S--E--C--F--N--C--G--K--C--S--V--S--L--V  
961 GGGTGAAGGATTCTTGACCCATAACATGGAAATCTTATGCCGCAAGTGTGGCTCCGGGGC  
780 GGGTGAAGGATTCTTGACCCATAACATGGAAATCTTATGCCGCAAGTGTGGCTCCGGGGC  
260 --G--E--G--F--L--T--H--N--M--E--I--L--C--R--K--C--G--S--G--A  
1021 AGACACTGACGCTTAG  
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840 AGACACTGACGCTTAG  
280 --D--T--D--A--*-  
 
 
Figure 7.14: DNA (top line) and transcript (middle line) sequences of FHL5 gene  
and its corresponding peptide sequences (bottom line). The untranslated region of 
the transcript is highlighted yellow, exons are alternately coloured black and blue 
(and codons are alternately coloured pale yellow/black or blue). Taken from  
www.ensembl.org.  
 
 
7.3.4.1 Amplification of FHL5 by PCR and Cloning into the pET100/D-  
 
TOPO®  
 
 
Following isolation of mouse testis RNA and production of cDNA from it,  
 
FHL5 was amplified as described in the methods section (2.8.9). The final  
 
PCR products were analyzed by electrophoresis through a 1% w/v agarose  
 
gel, and DNA was stained with ethidium bromide for observation under UV  
 
light (Figure 7.15).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.15: PCR amplification of FHL5 product (854bp). The samples were  
subjected to electrophoresis through a 1.5% w/v agarose gel in 1 X TBE with 1 
µg/ml ethidium bromide staining. The PCR conditions were 94°C (30sec), 
57°C (30sec), 72°C (30sec) for 30 cycles. The primers were forward 5-  
CACCATGACAAGTAGTCAATTTGATTGT-3  and  reverse  5-  
CTAAGCGTCAGTGTCTGC-3. Lane 1 shows a DNA ladder. Lane 2 is a 
negative control containing no cDNA template. Lane 3 shows positive  
amplification of FHL5 (854bp) product.  
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To confirm the FHL5 PCR product was correct the product was restriction  
 
enzyme digested with PstI (data not shown).  Full length of FHL5 PCR  
 
product was cut with PstI at correct position (277 to 577 bp) respectively of  
 
the act PCR product (854bp), which confirmed the likely complete correct  
 
sequence of FHL5 PCR product.  
 
 
7.3.4.2 Confirmation of the Successful Cloning into pET100/D-TOPO®  
 
 
Plasmid DNA from 15 E. coli clones was obtained and screened for the  
 
presence of the FHL5 gene using PCR (Figure 7.16). The plasmid DNA  
 
containing the FHL5 gene was PCR amplified using the primers sets T7  
 
forward / Native FHL5 reverse and pET- FHL5 forward / T7 reverse yielding  
 
fragments of 854 bp and 679 bp respectively, confirming that FHL5 was  
 
inserted into the vector (Figure 7.16).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.16: Confirmation of the Successful Cloning into pET100/D-TOPO®.  
 
The samples were subjected to electrophoresis through a 1% w/v agarose  
 
gel in 1X TBE with 1ug/ml ethidium bromide staining. Lane 1 shows DNA  
 
ladder. Lane 2, 3, 4 and 5 shows PCR products generated by primers sets,  
 
which successfully confirmed the correct orientation of the insert (854bp).  
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7.3.4.3 Effect of ENU and MMS treatment on FHL5  
 
 
Quantitative real-time PCR assay was conducted on untreated or treated  
 
DNA plasmid isolated from the host cells BL21 (DE3) treated with 0.05 mM,  
 
0.5 mM, 1 mM, ENU or MMS as described in sections 2.10.2. ENU and MMS  
 
showed down-regulation of FHL5 expression.  
 
 
Statistical analysis showed that there was no significant effect on expression  
 
level of FHL5 gene after treatment with ENU and MMS (0.05 mM) compared  
 
with untreated control cells. There was however a significant decrease in the  
 
level of expression of FHL5 when cells treated with 0.5 mM ENU or MMS  
 
(both *P <0.05). These results are shown in Figures 7.17 and 7.18. However,  
 
further decrease was shown when the cells were treated with ENU and MMS  
 
1mM (**p<0.01) these results are shown in Figures 7.17 and 7.18.  
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Figure 7.17: Effect of ENU on FHL5 expression in DNA plasmid purified  
 
from the host cells BL21 (DE3) and analysed by qPCR after 1 h treatment at  
 
37 ºC with ENU at different concentrations: 0.05 mM, 0.5 mM and 1 mM.  
 
Non-treated cells values were defined as 100% and other values were  
 
adjusted accordingly. Data are expressed as the mean ± SEM. n=3 different  
 
biological replicates performed on three different occasions (*p<0.05,  
 
**p<0.01).  
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Figure 7.18: Effect of MMS on FHL5 expression in DNA plasmid purified  
 
from the host cells BL21 (DE3) analysed by qPCR after 1 h treatment at 37  
 
ºC with MMS at different concentrations: 0.05 mM, 0.5 mM and 1 mM. Non-  
 
treated cell values were defined as 100% and other values were adjusted  
 
accordingly. Data are expressed as the mean ± SEM. n=3 different biological  
 
replicates performed on three different occasions (*p<0.05, **p<0.01).  
 
 
 
7.3.4.4 Western blot analysis of purified recombinant protein of FHL5  
 
 
Expression of FHL5-pET100D was performed as for the TbpI1-pET100  
 
construct. IPTG was used to turn on the lacUV5 promoter in FHL5-PET  
 
100/D transformed E. coli which resulted in overexpression of the protein  
 
encoded by the FHL5 PCR product that had been inserted into the pET  
 
vectors cloning site. Since overexpression can be a problem with toxic  
 
proteins, the BL21 Star™ (DE3) pLysS strain were used to express FHL5  
 
since they also produce a T7 lysozyme that slowed expression by binding to  
 
T7 RNA polymerase and inactivating it. The BL21 cells transformed with  
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FHL5-pET100D were induced with IPTG for 4 hours. After each hour,  
 
samples were taken and stored for further analysis. The Western blot of  
 
native FHL5 protein under identical conditions showed that a high  
 
concentration of the protein was obtained. There was a major 35 kDa  
 
recombinant protein band corresponding to the 32 kDa Gtf2a1l fused with a 3  
 
kDa His-Tag as shown in 7.19. The FHL5 protein preparation was equally  
 
free of degradation product as shown Figure 7.20. The purified protein from  
 
cells containing the pET100 FHL5 plasmid that had not been induced  
 
showed no expression of the FHL5 protein showing that its expression was  
 
controllable.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.19: Western blotting analysis of his tagged FHL5 protein expressed  
in the pET vector systems. Lane 1 shows the biotinylated protein ladder. 
Lane 2 shows negative control of host strain without protein expression. 
Lane 3 Purified recombinant protein using his select spin column under 
native condition from a 10 ml culture of expressed from the PET100- FHL5 
induced with 1 mM IPTG for 4 hours at 37 ºC. Expression of the fusion 
protein was tested by western blot analysis using a mouse specific antibody 
to his-tag as a primary antibody and HRP conjugated mouse as a secondary  
antibody.  
 
 
 
 
 
209  
 
Figure 7.20: Western blotting analysis of FHL5 protein expressed in the pET  
vector systems. Lane 1 shows biotinylated protein Ladder. Lane 2 shows 
negative control of host strain without protein expression. Lane 3 shows 
purified recombinant protein using his select spin column under native 
condition. from a 10 ml culture of expressed from the PET100- FHL5 induced 
with 1mM IPTG for 4 hours at 37 C. Expression of the fusion protein was 
tested by western blot analysis using a rabbit anti- FHL5 antibody as a  
primary antibody and HRP conjugated rabbit as a secondary antibody.  
 
 
To determine the effect of ENU and MMS treatment on FHL5 gene  
 
expression, FHL5 was produced as recombinant protein in E. coli after  
 
exposure. A Western blot analysis was performed for the samples taken at 1  
 
h following ENU and MMS treatment for both ENU and MMS treated and  
 
untreated control cultures, and the expression levels were compared. A  
 
FHL5 protein which was differentially expressed in ENU or MMS-treated cells  
 
compared with the controls (ENU and MMS-untreated cells) was considered  
 
to be meaningfully down-regulated by ENU or MMS treatment. Statistical  
 
analysis has shown that there was not any effect of the expression level of  
 
FHL5 protein, when cells treated with at low concentration of ENU and MMS  
 
(0.05 mM). The concentrations of ENU and MMS 0.5 mM and 1 mM  
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significantly decreased FHL5 protein levels compared with GAPDH (P <0.05,  
 
and P <0.01, respectively).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.21: Western blot analysis of purified recombinant FHL5 protein with  
 
FHL5 antibody treated with ENU at different concentration at 1 h after  
 
treatment. Sample Western blots of FHL5 and GAPDH proteins are shown in  
 
(A) and quantified summary data are shown in (B). The density of each band  
 
was quantified by the use of Image 1.45 software. The relative expression  
 
level of FHL5 was measured by FHL5 / GAPDH ratio. Data are expressed as  
 
the mean ± SEM. n=3 different biological replicates performed on three  
 
different occasions (*p<0.05, **p<0.01).  
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Figure 7.22: Western blot analysis of purified recombinant FHL5 protein with  
 
FHL5 antibody treated with MMS at different concentrations, 1 h after  
 
treatment. Sample Western blots of FHL5 and GAPDH proteins are shown in  
 
(A) and quantified summary data are shown in (B). The density of each band  
 
was quantified by the use of Image 1.45 software. The relative expression  
 
level of FHL5 was measured by FHL5 / GAPDH ratio. Data are expressed as  
 
the mean ± SEM. n=3 different biological replicates performed on three  
 
different occasions (*p<0.05, **p<0.01).  
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7.3.5  General transcription factor IIA, 1-like (Gtf2a1l)  
 
 
The full genomic sequence of the Gtf2a1l is located on chromosome 17 at  
 
location 88.668.660-88.715.152 the genomic sequence spanning over 46.49  
 
kb. Gtf2a1l has 9 exons with a transcription length 1,621 bps, which encodes  
 
a peptide 468 amino acids in size. The protein of Gtf2a1l is 51,524.58 g/mol  
 
(52Kda).  
 
 
 
 
 
1 TGGCGGCTCTCTGCCACGCAGGCGCAAACGGTTAGGCACAGAGCGGCTGGCATGGCCTTC  
ATGGCCTTC  
-M--A--F-  
61 ATCAACCTGGTGCCCAAACTCTACCAGTCTGTAATTGAAGATGTCATCGAGGGCGTGCGG  
10 ATCAACCTGGTGCCCAAACTCTACCAGTCTGTAATTGAAGATGTCATCGAGGGCGTGCGG  
4 -I--N--L--V--P--K--L--Y--Q--S--V--I--E--D--V--I--E--G--V--R- 121 
GACCTGTTTGCTGAGGAAGGCATCGAGGAGCAGGTGTTGAAAGACCTGAAGAAGCTCTGG  
70 GACCTGTTTGCTGAGGAAGGCATCGAGGAGCAGGTGTTGAAAGACCTGAAGAAGCTCTGG  
24 -D--L--F--A--E--E--G--I--E--E--Q--V--L--K--D--L--K--K--L--W- 181 
GAAACCAAAGTGTTACAATCTAAAGCCACAGAGGACTTCTTCAGAAACAGCACGCAGGTG 130 
GAAACCAAAGTGTTACAATCTAAAGCCACAGAGGACTTCTTCAGAAACAGCACGCAGGTG  
44 -E--T--K--V--L--Q--S--K--A--T--E--D--F--F--R--N--S--T--Q--V-  
241 CCTCTTCTCACTCTCCAGCTGCCTCATGCCTTACCACCAGCCCTGCAGCCCGAAGCATCG 190 
CCTCTTCTCACTCTCCAGCTGCCTCATGCCTTACCACCAGCCCTGCAGCCCGAAGCATCG  
64 -P--L--L--T--L--Q--L--P--H--A--L--P--P--A--L--Q--P--E--A--S- 301 
CTGCTGATCCCAGCTGGTAGAACTCTGCCGAGTTTTACGCCGGAAGACCTGAACACCGCC 250 
CTGCTGATCCCAGCTGGTAGAACTCTGCCGAGTTTTACGCCGGAAGACCTGAACACCGCC  
84 -L--L--I--P--A--G--R--T--L--P--S--F--T--P--E--D--L--N--T--A- 361 
AACTGTGGTGCAAACTTTGCCTTTGCTGGCTATCCGATCCACGTCCCAGCAGGCATGGCC 310 
AACTGTGGTGCAAACTTTGCCTTTGCTGGCTATCCGATCCACGTCCCAGCAGGCATGGCC 104 -N--
C--G--A--N--F--A--F--A--G--Y--P--I--H--V--P--A--G--M--A- 421 
TTCCAGACGGCATCTGGTCACCTTTACAAAGTCAATGTACCAGTCATGGTGACACAGACT 370 
TTCCAGACGGCATCTGGTCACCTTTACAAAGTCAATGTACCAGTCATGGTGACACAGACT 124 -F--
Q--T--A--S--G--H--L--Y--K--V--N--V--P--V--M--V--T--Q--T- 481 
TCTGGGAGAACAGAAATTCTCCAGCATCCATTTCAGCAAGTCCTTCAGCAGCTCGGGCAG 430 
TCTGGGAGAACAGAAATTCTCCAGCATCCATTTCAGCAAGTCCTTCAGCAGCTCGGGCAG 144 -S--
G--R--T--E--I--L--Q--H--P--F--Q--Q--V--L--Q--Q--L--G--Q- 541 
CCTTTAGTAATACAGACCACTGTTCCAACATTGCACCCATGTTCTCTTCAAGCAGCAACT 490 
CCTTTAGTAATACAGACCACTGTTCCAACATTGCACCCATGTTCTCTTCAAGCAGCAACT 164 -P--
L--V--I--Q--T--T--V--P--T--L--H--P--C--S--L--Q--A--A--T- 601 
GAGAAATCCCTCAGAATGGAAGCTGTGCTGCAGCCACCTCCCATTCTGCATCCTCCTCCA 550 
GAGAAATCCCTCAGAATGGAAGCTGTGCTGCAGCCACCTCCCATTCTGCATCCTCCTCCA 184 -E--
K--S--L--R--M--E--A--V--L--Q--P--P--P--I--L--H--P--P--P-  
661 GTGGACAGGACACATGTAGAAAATGCTGCGAGCGACAGGCGCCTTCTCCCGGGAAATGAG  
610 GTGGACAGGACACATGTAGAAAATGCTGCGAGCGACAGGCGCCTTCTCCCGGGAAATGAG 204 
-V--D--R--T--H--V--E--N--A--A--S--D--R--R--L--L--P--G--N--E- 721 
CTGAGGCCGCAGGAAAGCTCTCCATACCTCAGCCTTCCCGGTGTGGGCTTTCCTCCTCAG 670 
CTGAGGCCGCAGGAAAGCTCTCCATACCTCAGCCTTCCCGGTGTGGGCTTTCCTCCTCAG 224 -L--
R--P--Q--E--S--S--P--Y--L--S--L--P--G--V--G--F--P--P--Q- 781 
GCCGCTCTGACAGAGTCTAGCCTGGAGCCAGTGCTTGGTGTCTCAGCGAGCCTGACTCAG 730 
GCCGCTCTGACAGAGTCTAGCCTGGAGCCAGTGCTTGGTGTCTCAGCGAGCCTGACTCAG 244 -A--
A--L--T--E--S--S--L--E--P--V--L--G--V--S--A--S--L--T--Q-  
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841  
790  
264  
901  
850  
284  
961  
910  
304 
1021  
970  
324 
1081 
1030  
344 
1141 
1090  
364 
1201 
1150  
384 
1261 
1210  
404 
1321 
1270  
424 
1381 
1330  
444 
1441 
1390  
464  
AATCTGCACAGTGACCCTTTCTCACAGGGCCCCCCAGGCCCTCTCCACCACCACTTGCTA  
AATCTGCACAGTGACCCTTTCTCACAGGGCCCCCCAGGCCCTCTCCACCACCACTTGCTA -N--
L--H--S--D--P--F--S--Q--G--P--P--G--P--L--H--H--H--L--L- 
GAGTCACAGCTTCAAAGCCTTAAAGACAGTATATATGGATGCGACTCCACAAAGCAACTG 
GAGTCACAGCTTCAAAGCCTTAAAGACAGTATATATGGATGCGACTCCACAAAGCAACTG -E--
S--Q--L--Q--S--L--K--D--S--I--Y--G--C--D--S--T--K--Q--L- 
AGAAAAGCAGAGGAGCCCAGCAGCCTCCGTGTGTCAGAGAAGAATTGTACTTCAGAGAGG 
AGAAAAGCAGAGGAGCCCAGCAGCCTCCGTGTGTCAGAGAAGAATTGTACTTCAGAGAGG -R--
K--A--E--E--P--S--S--L--R--V--S--E--K--N--C--T--S--E--R- 
GATCTGAATATTCGGGTAACCGATGATGATATTAATGAAATAATCCAAATAGATGGAACC 
GATCTGAATATTCGGGTAACCGATGATGATATTAATGAAATAATCCAAATAGATGGAACC -D--
L--N--I--R--V--T--D--D--D--I--N--E--I--I--Q--I--D--G--T- 
GGCGATAACTCTTCTACTGAAGAGATGGGAAGTATAAGGGATGCAGATGAGAATGAATTC 
GGCGATAACTCTTCTACTGAAGAGATGGGAAGTATAAGGGATGCAGATGAGAATGAATTC -G--
D--N--S--S--T--E--E--M--G--S--I--R--D--A--D--E--N--E--F- 
CCAGGGATCATTGATGCCGGCGACCTCAATGTGCTTGAAGAAGTGGACAGCGTATCGAAT 
CCAGGGATCATTGATGCCGGCGACCTCAATGTGCTTGAAGAAGTGGACAGCGTATCGAAT -P--
G--I--I--D--A--G--D--L--N--V--L--E--E--V--D--S--V--S--N- 
GAAGATTCAACTGCAAATAGCAGCGACAACGAGGACCATCAAATAAATGCCCCAGAAGAG 
GAAGATTCAACTGCAAATAGCAGCGACAACGAGGACCATCAAATAAATGCCCCAGAAGAG -E--
D--S--T--A--N--S--S--D--N--E--D--H--Q--I--N--A--P--E--E- 
GATCCCCTAAATTCTGGCGATGATGTCAGTGAGCAGGATGTGCCAGACCTGTTTGATACA 
GATCCCCTAAATTCTGGCGATGATGTCAGTGAGCAGGATGTGCCAGACCTGTTTGATACA -D--
P--L--N--S--G--D--D--V--S--E--Q--D--V--P--D--L--F--D--T- 
GAGAATGTAATTGTCTGTCAGTATGATAAGATCCACCGGAGCAAGAACAGATGGAAATTC 
GAGAATGTAATTGTCTGTCAGTATGATAAGATCCACCGGAGCAAGAACAGATGGAAATTC -E--
N--V--I--V--C--Q--Y--D--K--I--H--R--S--K--N--R--W--K--F- 
TACTTGAAAGATGGTGTCATGTGCTTTGGAGGGAGAGACTACGTATTTGCCAAAGCCATT 
TACTTGAAAGATGGTGTCATGTGCTTTGGAGGGAGAGACTACGTATTTGCCAAAGCCATT -Y--
L--K--D--G--V--M--C--F--G--G--R--D--Y--V--F--A--K--A--I-  
GGTGAAGCTGAGTGGTAA 
GGTGAAGCTGAGTGGTAA -
G--E--A--E--W--*-  
 
 
Figure 7.23: DNA (top line) and transcript (middle line) sequences of Gtf2a1l  
 
gene and its corresponding peptide sequences (bottom line). The  
 
untranslated region of the transcript is highlighted yellow, exons are  
 
alternately coloured black and blue (and codons are alternately coloured pale  
 
yellow/black or blue). Taken from www.ensembl.org.  
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7.3.5.1 Amplification of Gtf2a1l by PCR and Cloning into the pET100/D-  
 
TOPO®  
 
 
PCR was performed on the genomic DNA for identification and cloning of the  
 
Gtf2a1l gene in open reading frame The PCR products for the pET100/D-  
 
TOPO® were amplified using the Pfu DNA polymerase (Promega), which  
 
resulted in blunt ended PCR products (Figure7.24).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.24: PCR amplification of Gtf2a1l product (1404 bp) the sample was  
 
subjected to electrophoresis through a 1.5 % w/v agarose gel in 1 X TBE  
 
with 1ug/ml ethidium bromide staining. The PCR reactions were 94°C  
 
(30sec), 62°C (30sec), 72°C (30sec) for 30 cycles. The primers were forward  
 
5´CACCATGGCCTTCATCAACCTG'3  and  reverse  5´  CCACTCAGCT-  
 
TCACCAATG'3. Lane 1 shows the DNA ladder. Lane 3 is a negative control  
 
containing no cDNA template. Lane 3 shows positive amplification of Gtf2a1l  
 
(1404 bp) product.  
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7.3.5.2 Confirmation of the Successful Cloning into pET100/D-TOPO®  
 
 
Plasmid DNA from five E. coli clones were obtained and screened for the  
 
presence of the Gtf2a1l gene using PCR (Figure 7.25). The plasmid DNA  
 
containing the Gtf2a1l gene was PCR amplified using the primers sets T7  
 
forward / native Gtf2a1l yielding fragments of 1404 bp, confirming that  
 
Gtf2a1l had been inserted into the vector. Correct orientation was confirmed  
 
by amplification with different primers (Figure 7.25).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
. 
 
 
Figure 7.25: Confirmation of successful insertion of the Gtf2a1l gene into  
 
PET100/D-TOPO. The samples were subjected to electrophoresis through a  
 
1% w/v agarose gel in 1X TBE with 1ug/ml ethidium bromide staining. Lane 1  
 
shows DNA ladder. Lane 2, 3, 4 and 5 shows PCR products generated  
 
confirmed successfully the correct orientation of the insert (1404bp).  
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7.3.5.3 Effect of ENU and MMS treatment on Gtf2a1l  
 
 
Real Time PCR was chosen as the technique to provide confirmation of the  
 
changes in Gtf2a1l gene expression that was seen after cells treated with  
 
different concentrations of both ENU and MMS compounds.  
 
 
There was no statistically significant difference in the levels of Gtf2a1l after  
 
1h of treatment with ENU or MMS (0.05 mM) compared with non-treated  
 
control cells. Statistical analysis showed a significant decrease in the level of  
 
expression of Gtf2a1l when cells treated with 0.5 mM ENU or MMS  
 
respectively (*p<0.05) and a further decrease was shown when the cells  
 
were treated with 1mM ENU or MMS (***p<0.001) these results are shown in  
 
Figures 7.26 (ENU) and 7.27 (MMS).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.26: Effect of ENU on the Gtf2a1l expression in DNA plasmids  
purified from the host cells BL21 (DE3) by qPCR after 1 h treatment at 37 ºC 
with ENU at different concentrations: 0.05 mM, 0.5 mM and 1 mM. Non- 
treated cells values were defined as 100% and other values were adjusted 
accordingly. Data are expressed as the mean ± SEM. n=3 different biological  
replicates performed on three different occasions (*p<0.05, **p<0.01).  
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Figure 7.27: Effect of MMS on the Gtf2a1l expression in DNA plasmids  
 
purified from the host cells BL21 (DE3) by qPCR after 1 h treatment at 37 ºC  
 
with MMS at different concentrations: 0.05 mM, 0.5 mM and 1 mM. Non-  
 
treated cells values were defined as 100% and other values were adjusted  
 
accordingly. Data are expressed as the mean ± SEM. n=3 different biological  
 
replicates performed on three different occasions (**p<0.01, ***p<0.001).  
 
 
 
7.3.5.4 Western Blot analysis of Purified Recombinant Protein of  
 
Gtf2a1l  
 
 
The Western blot of the Gtf2a1l His-tagged protein isolated under native  
 
condition was free of degradation products and showed that a high  
 
concentration of the protein was obtained at a molecular mass of  
 
approximately 55 kDa that was confirmed using an antibody directed at the  
 
histidine Tag as shown in 7.28, there was a major 55 kDa recombinant  
 
protein band corresponding to the 52 kDa Gtf2a1l fused with a 3kDa His-  
 
Tag. Furthermore, it showed that distinctive band at molecular masses of  
 
approximately 52 kDa that confirmed using anti-Gtf2a1l antibody as shown in  
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figure 7.29.The purification of protein from uninduced cells containing the  
 
pET100- Gtf2a1l plasmid shows no expression of the TbpI1 protein, showing  
 
that expression is controllable.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.28: Western blotting analysis of his tagged Gtf2a1l protein  
 
expressed in the pET vector systems. Lane 1 shows biotinylated protein  
 
Ladder. Lane 2 shows negative control of host strain without protein  
 
expression. Lane 3 Purified recombinant protein using his select spin column  
 
under native conditions from a 10 ml culture of expressed from the Gtf2a1l-  
 
PET100 induced with 1mM IPTG for 4 hours at 37 ºC. Expression of the  
 
fusion protein was tested by western blot analysis using a mouse specific  
 
antibody to his-tag as a primary antibody and HRP conjugated mouse as a  
 
secondary antibody.  
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Figure 7.29: Western blotting analysis of Gtf2a1l protein expressed in the  
 
pET vector systems. Lane 1 shows biotinylated protein Ladder. Lane 2  
 
shows negative control of host strain without protein expression. Lane 3  
 
shows purified recombinant protein using his select spin column under native  
 
conditions from a 10 ml culture of Gtf2a1l-PET100 induced with 1 mM IPTG  
 
for 4 hours at 37 ºC. Expression of the fusion protein was tested by Western  
 
blot analysis using a mouse anti-Gtf2a1l antibody as a primary antibody and  
 
HRP-conjugated anti-mouse IgG as a secondary antibody.  
 
 
 
To determine the effect of each ENU and MMS mutation on Gtf2a1l gene  
 
expression, Gtf2a1l was produced as recombinant proteins in E. coli. A  
 
Western blot analysis was performed for the samples taken at 1 h following  
 
ENU and MMS treatment for both ENU and MMS-treated and untreated  
 
control cultures, and the expression levels were compared. A Gtf2a1l protein  
 
that was differentially expressed in ENU and MMS-treated cells compared  
 
with the controls were considered to be meaningfully down-regulated by ENU  
 
and MMS treatment. Statistical analysis has shown that there was no  
 
significant effect on the expression level of Gtf2a1l protein when cells were  
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treated with a low concentration of ENU or MMS (0.05 mM). The  
 
concentrations of ENU or MMS 0.5 mM and 1 mM significantly decreased  
 
the Gtf2a1l protein levels compared with GAPDH (*p<0.05, **p<0.01and  
 
***p<0.01, respectively) results shown in Figure 7.30 A and B and 7.31 A and  
 
B.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.30: Western blot analysis of purified recombinant Gtf2a1l protein  
 
with Gtf2a1l antibody treated with ENU at different cocentrations, 1 h after  
 
treatment. Sample Western blots of Gtf2a1l and GAPDH proteins are shown  
 
in (A) and quantified summary data are shown in (B). The density of each  
 
band was quantified by the use of Image 1.45 software. The relative  
 
expression level of Gtf2a1l was measured by Gtf2a1l / GAPDH ratio. Data  
 
are expressed as the mean ± SEM. n=3 different replicates performed on  
 
three different occasions (*p<0.05, **p<0.01).  
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Figure 7.31: Western blot analysis of purified recombinant Gtf2a1l protein  
 
with Gtf2a1l antibody treated with MMS at different concentration at 1 h after  
 
the treatment. Sample Western blots of Gtf2a1l and GAPDH proteins are  
 
shown in (A) and quantified summary data are shown in (B). MMS treatment  
 
decreased Gtf2a1l protein level. The density of each band was quantified by  
 
the use of Image 1.45 software. The relative expression level of Gtf2a1l was  
 
measured by Gtf2a1l / GAPDH ratio. Data are expressed as the mean ±  
 
SEM. n=3 different biological replicates performed on three different  
 
occasions (*p<0.05, ***p<0.001).  
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7.4 Discussion  
 
 
The present study is aimed at the production and use of cDNA from testicular  
 
mRNA and PCR-amplification of the spermiogenesis-specific transcription  
 
factors Tbpl1, FHL5 and Gtf2a1l respectively, since it was shown in Chapter  
 
6 that, in spermatids particularly, they can be susceptible to genotoxins in a  
 
way that housekeeping genes are not. The TOPO system was used in the  
 
cloning of amplified Tbpl1, FHL5 and Gtf2a1l cDNAs into the expression  
 
vector pET100/D-TOPO in frame and directionally in order to ensure their  
 
expression. Primers were designed directly on the start and stop codons so  
 
that only the open reading frame could be amplified by PCR. The construct  
 
was sub cloned into E. coli and cultures exposed to the same genotoxins that  
 
were used in the equivalent experiments with isolated mouse testicular cells  
 
(chapter 6).  
 
 
The recombinant protein appeared to be associated with the insoluble  
 
membrane fraction of the recombinant E. coli and consequently was difficult  
 
to recover from the insoluble pellet. Yet, Western blot analysis of the purified  
 
protein confirmed that the expressed, purified protein was the desired  
 
proteins.  
 
 
To enable the recombinant construct of Tbpl1, FHL5 and Gtf2a1l proteins to  
 
be used for in vitro studies the Tbpl1, FHL5 and Gtf2a1l was first amplified by  
 
RT-PCR. The present study is aimed at the production of cDNA from  
 
testicular mRNA and PCR-amplification of the spermiogenesis-specific  
 
transcription factors Tbpl1, FHL5 and Gtf2a1l respectively and TOPO was  
 
used in the cloning of amplified Tbpl1, FHL5 and Gtf2a1l genes for further  
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sequence analysis. Once the sequences were established a strategy was  
 
devised in order to clone the Tbpl1, FHL5 and Gtf2a1l gene into the  
 
expression vector pET100/D-TOPO in frame and directionally in order to  
 
insure its expression. Primers were designed directly on the start and stop  
 
codon so that only the open reading frame can be amplified by PCR. Due to  
 
the error prone nature of Taq polymerase as compared to the proof reading  
 
Pfu polymerase, the latter was used in the Tbpl1, FHL5 and Gtf2a1l genes  
 
amplification for cloning into pET100/D-TOPO. This enzyme is characterized  
 
by a 3'-5' exonuclease activity that minimizes the possibility of inserting  
 
mutations during RT-PCR amplification. The current study demonstrated that  
 
the full open reading frames of the three transpiration factors TbpI1, FHL5  
 
and Gtf2a1l were successfully amplified using RT-PCR as shown in Figures  
 
7.4, 7.15 and 7.24 respectively). Moreover, the results showed that the  
 
TbpI1, FHL5 and Gtf2a1l PCR products were cloned successfully into the  
 
expression vector pET100/D-TOPO to enable the recombinant TbpI1, FHL5  
 
and Gtf2a1l proteins to be expressed as a fusion protein with an N-terminal  
 
HIS Tag. Furthermore, the confirmation of insertion of the PCR product of  
 
TbpI1, FHL5 and Gtf2a1l gene into PET100/D-TOPO was showed confirmed  
 
successfully in the correct orientation of the insert which was generated by  
 
different primers sets as shown in Figure 7.5, 7.16 and 7.25 respectively.  
 
The cloned Tbpl1, FHL5 and Gtf2a1l genes were successfully expressed as  
 
a 21, 32 and 52 kDa protein at high levels after induction with IPTG (Figures  
 
7.11, 7.19 and 7.29). The recombinant protein appeared to be associated  
 
with the insoluble membrane fraction of the recombinant E. coli and  
 
consequently was difficult to recover from the insoluble pellet. Yet, western  
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blot analysis of the purified protein confirmed that the expressed, purified  
 
protein was the desired proteins. As shown in (Figures 7.10, 7.20 and 7.28)  
 
the recombinant protein Tbpl1, FHL5 and Gtf2a1l of 21, 32 and 52 kDa on  
 
fusion with 3 KDa his tag increased their mass to 24, 35 and 55 kDa. These  
 
results showed that the expression of Tbpl1 studies by using standard  
 
techniques such as, RT-PCR demonstrated the presence of Tbpl1 in mouse  
 
testis. The fusion protein containing full-length Tbpl1 was expressed in the  
 
developing male germ cells and purified in E. coli (Martianov et al., 2001,  
 
Martianov et al., 2002). Furthermore, the expression studies utilizing  
 
standard techniques such as RT-PCR have previously confirmed that FHL5  
 
is present in the mouse testis (Palermo et al., 2001, Lardenois et al., 2009).  
 
Moreover, many studies have showed that Gtf2a1l is expressed in  
 
developing ale germ cells (Han et al., 2001, Han et al., 2004).  
 
 
Alkylating agents such as, ENU and MMS are electrophilic chemicals that  
 
can modify cellular macromolecules. Damage to both proteins and nucleic  
 
acids can be occurred after exposure to alkylating agents, due to alkylation  
 
of adenine, cytosine, and guanine bases in nucleic acids, and arginine,  
 
lysine, and cysteine residues in proteins these represents common sites of  
 
damage (Burgis and Samson, 2007). The baseline results in this study  
 
showed that recombinant DNA and recombinant protein of the three  
 
transcriptions factors Tbpl1, FHL5 and Gtf2a1l were detected in E. coli and  
 
found to be down regulated.  
 
 
QPCR data has showed ENU and MMS mutagenesis induced a significant  
 
decreased of the Tbpl1 level in DNA at 0.5 mM (p0.05). Following treatment  
 
with 1 mM ENU and MMS DNA Tbpl1level showed further significant  
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decreased the Tbpl1 DNA level in expression, which was statistically  
 
significant when compared with the corresponding controls (p  0.05, p0.01,  
 
Figure 7.8 and Figure 7.9). Western blot data has showed ENU and MMS  
 
mutagenesis induced a significant decreased of the expression protein level  
 
Tbpl1 at 0.5 mM (p 0.05). Following treatment with 1 mM ENU showed  
 
further significant decreased the of the expression protein level Tbpl1, which  
 
was statistically significant when compared with the corresponding controls  
 
(p 0.01, Figure 7.12 A and B). However, further decrease was shown when  
 
the cells were treated with MMS 1 mM (p0.001) these results are shown in  
 
Figure 7.13 A and B.  
 
 
From qPCR data, ENU and MMS mutagenesis induced a significant  
 
decrease of the FHL5 level in DNA at 0.5 mM (p0.05) as shown in Figure  
 
7.17 and 7.18. Following treatment with 1 mM ENU and MMS DNA FHL5  
 
level showed significant decreased the FHL5 DNA level in expression, which  
 
was statistically significant when compared with the corresponding controls  
 
(p0.05, p0.01) as shown in Figure 7.17 and 7.18. Western blot data has  
 
showed ENU and MMS mutagenesis induced a significant decreased of the  
 
expression protein level FHL5 at 0.5 mM (p 0.05, Figure 7.21 A and B,  
 
Figure 7.22 A and B).  Following treatment with 1 mM ENU and MMS  
 
showed further significant decreased the of the expression protein level Fhl5,  
 
which was statistically significant when compared with the corresponding  
 
controls (p 0.01, Figure 7.21 A and B, Figure 7.22 A and B). The level of  
 
Gtf2a1l was significantly decreased when cells were treated with ENU or  
 
MMS 0.5 mM (p 0.05 and p 0.01) Figures 7.26 and 7.27. Moreover, further  
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significant decreased was shown on the level of Gtf2a1l expression when the  
 
cells were treated with 1 mM (p0.01 and p0.001) Figures 7.26 and 7.27.  
 
 
Western blot data has showed ENU and MMS mutagenesis induced a  
 
significant decreased of the expression protein level Gtf2a1l at 0.5 mM (p  
 
0.05) Figures 7.30 A and B and 7.31 A and B. Following treatment with 1 mM  
 
ENU showed further significant decreased the of the expression protein level  
 
Gtf2a1l, which was statistically significant when compared with the  
 
corresponding controls (p 0.01) Figure 7.30 A and B. However, further  
 
decrease was shown when the cells were treated with MMS 1 mM (p0.001)  
 
Figure 7.31 A and B.  
 
 
In the current study, the data clearly showed that DNA and protein  
 
expression decreased with increased ENU or MMS. This result was  
 
consistent with evidence from the literature. It has been reported that  
 
alkylating agent caused damage in nucleic acids and proteins, thus  
 
promoting mutagenesis and cell death (Burgis and Samson, 2007, Smith and  
 
Grisham, 1983). However, functional and computational mapping of the  
 
alkylating agent toxicity modulating gene produces identified protein  
 
networks specific to transcription, mRNA processing, and translation has  
 
being vital after alkylation damage (Rooney et al., 2009)  
 
 
In vitro reconstruction of E.coli transcription initiation during this study  
 
demonstrates a general strategy for in vitro experimental reconstruction of a  
 
multi-component biological process. The strategy couples expression of  
 
multiple gene products with detection of the resulting biological activities in a  
 
reconstituted  protein  synthesis  system  and  allows  rapid  in  vitro  
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reconstruction of a functional biological complex or process from DNA  
 
templates instead of purified components.  
 
 
The results suggest that both ENU and MMS decreased level expression  
 
due to DNA alteration and decreased protein expression in a dose -  
 
dependent manner in E.coli. Moreover, Tbpl1, FHL5 and Gtf2a1l expression  
 
on treated with ENU and MMS was highly down-regulate so this suggests  
 
that the Tbpl1, FHL5 and Gtf2a1l appear essential for the progression of  
 
germ cells development and changes in the expression levels of Tbpl1, FHL5  
 
and Gtf2a1l in the treated samples lead us to believe that Tbpl1, FHL5 and  
 
Gtf2a1l may function in spermatogenesis.  
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Chapter 8. Discussion and future work  
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8.1 Discussion  
 
 
Male germ cell is a complex and ordered differentiation process that takes  
 
place continuously in adult organisms. In mammals, spermatogenesis occurs  
 
in the seminiferous epithelium under complex endocrine control.  A 
 
spermatogonial stem cell population undergoes self-renewal and gives rise  
 
to primary spermatocytes followed by a major biochemical and structural  
 
reorganization of the haploid cells to generate maturation-phase elongating  
 
spermatids (White-Cooper and Davidson, 2011, de Rooij, 2001). This  
 
process is regulated by complex regulatory program leading the expression  
 
of  specific  sets  of  genes  at  various  developmental  stages  of  
 
spermatogenesis. In mouse, a first set of germ cell specific genes are  
 
expressed in pachytene spermatocytes followed by a second wave of  
 
postmeiotic transcription in round spermatids where most genes required for  
 
morphological and biochemical reprogramming are expressed (Sassone-  
 
Corsi, 2002). Male germ cells are well known to be susceptible to  
 
environmental factors, such as free radicals, anticancer alkylating agents,  
 
radiation, reproductive and somatic pathologies, and by endogenous factors,  
 
such as genetic predisposition and stress, which can result in an increase in  
 
the constitutive levels of apoptosis, DNA repair, cell cycle arrest, mutation or  
 
unrepaired genetic damage in germ cells (Tripathi et al., 2009, Lagos-Cabre  
 
and Moreno, 2012). Despite current advances in the study of male germ cells  
 
in terms of genetics and development, our understanding of the effect of  
 
toxins on specific cell types has been largely limited to what can be achieved  
 
by, often cumbersome, in vivo studies to make such distinctions. The results  
 
presented here demonstrate that a suspension of mouse germ cells obtained  
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from testicular tissue and fractionated into large, almost homogeneous  
 
populations of spermatogonia, spermatocytes, spermatids and spermatozoa  
 
using staput Velocity Sedimentation at unit gravity. Validation of the system  
 
involved using immunohistochemistry to deter-mine the purity of the cells  
 
populations isolated by Staput (Bellve et al., 1977), using antibodies against:  
 
TP1 to detect spermatids; SCP3 to detect spermatocytes; and GDNFR to  
 
detect spermatogonia. TP1 is an important nuclear protein in spermatids as  
 
histones are replaced by protamines during spermiogenesis. Its specificity to  
 
the haploid phase of spermatogenesis makes it a useful marker for  
 
spermatids (Meistrich et al., 1994a). Spermatocytes can be located by the  
 
presence of synaptonemal complex protein 3 (SCP 3). Synaptonemal  
 
complexes are structures formed between homologous chromosomes during  
 
meiotic pro-phase, thought to be involved in chromosome pairing and  
 
recombination (Dobson et al., 1994b, Lammers et al., 1995). Spermatogonia  
 
can be labeled by Glial cell line-derived neurotrophic factor receptor  
 
(GDNFR). Sertoli cells secrete a ligand to GDNFR called GFR-1 (Viglietto  
 
et al., 2000). The binding of this substrate-ligand complex activates the Ret  
 
receptor tyrosine kinase (Tadokoro et al., 2002b). This mediates an  
 
intracellular response that is linked to the proliferation of an undifferentiated  
 
type A spermatogonium and is therefore considered a good marker for these  
 
types of spermatogonia (Meng et al., 2000).  
 
 
Hydrogen peroxide (H2O2) has been found to induce apoptosis in a diversity  
 
of cells and although the sensitivity of germ line cells to H2O2 is not fully  
 
understood, DNA strand breakage by the production of free radicals is the  
 
trigger for the programmed cell death. The results of the present study show  
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that H2O2, even at a low concentration of H2O2 of 1M, has the ability to  
 
induce apoptosis in testicular germ cells in vitro. Furthermore, statistically  
 
significant differences were observed between DNA strand breaks in  
 
spermatogonial cells incubated with ENU and MNU cells showed significantly  
 
increased in apoptotic cells in spermatogonia. These results showed  
 
similarities to studies by Russell et al., (2007) who also found genetic  
 
damage in spermatogonia when treated with ENU and MNU but in vivo, and  
 
(Verhofstad et al., 2011) who found ENU and MNU to be highly mutagenic in  
 
the rodent germline. The present work also supports an early study that  
 
showed 6-MP be the most potent chemical for inducing DNA damage in  
 
spermatocytes (Mosesso and Palitti, 1993) and one 10 years later that  
 
showed that spermatocytes was highly sensitive to 5-BrdU (Perrard et al.,  
 
2003). Likewise, the results are in agreement with those indicating that  
 
quantitative evaluation of germ cells treated with MMS showed a decrease in  
 
the number of spermatids and high frequency of chromosome aberrations  
 
induced in spermatids (Kuriyama et al., 2005, Matsuda et al., 1989). This is  
 
in line with what has been reported previously, demonstrating concordance  
 
between our approach to preparing testicular germ cells and previous  
 
methodologies (Maheshwari et al., 2009). Thus, it is highly likely that the  
 
methodology developed here has the potential to enable the rapid screening  
 
of chemicals for male reproductive genetic toxicity and reduce dependence  
 
 
on animal-intensive time-consuming in vivo studies. The results with H2O2  
 
and doxorubicin also demonstrate that the spermatogonia was significantly  
 
more affected than the spermatocytes, which in turn were significantly more  
 
affected than spermatids. This correlates with the proportion of dividing cells  
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expected to be present in these populations. Thus, if dividing cells are more  
 
susceptible to genetic damage than non-dividing cells, this could account for  
 
the lowest amount of apoptosis occurring in the latter population. Indeed,  
 
there are a number of different types of cells within spermatogonia,  
 
spermatocytes and spermatids, each of which could have different  
 
susceptibilities to genetic damage, depending on which phase of the cell  
 
cycle they represent.  
 
 
It is well recognized that doxorubicin induces apoptosis in early  
 
spermatogonia, which results in a decrease in the size of the pool of  
 
germline stem cells (Holm et al., 2009, Hou et al., 2005). These cells are  
 
extremely vulnerable to cytotoxic effects due to their rapid proliferation,  
 
whereas the non-proliferating cells survive most of the cytotoxic therapies,  
 
although they could suffer functional damage (Wang et al., 1998). The  
 
findings of the present study showed a statistically significant minor effect of  
 
the doxorubicin on germ cells. These results suggest that the initiation phase  
 
of spermatogenesis is highly sensitive to doxorubicin-induced apoptosis. The  
 
observations confirm the genotoxic capacity of doxorubicin as previously  
 
demonstrated by other authors using rat testes, suggests that the initiation  
 
phase of spermatogenesis is especially sensitive to the toxic effects of this  
 
compound (Hou et al., 2005). Moreover, a previous study has also  
 
demonstrated testicular vulnerability to the toxicity of doxorubicin at critical  
 
stages of maturation (Bechter et al., 1987) and recent research has also  
 
established its serious impact on spermatogenesis. Alkylating agent  
 
exposure resulted in a substantial decrease in gene expression, in  
 
spermatocytes and spermatids. Cytotoxic effects are exerted by the transfer  
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of the alkyl group(s) to many cellular constituents; however, DNA alkylation  
 
events during the nucleus may be the major changes that lead to cell death  
 
(Shiraishi et al., 2000). It also can be lead to DNA repair, mutation,  
 
persistence of unrepaired DNA damage, cell cycle arrest. Altered  
 
transcription patterns may be a new response to genotoxicity. RT-PCR was  
 
used to detect the expression of transcripts factor of TbpI1, FHL5 and  
 
Gtf2a1I selected genes in two types of germ cells, and found that the  
 
transcripts were highly expressed in spermatocytes and spermatids. The  
 
results agree with the observations of Martianov et al., 2001; and Zhang et  
 
al., 2001a, who found that TbpI1 is strongly upregulated with the appearance  
 
of spermatocytes and spermatids (Martianov et al., 2001, Zhang et al.,  
 
2001). They also support the expression of FHL5 highly specifically in  
 
spermatocytes and spermatids (Steger et al., 2004, De Cesare et al., 2003).  
 
Lastly, the results also agree with the observations by Han et al and Huang  
 
et al, (2001 and 2006). Who showed that Gtf2a1I mRNA is present in mouse  
 
spermatocytes and spermatids (Han et al., 2001, Huang et al., 2006),  
 
abnormal sperm formation (Huang et al., 2006). Thus, the use of RT-qPCR  
 
in isolated cells appears to give the same result as the equivalent in vivo  
 
studies. The present work also shows that treating spermatocytes and  
 
spermatids isolated by staput with ENU and MMS reduced the effect on  
 
mRNA level and proteins of TbpI1, FHL5 and Gtf2a1I. Therefore, it is  
 
proposed that consideration be given to investigating mRNA and protein  
 
production in routine genotoxicity studies.  
 
 
Interestingly, it was found that mRNA levels and proteins were more affected  
 
by MMS and ENU in spermatids than in spermatocytes. This is probably  
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unlikely to be due to the mutational susceptibility of the different germ cell  
 
types because the spermatids were still more heavily affected than the  
 
spermatocytes, even when a spermatogonial toxin (ENU) was used. (Work in  
 
Chapter 5 shows that in terms of apoptosis induction and Comet assay, the  
 
order of susceptibility was reversed and spermatids were the least  
 
susceptible cell type to ENU). This might be due to high sensitivity of the  
 
postmeiotic period to mutagenic exposure which has been found associated  
 
with the reduced DNA repair capacity, recombination and the types of  
 
chromosome-associated  proteins  and  the  extent  of  chromosomal  
 
condensation  of  late  spermatids  and  sperm  as  compared  other  
 
spermatogenic cell types (Singer et al., 2006, Sega, 1974, Olsen et al.,  
 
2005). Functional and computational mapping of the alkylating agent toxicity  
 
modulating  gene  produces  identified  protein  networks  specific  to  
 
transcription, mRNA processing, and translation as being vital after alkylation  
 
damage (Rooney et al., 2009).  
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8.2 Future work  
 
 
Staput separation of specific germ cell types, coupled with short term in vitro  
 
culture shows potential for the rapid assessment of toxins in multiple germ  
 
cell types with high sensitivity. Particularly, it allows the examination of high  
 
numbers of cells for example spermatogonia, which are normally present in  
 
relatively low amounts in vivo, compared with spermatocytes and  
 
spermatids. Therefore further work should focus on developing this as a  
 
viable assay for reproductive genetic toxicology. The addition of flow  
 
cytometry to sort and purify cells and to detect apoptotic cells would  
 
dramatically enhance the efficiency of such an assay. Many of the results of  
 
this study were in agreement with other studies in that a decrease in germ  
 
 
cells viability was observed when cells were treated with H2O2, doxorubicin,  
 
N-ethyl-N-nitrosourea,  N-methyl-N-nitrosourea,  6-mercaptopurine,  5-  
 
bromodeoxyuridine, Methyl methanesulfonate and Ethyl methanesulfonate.  
 
The results also suggest that these compounds increase apoptosis in male  
 
germ cells types. Male germ cells types in a dose-dependent manner. More  
 
studies are needed to fully understand the mechanism of this action and to  
 
assess the effect of genotoxicity and in the extrinsic and intrinsic pathways of  
 
apoptosis.  
 
 
Caspases are central components for apoptosis. Caspases involved in  
 
apoptosis are generally divided into two groups, the initiator caspases, which  
 
include caspase-2, -8, -9, and -10, and the effector caspases, which include  
 
caspase-3, -6, and -7. It will be useful to assess the capacity of this toxicity to  
 
activate the caspases. Changes in levels of caspase expression can be  
 
measured using Western blotting and changes in activity by specific ELISAs.  
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These experiments will clarify which caspases important in apoptosis are  
 
modulated by toxins. Also in parallel with this, it will be useful to compare  
 
other compounds which play an important role in modulating the apoptosis  
 
pathways such as cytochrome c, BAX and BAD. Activation of the extrinsic  
 
apoptosis pathway may also be a mechanism of toxicity drugs action to  
 
induce apoptosis. This pathway is commonly activated by death receptors.  
 
Death receptors may be activated directly by the toxicity or their bioactive  
 
mediators. This could be assessed by treating the male germ cells with  
 
toxicity in the presence and absence of specific inhibitors of the death  
 
receptors. A better understanding of how toxicity modulates apoptosis may  
 
help to explain the mechanisms of  act ion for this toxic ity in the  
 
spermatogenesis and in turn help refine future assays.  
 
 
The intracellular concentration of ROS appears to dictate stress survival  
 
apoptotic responses. Low levels of ROS are used during the cells as  
 
signalling intermediates for normal homeostasis. However, high levels of  
 
ROS directly damages cellular structural components and can induce  
 
apoptosis. Furthermore, it has been reported that certain toxins such as  
 
doxorubicin can produce ROS resulting in the formation of free radicals  
 
leading to induced apoptosis and prevention of the growth of cancer cells.  
 
This mechanism can be followed by co-treating the germ cells with anti-  
 
oxidants such as vitamin C or superoxide dismutase. If antioxidants could be  
 
upregulated in normal cells but not cancer cells, this could then be utilised to  
 
prevent some of the adverse effects of anti-cancer drugs.  
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